Home Cart Sign in  
Chemical Structure| 85622-93-1 Chemical Structure| 85622-93-1

Structure of Temozolomide
CAS No.: 85622-93-1

Chemical Structure| 85622-93-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Temozolomide is a DNA-methylating agent and an alkylating cytostatic drug used in the treatment of some brain cancers, astrocytoma and glioblastoma multiforme.

Synonyms: NSC 362856; CCRG 81045; MB 39831

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Marlhoux, Léna ; Arnaud, Alexandre ; Hervieu, Céline ; Makulyte, Gabriela ; Martinasso, Charlotte ; Mularoni, Angélique , et al.

Abstract: Casein kinase 2 (CK2) has emerged as a promising therapeutic target across a broad spectrum of malignancies, including pediatric and orphan cancers. The identification of a ligandable allosteric αD pocket on the CK2α subunit has enabled the development of bivalent inhibitors, which bind simultaneously to both the (ATP) site and the allosteric pocket. Here, we report the discovery and pharmacological characterization of KDX1381, a structure-guided bivalent CK2α inhibitor with low-nanomolar potency and high selectivity, confirmed by cocrystal structures. In mice, KDX1381 suppressed CK2-driven tumor growth as a monotherapy and enhanced therapeutic efficacy when combined with vascular endothelial growth factor receptor (VEGFR) inhibitors or DNA-damaging agents in hepatocellular carcinoma and glioma models. These findings support bivalent CK2α inhibition as a differentiated therapeutic strategy with broad applicability in CK2-dependent cancers.

Ingraham, Charles H. IV ; Stalinska, Joanna ; Carson, Sean C. ; Colley, Susan B. ; Rak, Monika ; Lassak, Adam , et al.

Abstract: Glioblastomas are highly aggressive brain tumors for which therapeutic options are very limited. In a quest for new anti-glioblastoma drugs, we focused on specific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common lipid-lowering drug, fenofibrate, and in our first prototype glioblastoma drug, PP1. Here, we propose extensive computational analyses to improve the selection of the most effective glioblastoma drug candidates. Initially, over 100 structural BPA variations were analyzed and their physicochemical properties, such as water solubility (- logS), calculated partition coefficient (ClogP), probability for BBB crossing (BBB_SCORE), probability for CNS penetration (CNS-MPO) and calculated cardiotoxicity (hERG), were evaluated. This integrated approach allowed us to select pyridine variants of BPA that show improved BBB penetration, water solubility, and low cardiotoxicity. Herein the top 24 compounds were synthesized and analyzed in cell culture. Six of them demonstrated glioblastoma toxicity with IC50 ranging from 0.59 to 3.24 µM. Importantly, one of the compounds, HR68, accumulated in the brain tumor tissue at 3.7 ± 0.5 µM, which exceeds its glioblastoma IC50 (1.17 µM) by over threefold.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; 2706-56-1 ; ; ; ; ; ; ; ; 20173-24-4 ; ; ; ; ; ; ; ; 42017-89-0 ; 90-45-9

Alternative Products

Product Details of Temozolomide

CAS No. :85622-93-1
Formula : C6H6N6O2
M.W : 194.15
SMILES Code : C1=NC(=C2[N]1C(N(C)N=N2)=O)C(N)=O
Synonyms :
NSC 362856; CCRG 81045; MB 39831
MDL No. :MFCD00866492
InChI Key :BPEGJWRSRHCHSN-UHFFFAOYSA-N
Pubchem ID :5394

Safety of Temozolomide

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H319-H335-H340-H350-H401-H411
Precautionary Statements:P201-P202-P261-P264-P270-P271-P273-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P308+P313-P332+P313-P337+P313-P403+P233-P405-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of Temozolomide

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 cells >800 μM(IC50) 7 days Evaluate the anticancer activity of TMZ in HCT116 cells ACS Chem Biol. 2022 Feb 18;17(2):299-313
T98G cells >550 μM(IC50) 7 days Evaluate the anticancer activity of TMZ in T98G cells ACS Chem Biol. 2022 Feb 18;17(2):299-313
HG11R cells 100 μM TMZ 72 hours Evaluate the effect of Linc00942 knockout on TMZ sensitivity, results showed decreased IC50 after knockout Adv Sci (Weinh). 2024 Nov;11(44):e2402600.
HG7R cells 100 μM TMZ 72 hours Evaluate the effect of Linc00942 knockout on TMZ sensitivity, results showed decreased IC50 after knockout Adv Sci (Weinh). 2024 Nov;11(44):e2402600.
U251R cells 100 μM TMZ 72 hours Evaluate the effect of Linc00942 knockout on TMZ sensitivity, results showed decreased IC50 after knockout Adv Sci (Weinh). 2024 Nov;11(44):e2402600.
LN229R cells 100 μM TMZ 72 hours Evaluate the effect of Linc00942 knockout on TMZ sensitivity, results showed decreased IC50 after knockout Adv Sci (Weinh). 2024 Nov;11(44):e2402600.
U87-MG cells 100μM 48 hours To study the effect of TMZ on the p38-MK2-RSK-EphA2 axis, results showed TMZ activated MK2 and enhanced the RSK-EphA2 axis. J Biol Chem. 2023 May;299(5):104699
Human U251 glioma cells 155 μM 1-3 days Inhibited the migration of human U251 glioma cells Molecules. 2022 Aug 5;27(15):4988.
GBM cells 250 μM 5 days To test the effect of TMZ on GBM cells, results showed that qGBM cells exhibited higher resistance to TMZ. EBioMedicine. 2019 Apr;42:252-269.
Human U251 glioma cells 155 μM 1-3 days Inhibited the clonogenic capability of human U251 glioma cells Molecules. 2022 Aug 5;27(15):4988.
GL26 cells 200 μM 48 h To assess HMGB1 release from GL26 cells after temozolomide treatment, results showed significant increase in HMGB1 release. PLoS Med. 2009 Jan 13;6(1):e10.
LLc1 cells 200 μM 48 h To assess HMGB1 release from LLc1 cells after temozolomide treatment, results showed significant increase in HMGB1 release. PLoS Med. 2009 Jan 13;6(1):e10.
GL261 cells 200 μM 48 h To assess HMGB1 release from GL261 cells after temozolomide treatment, results showed significant increase in HMGB1 release. PLoS Med. 2009 Jan 13;6(1):e10.
B16-F10 cells 200 μM 48 h To assess HMGB1 release from B16-F10 cells after temozolomide treatment, results showed significant increase in HMGB1 release. PLoS Med. 2009 Jan 13;6(1):e10.
SHSY5Y-Luc 868.1 μM 24 h and 72 h To evaluate the growth inhibitory effect of Temozolomide alone or in combination with idasanutlin on neuroblastoma cells, showing that Temozolomide in combination with idasanutlin has a synergistic effect. Int J Cancer. 2019 Jun 15;144(12):3146-3159.
NB1691-Luc 868.1 μM 24 h and 72 h To evaluate the growth inhibitory effect of Temozolomide alone or in combination with idasanutlin on neuroblastoma cells, showing that Temozolomide in combination with idasanutlin has a synergistic effect. Int J Cancer. 2019 Jun 15;144(12):3146-3159.
LLC-PK1 cells 40 μg/ml 2 h To study P-gp-mediated transport of Temozolomide, results showed very limited transport by P-gp. Neoplasia. 2018 Jul;20(7):710-720.
MDCKII cells 40 μg/ml 2 h To study Bcrp1-mediated transport of Temozolomide, results showed clear vectorial transport by Bcrp1. Neoplasia. 2018 Jul;20(7):710-720.
GBM12 cells 1 µM and 3 µM 14 days Evaluate the combination effect of rucaparib and TMZ, results showed that rucaparib significantly enhanced the efficacy of TMZ Mol Cancer Ther. 2015 Dec;14(12):2735-43.
LN229, U251HF, A172 0.1 – 0.8 μM 24–96 h To evaluate the anti-proliferative effects of Onalespib in combination with Temozolomide on glioma cells, results showed synergistic or additive effects. Clin Cancer Res. 2017 Oct 15;23(20):6215-6226.
GL261 cells 100, 300, 500 μM 8 h Detection of O6-methyl-2′-deoxyguanosine or O6-propargyl-2′-deoxyguanosine formation. A dose-dependent increase in O6-Me-dG was observed in TMZ-treated cells, while no O6-Prop-dG was detected in CPZ-treated cells. ACS Chem Biol. 2022 Feb 18;17(2):299-313

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Orthotopic GBM model Intraperitoneal injection 60 mg/kg TMZ Every 7 days Validate the effect of Linc00942 overexpression on TMZ resistance, results showed significant inhibition of TMZ efficacy in overexpressing cells Adv Sci (Weinh). 2024 Nov;11(44):e2402600.
BALB/c nude mice Intracranial glioblastoma xenograft model Oral gavage 5 mg/kg Not specified To evaluate the inhibitory effect of Cobicistat (CYP3A5 inhibitor) on glioblastoma growth. Results showed that the combination of Cobicistat and TMZ significantly suppressed tumor growth and prolonged mouse survival. J Exp Clin Cancer Res. 2025 Jan 3;44(1):3
Nude mice Intracranial injection of MES28 or U87 cells Intraperitoneal injection 20 mg/kg 5 consecutive days Evaluate the effect of HPRT1 depletion on TMZ treatment sensitivity, showing that HPRT1 depletion significantly enhanced TMZ's inhibitory effect on brain tumors and extended survival time. Nat Commun. 2023 Sep 22;14(1):5913
Nude mice Human nonsmall cell lung cancer xenograft model Intraperitoneal injection 150 mg/kg Once daily for 5 consecutive days To evaluate the antitumor effect of temozolomide in combination with methoxyamine. The results showed that the combination significantly enhanced the antitumor activity of temozolomide. Cell Death Dis. 2012 Jan 12;3(1):e252
Mice Glioblastoma xenograft model Oral 50 mg/kg Daily for 5 days To evaluate the therapeutic effect of TMZ on glioblastoma, results showed that both TMZ monotherapy and RT/TMZ combination therapy extended survival, and MGMT promoter methylation was associated with treatment response. Clin Cancer Res. 2020 Mar 1;26(5):1094-1104
Mice TP53wt neuroblastoma model Oral 34 mg/kg Daily for 5 days, over 3 weeks To evaluate the effect of Temozolomide alone or in combination with RO6839921 on tumor growth inhibition and lifespan extension in neuroblastoma models, showing that combination therapy has stronger tumor growth inhibition and lifespan extension effects compared to Temozolomide alone. Int J Cancer. 2019 Jun 15;144(12):3146-3159.
Mice WT, Abcg2−/−, Abcb1a/b−/−and Abcb1a/b;Abcg2−/−mice Intravenous injection in the tail vein 50 mg/kg Single dose To study the impact of P-gp and BCRP on the brain distribution of Temozolomide, results showed that Abcb1a/b;Abcg2?/?mice accumulated 50% more drug in the brain compared to WT mice. Neoplasia. 2018 Jul;20(7):710-720.
Mice GBM12 flank xenograft model Oral and intraperitoneal injection 50 mg/kg Days 1-5 every 28 days × 3 cycles Evaluate the combination effect of rucaparib and TMZ, results showed that rucaparib significantly prolonged the time to tumor regrowth Mol Cancer Ther. 2015 Dec;14(12):2735-43.
Zebrafish Zebrafish glioma model Fish water 10 μM 5 days To evaluate the anti-tumor effects of Onalespib in combination with Temozolomide in a zebrafish glioma model, results showed significant reduction in tumor burden and extended survival. Clin Cancer Res. 2017 Oct 15;23(20):6215-6226.
Mice Mice Intravenous injection 25 mg/kg Single dose Evaluate the BBB permeability of TMZ ACS Chem Biol. 2022 Feb 18;17(2):299-313

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00611247 Leukemia, Myeloid PHASE2 COMPLETED 2025-01-10 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less <<
NCT00611247 Leukemia, Myeloid PHASE2 COMPLETED 2025-01-10 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less <<
NCT00869050 Neuroendocrine Tumors Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00869050 - Completed - -
NCT00389090 Glioma Astroc... More >>ytoma Oligodendroglioma Oligoastrocytoma Less << Phase 2 Terminated(AOI Pharma terminat... More >>ed the license agreement. IND Transferred to NCI) Less << - United States, California ... More >> AOI Pharmaceuticals Investigative Site Los Angeles, California, United States, 90033 United States, Florida AOI Pharmaceuticals Investigative Site Orlando, Florida, United States, 32804 United States, Illinois AOI Pharmaceuticals Investigative Site Chicago, Illinois, United States, 60611 AOI Pharmaceuticals Investigative Site Evanston, Illinois, United States, 60201 United States, Kentucky AOI Pharmaceuticals Investigative Site Lexington, Kentucky, United States, 40536 AOI Pharmaceuticals Investigative Site Louisville, Kentucky, United States, 40202 United States, Minnesota AOI Pharmaceuticals Investigative Site Minneapolis, Minnesota, United States, 54407 United States, North Carolina AOI Pharmaceuticals Investigative Site Durham, North Carolina, United States, 27710 United States, South Carolina AOI Pharmaceuticals Investigative Site Greenville, South Carolina, United States, 29605 United States, Texas AOI Pharmaceuticals Investigative Site Dallas, Texas, United States, 75246 AOI Pharmaceuticals Investigative Site Houston, Texas, United States, 77024 United States, Utah AOI Pharmaceuticals Investigative Site Salt Lake City, Utah, United States, 84132 Less <<
NCT00704080 Mixed Gliomas ... More >> Malignant Gliomas Glioblastoma Multiforme Less << Phase 1 Completed - United States, Alabama ... More >> Investigational Site Number Birmingham, Alabama, United States, 35205 United States, California Investigational Site Number Los Angeles, California, United States, 90024 United States, Massachusetts Investigational Site Number Boston, Massachusetts, United States, 02115 United States, New York Investigational Site Number New York, New York, United States, 10021 Investigational Site Number Rochester, New York, United States, 14642 United States, Ohio Investigational Site Number Cleveland, Ohio, United States, 44195 Less <<
NCT00098865 Central Nervous System Tumor, ... More >>Pediatric Neuroblastoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02477813 Small Cell Lung Cancer Recurre... More >>nt Less << PHASE2 TERMINATED 2025-06-18 Ircc Irst, Meldola, FC, 47014,... More >> Italy|Oncologia Medica, Azienda ospedaliera universitaria di Ferrara, Ferrara, FE, 44124, Italy|Oncologia Medica AOU Policlinico di Modena, Modena, MO, 41100, Italy|U.O. Oncologia Medica, Faenza, RA, 48018, Italy|U.O Oncologia medica, Lugo, RA, 48022, Italy|UO Oncologia Medica, Ospedale S.Maria delle Croci, Ravenna, RA, 48121, Italy|U.O Oncologia medica, Rimini, RN, 47923, Italy|Oncologia Medica Ospedale Guglielmo da Saliceto, Piacenza, 29121, Italy Less <<
NCT00098865 - Completed - -
NCT00883298 Recurrent Glioblastoma Multifo... More >>rme Recurrent Gliosarcoma Less << Phase 2 Completed - United States, Arizona ... More >> Center for Neurosciences Tucson, Arizona, United States, 85718 Less <<
NCT00632203 Carcinoma, Non-Small-Cell Lung... More >>|Adenocarcinoma|Carcinoma, Large Cell|Carcinoma, Squamous Cell Less << PHASE2 TERMINATED 2011-01-07 -
NCT01550224 Acute Myeloid Leukemia With 11... More >>q23-abnormality in Relapse Less << Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT02928575 Glioblastoma Multiforme Phase 2 Unknown June 2017 Canada, Alberta ... More >> Tom Baker Cancer Center and University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Jacob Easaw, MD PhD FRCPC    403-521-3446    Jay.Easaw@albertahealthservices.ca    Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Bassam Abdulkarim, MD PhD FRCPC    514-934-1934 ext 43915    bassam.abdulkarim@mcgill.ca Less <<
NCT00501891 Glioblastoma Multiforme Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center (Brain Tumor Center) Durham, North Carolina, United States, 27710 Less <<
NCT01550224 - Completed - -
NCT03749187 Glioblastoma ... More >>IDH1 Gene Mutation IDH2 Gene Mutation Low Grade Glioma Malignant Glioma Recurrent Glioblastoma Recurrent WHO Grade II Glioma Recurrent WHO Grade III Glioma WHO Grade II Glioma WHO Grade III Glioma Less << Phase 1 Not yet recruiting July 2027 -
NCT00501891 - Completed - -
NCT03156036 Advanced Rectal Cancer Phase 2 Recruiting February 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa, Korea, Republic of, 05505 Contact: Yong Sang Hong, M.D., Ph.D.    +82-2-3010-3227    yshong@amc.seoul.kr    Contact: Tae Won Kim, M.D., Ph.D.    +82-2-3010-3910    twkimmd@amc.seoul.kr Less <<
NCT02337426 Adult Brain Glioblastoma ... More >> Adult Giant Cell Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00990652 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00632203 Carcinoma, Non-Small-Cell Lung... More >>|Adenocarcinoma|Carcinoma, Large Cell|Carcinoma, Squamous Cell Less << PHASE2 TERMINATED 2011-01-07 -
NCT00990652 - Completed - -
NCT02395692 Adult Brain Glioblastoma Phase 2 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Henry Ford Cancer Institute¿Downriver Brownstown, Michigan, United States, 48183 Henry Ford Hospital Detroit, Michigan, United States, 48202 Henry Ford West Bloomfield Hospital West Bloomfield, Michigan, United States, 48322 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01189643 Sarcoma Desmo... More >>plastic Small Round Cell Tumor (DSRCT) Less << Early Phase 1 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01180816 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 1 Active, not recruiting December 2018 United States, New York ... More >> Lenox Hill Brain Tumor Center New York, New York, United States, 10065 Less <<
NCT00362817 - Completed - -
NCT01009788 Breast Cancer ... More >> Metastatic Breast Cancer BRCA1 Gene Mutation brca2 Gene Mutation Less << Phase 2 Active, not recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00266812 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(Patient target coul... More >>d not be reached within the planned timeframe.) Less << - -
NCT03672773 Recurrent Extensive Stage Smal... More >>l Cell Lung Carcinoma Refractory Extensive Stage Small Cell Lung Carcinoma Less << Phase 2 Not yet recruiting November 1, 2020 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90095 Contact: Jonathan W. Goldman    310-633-8400    jwgoldman@mednet.ucla.edu    Principal Investigator: Jonathan W. Goldman Less <<
NCT02530502 Adult Glioblastoma Phase 1 Phase 2 Active, not recruiting November 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03204019 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 2 Recruiting September 2018 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi       yihebalichi@yahoo.com.cn Less <<
NCT00313729 CNS Tumor, Adult Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00362817 Brain Tumor B... More >>rain Metastases Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00590681 Glioblastoma Multiforme Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 NorthShore University health system Evanston, Illinois, United States, 60201 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48103 United States, Wisconsin Medical college of Wisconsin Milwaukee, Wisconsin, United States, 53226 Waukesha health care Waukesha, Wisconsin, United States, 53188 Less <<
NCT03011671 Malignant Glioma of Brain Phase 1 Not yet recruiting March 2020 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Bakhtiar Yamini, MD       byamini@surgery.bsd.uchicago.edu Less <<
NCT00266812 - Terminated(Patient target coul... More >>d not be reached within the planned timeframe.) Less << - -
NCT03363659 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 2 Recruiting January 21, 2027 United States, Wisconsin ... More >> Aurora Health Care, Aurora St. Luke's Medical Center Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Lynda Yanny    414-649-6685    lynda.yanny@aurora.org    Principal Investigator: George Bobustuc, MD          Sub-Investigator: Richard A Rovin, MD          Sub-Investigator: Asad Khan, MD          Sub-Investigator: Amin Kassam, MD          Sub-Investigator: Santhi Konduri, PhD Less <<
NCT00576680 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00792012 Glioblastoma Multiforme Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT02689336 Glioma Rhabdo... More >>myosarcoma Osteosarcoma Medulloblastoma Neuroectodermal Tumor Ependymoma Ewing's Sarcoma Wilms Tumor Less << Phase 2 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Alok Kothari, M.D.    314-454-6018    alok@wustl.edu    Principal Investigator: Alok Kothari, M.D. Less <<
NCT03535350 Glioblastoma Phase 1 Recruiting April 1, 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet S. Ahluwalia, MD, FACP    216-444-6145    ahluwam@ccf.org Less <<
NCT00012116 Metastatic Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00687323 Leukemia, Acute Myeloid ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - -
NCT00687323 - Completed - -
NCT00841555 Glioblastoma Multiforme/Anapla... More >>stic Astrocytoma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00597493 - Completed - -
NCT03466450 Glioblastoma Phase 1 Phase 2 Recruiting March 2021 Spain ... More >> Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Carmen Balañá, M.D.    +34 972 22 58 34    cbalana@iconcologia.net    Principal Investigator: Carmen Balañá, M.D.          Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta Recruiting Girona, Spain, 17007 Contact: Sonia del Barco, M.D.    +34 972 22 58 34 ext 7977    sdelbarco@iconcologia.net    Principal Investigator: Sonia del Barco, M.D.          Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain Contact: Mª Ángeles Vaz    91 336 80 00 ext 7977    mavaz4@gmail.com    Principal Investigator: Mª Ángeles Vaz, M.D.          Hospital Universitario y Politécnico La Fe Recruiting Valencia, Spain, 46009 Contact: José Muñoz Langa, M.D.    +34 934344412    munyoz_joslan@gva.es    Principal Investigator: José Muñoz Langa, M.D. Less <<
NCT00597493 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01110876 Brain Cancer ... More >>Glioblastoma Multiforme Less << Phase 1 Phase 2 Terminated(Unanticipated Toxic... More >>ities) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00492141 Ewing's Sarcoma Phase 1 Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02934204 Primary CNS Lymphoma Phase 2 Recruiting February 2019 China, Guangdong ... More >> Guangdong general hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Sichu Liu, MD PhD    +86 20 81884713 ext 80411    sisi.lau@foxmail.com Less <<
NCT00515788 Neoplastic Meningitis Phase 1 Terminated(Study terminated du... More >>e to slow accrual with no expansion to additional phase.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01765088 Anaplastic Oligoastrocytoma ... More >> Anaplastic Astrocytoma Glioblastoma Less << Phase 3 Recruiting December 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhong-ping Chen, MD,PhD    +86-20-87343310    chenzhp@sysucc.org.cn    Contact: Cheng-cheng Guo, MD,PhD    +86-20-87343656    guochch@sysucc.org.cn    Principal Investigator: Zhong-ping Chen, MD,PhD Less <<
NCT00841555 - Completed - -
NCT00392171 Glioma|Astrocytoma|Oligodendro... More >>glioma|Glioblastoma Less << PHASE2 COMPLETED 2009-09-15 -
NCT01235793 B-Cell Lymphoma Originating in... More >> the CNS Less << PHASE2 TERMINATED 2018-04-18 Cedars Sinai Medical Center, L... More >>os Angeles, California, 90048, United States Less <<
NCT00614978 Metastatic Breast Cancer ... More >> Brain Metastases HER2 Positive Less << Phase 1 Completed - Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 Less <<
NCT02761070 Glioblastoma ... More >>Recurrence Progression Less << Phase 3 Recruiting July 2023 Japan ... More >> Hirosaki University School of Medicine Recruiting Hirosaki, Aomori, Japan, 036-8563 Contact: Kenichiro Asano, M.D.    +81-172-39-5111    asanoken@hirosaki-u.ac.jp    Ehime University Graduate School of Medicine Recruiting Shizukawa, Ehime, Japan, 791-0295 Contact: Shohei Kouno, M.D.    +81-89-960-5338    kouno1220@gmail.com    Iwate Medical University Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Takaaki Beppu, M.D.    +81-19-651-5111    tbeppu@iwate-med.ac.jp    Tohoku University Graduate School of Medicine Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Masayuki Kanamori, M.D.    +81-22-717-7000    mkanamori@med.tohoku.ac.jp    Kansai Medical University Recruiting Hirakata, Osaka, Japan, 573-1191 Contact: Akio Asai, M.D.    +81-72-804-0101    aasaikun@hirakata.kmu.ac.jp    Contact: Masahiro Nonaka, M.D.    +81-72-804-0101    nonakamasa65@gmail.com    Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0871 Contact: Naoki Kagawa, M.D.    +81-6-6879-3652    nkagawa@nsurg.med.osaka-u.ac.jp    Saitama Medical University International Medical Center Recruiting Hidaka, Saitama, Japan, 350-1298 Contact: Ryo Nishikawa, M.D., Ph.D.    +81-42-984-4111    rnishika@saitama-med.ac.jp    Contact: Kazuhiko Misima, M.D., Ph.D.    +81-42-984-4111    kmishima@saitama-med.ac.jp    Kusyu University Graduate School of Medical Sciences Recruiting Fukuoka, Japan, 812-8582 Contact: Koji Yoshimoto, M.D., Ph.D.    +81-92-642-5524    kyoshimo@ns.med.kyushu-u.ac.jp    Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Kazuhiko Sugiyama, M.D.    +81-82-257-5227    sugiyama-hma@umin.ac.jp    Kagoshima University Graduate School of Medical and Dental Sciences Recruiting Kagoshima, Japan, 890-8520 Contact: Hirofumi Hirano, M.D.    +81-99-275-5111    hirahira@m2.kufm.kagoshima-u.ac.jp    Kitasato University School of Medicine Recruiting Kanagawa, Japan, 252-0374 Contact: Toshihiro Kumabe, M.D., Ph.D.    +81-3-3972-8111    kuma@kitasato-u.ac.jp    Kyoto University Graduate School of Medicine Recruiting Kyoto, Japan, 606-8507 Contact: Yoshiki Arakawa, M.D.    +81-75-366-7776    yarakawa@kuhp.kyoto-u.ac.jp    Osaka International Cancer Institute Recruiting Osaka, Japan, 541-8567 Contact: Manabu Kinoshita, M.D.    +81-6-6945-1181    mail@manabukinoshita.com    Nakamura Memorial Hospital Recruiting Sapporo, Japan, 060-8570 Contact: Kenichi Sato, M.D.    +81-11-231-8555    satoken@med.nmh.or.jp    Hokkaido University Graduate School of Medicine Recruiting Sapporo, Japan, 060-8648 Contact: Hiroyuki Kobayashi, M.D.    +81-11-716-1161    hiro-ko@med.hokudai.ac.jp    Shizuoka Canser Center Hospital Recruiting Shizuoka, Japan, 411-8777 Contact: Yoko Nakasu, M.D.    +81-55-989-5222    y.nakasu@scchr.jp    Contact: Kouichi Mitsuya, M.D.    +81-55-989-5222    k.mitsuya@scchr.jp    National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Yoshitaka Narita, M.D., Ph.D.    +81-3-542-2511    yonarita@ncc.go.jp    The University of Tokyo Hospital Recruiting Tokyo, Japan, 113-8655 Contact: Shota Tanaka, M.D.    +81-3-5800-8853    tanakas-tky@umin.ac.jp    Keio University Hospital Recruiting Tokyo, Japan, 160-8582 Contact: Hikaru Sasaki, M.D.    +81-3-3353-1211    hsasaki@a5.keio.jp    Nihon University School of Medicine Itabashi Hospital Recruiting Tokyo, Japan, 173-0032 Contact: Atsuo Yoshino, M.D.    +81-3-3972-8111    yoshino.atsuo@nihon-u.ac.jp    Contact: Shun Yamamuro, M.D.    +81-3-3972-8111    yamamuro.shun@nihon-u.ac.jp    Kyorin University Faculty of Medicine, Department of Neurosurgery Recruiting Tokyo, Japan, 181-8611 Contact: Keiichi Kobayashi, M.D., Ph.D.    +81-422-47-5511    kekobayashi@kki.biglobe.ne.jp    Contact: Motoo Nagane, M.D., Ph.D.    +81-422-47-5511    mnagane@ks.kyorin-u.ac.jp Less <<
NCT02168270 Anaplastic Astrocytoma ... More >> Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Glioblastoma Gliosarcoma Less << Phase 1 Terminated - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT01235793 B-Cell Lymphoma Originating in... More >> the CNS Less << PHASE2 TERMINATED 2018-04-18 Cedars Sinai Medical Center, L... More >>os Angeles, California, 90048, United States Less <<
NCT02168270 - Terminated - -
NCT00400816 Central Nervous System Tumors ... More >> Brain Tumor Less << Phase 2 Completed - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00392171 Glioma|Astrocytoma|Oligodendro... More >>glioma|Glioblastoma Less << PHASE2 COMPLETED 2009-09-15 -
NCT02340156 RECURRENT GLIOBLASTOMA Phase 2 Recruiting December 2019 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter    713-745-5769    kuhunter@mdanderson.org    Taiwan China Medical University Hospital Recruiting Taichung, Taiwan, 40447 Contact: Sophia Lin    886-937-722118    tinghsun3@gmail.com    Contact: Ya-Hui Lin    886-978-523673    yahuilin02@gmail.com    Principal Investigator: Der-Yang Cho, MD Less <<
NCT00643825 Glioblastoma Phase 2 Unknown January 2012 Belgium ... More >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Europe, Belgium, 1200 Contact: Jean-Francois BAURAIN, MD, PhD    +32 2 764 54 71    jean-francois.baurain@@uclouvain.be Less <<
NCT01124734 Malignant Melanoma Phase 2 Unknown August 2017 United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00612339 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00740636 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT00612339 - Completed - -
NCT01985451 Central Nervous System Tumors Phase 2 Unknown March 2015 -
NCT00629187 Central Nervous System Neoplas... More >>ms|Neoplasm Metastasis Less << PHASE1 TERMINATED 2025-04-12 Tufts Medical Center, Boston, ... More >>Massachusetts, 02111, United States Less <<
NCT03243851 Glioblastoma Phase 2 Recruiting December 31, 2018 Korea, Republic of ... More >> National Cancer Center Korea Recruiting Ilsan, Gyeonggi-Do, Korea, Republic of, 10408 Contact: Heon Yoo, MD., PhD.    +82-31-920-1249    heonyoo@ncc.re.kr    Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-Do, Korea, Republic of, 13620 Contact: Yu Jung Kim, MD., PhD.    +82-31-787-8210    cong1005@gmail.com    Ajou University Hospital Recruiting Suwon-si, Gyeonggi-Do, Korea, Republic of, 16499 Contact: Se Hyuk Kim, MD., PhD.    +82-31-219-3559    nsksh@ajou.ac.kr    Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam-Do, Korea, Republic of, 58128 Contact: Shin Jung, MD., PhD.    +82-2-379-8954    sjung@chonnam.ac.kr    Incheon St. Mary's Hospital Recruiting Incheon, Korea, Republic of, 21431 Contact: Dong Sup Chung, MD., PhD.    +82-32-280-5876    dschung@catholic.ac.kr    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Tae Min Kim, MD., PhD.    +82-2-2072-1672    gabriel9@snu.ac.kr    Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jong Hee Chang, MD., PhD.    +82-2-2228-2162    changjh@yuhs.ac    Konkuk University Hospital Recruiting Seoul, Korea, Republic of, 05030 Contact: Young Cho Koh, MD., PhD.    +82-2-2030-7622    kohyc@kuh.ac.kr    Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Jeong Hoon Kim, MD., PhD.    +82-2-3010-3559    jhkim1@amc.seoul.kr    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Do Hyun Nam, MD., PhD.    +82-2-3410-3497    nsnam@skku.edu    Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of, 06591 Contact: Yong-Kil Hong, MD., PhD.    +82-2-2258-2101    hongyk@catholic.ac.kr    Saint Vincent's Hospital, Korea Recruiting Suwon-si, Korea, Republic of, 16247 Contact: Seung Ho Yang, MD., PhD.    +82-31-249-8304    72ysh@catholic.ac.kr Less <<
NCT02389738 Blood Brain Barrier Defect Early Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT00740636 - Completed - -
NCT03139916 Glioblastoma Phase 2 Active, not recruiting July 31, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts general Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01534845 Anaplastic Glioma of Brain ... More >> Loss of Chromosomes 1p/19q Less << Phase 2 Unknown February 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02389738 - Completed - -
NCT01473901 Glioblastoma Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Highlands Oncology Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson DeGrout Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28040 Less <<
NCT01985087 Glioblastoma Phase 1 Phase 2 Recruiting May 2019 United States, Kentucky ... More >> James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: Clinical Trials Office    502-562-3429    ctobcc@louisville.edu    Principal Investigator: Eric Burton, MD          Sub-Investigator: Shiao Woo, MD Less <<
NCT02039778 Glioblastoma ... More >>Malignant Glioma Brain Tumors Anaplastic Astrocytoma Less << Not Applicable Terminated(Poor Accural) - United States, New York ... More >> Roosevelt Hospital New York, New York, United States, 10019 Less <<
NCT01591577 Newly Diagnosed Glioblastoma M... More >>ultiforme Less << Phase 2 Recruiting December 7, 2019 United States, California ... More >> UCLA Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Pioanh Nghiemphu, MD Less <<
NCT01067066 Melanoma Phase 1 Terminated(Phase I/II study ha... More >>lted as Phase I, Low Response Rate) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01601184 Histologically Confirmed Medul... More >>loblastoma Activation of the Sonic Hedgehog (SHH) Pathway Less << Phase 1 Phase 2 Terminated(The number of succe... More >>sses is not reached at the end of first stage of the phase II. The study is stopped.) Less << - France ... More >> CHU La Timone Marseille, Bouches Du Rhône, France, 13385 Institut Claudius Régaud (iuct-oncopole) Toulouse, Haute-Garonne, France, 31059 Hopital de La Pitié Salpétrière Paris, Ile De France, France, 75013 Institut de Cancérologie de l'Ouest - René Gauducheau St Herblain, Loire Atlantique, France, 44805 Hopital Central de Nancy Nancy, Meurthe Et Moselle, France, 54035 CHBS Hôpital du Scorff Lorient, Morbihan, France, 56322 CHRU de Lille Lille, Nord, France, 59037 Centre Léon Bérard Lyon, Rhone, France, 69373 Institut de Cancérologie de l'Ouest - Paul Papin Angers, France, 49933 Institut Bergonié Bordeaux, France, 33076 Italy BELLARIA Ospedale Bologna, Italy, 40139 University of Turin Torino, Italy, 10126 Switzerland Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, CH-8091 University Hospital Zurich Zurich, Switzerland, CH-8091 United Kingdom University College London Hospital - Mount Vernon Cancer Centre - Mount Vernon hospital London, United Kingdom, London-NW1-2PG Less <<
NCT02209428 Astrocytoma|Oligodendroglioma|... More >>Oligoastrocytoma Less << PHASE2 UNKNOWN 2025-05-19 Huashan Hospital Affiliated to... More >> Fudan University, Shanghai, Shanghai, 200040, China Less <<
NCT01205828 Hepatocellular Carcinoma Phase 2 Terminated(Lack of efficacy) - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT01736800 Central Nervous System (CNS) M... More >>etastases Brain Metastases Less << Phase 2 Withdrawn(No enrollment and PI... More >> requested study termination per IRB system.) Less << - United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Methodist Neurological Institute - Department of Neurosurgery Houston, Texas, United States, 77030 Less <<
NCT02039778 - Terminated(Poor Accural) - -
NCT01242566 Primary Brain Tumor|Glioblasto... More >>ma Less << PHASE2 COMPLETED 2025-09-10 Pitie salpetriere hospital, Pa... More >>ris, 75013, France Less <<
NCT02766270 Grade II/III Glioma Early Phase 1 Recruiting December 2018 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100050 Contact: Xiao-Guang Qiu, M.D.       ttyy6611@126.com    Principal Investigator: Tao Jiang, M.D. Less <<
NCT01900951 Carcinoma, Small Cell PHASE2 UNKNOWN 2025-06-16 PLA general hospital, BeiJing,... More >> Beijing, 100853, China Less <<
NCT03529448 Glioblastoma Phase 1 Phase 2 Not yet recruiting June 2020 Spain ... More >> Institut Català d'Oncología L'Hospitalet Not yet recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Miguel Gil, M.D.       secretaria@geino.es    Principal Investigator: Miguel Gil, M.D.          Hospital Universitario Son Espases Palma de Mallorca, Mallorca, Spain Consorcio Hospitalario Provincial de Castellón Not yet recruiting Castelló, Valencia, Spain, 12002 Contact: Ramón de las Peñas, M.D.       secretaria@geino.es    Principal Investigator: Ramón de las Peñas, M.D.          Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Contact: Maria Martinez, M.D.       secretaria@geino.es    Principal Investigator: María Martínez, M.D.          Complejo Hospitalario Regional Virgen de las Nieves Not yet recruiting Granada, Spain, 18004 Contact: Raquel Luque, MD       secretaria@geino.es    Principal Investigator: Raquel Luque, M.D.          Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact: Juan Sepúlveda       secretaria@geino.es    Principal Investigator: Juan Sepúlveda, M.D.          Hospital Regional Universitario de Malaga Malaga, Spain Hospital Clínico Universitario de Salamanca Not yet recruiting Salamanca, Spain, 37007 Contact: Luis Miguel Navarro, M.D.       secretaria@geino.es    Principal Investigator: Luis Miguel Navarro, M.D. Less <<
NCT00619112 - Completed - -
NCT01205828 - Terminated(Lack of efficacy) - -
NCT01858168 Ewing Sarcoma Phase 1 Recruiting July 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Barbara Anderson, RN    617-724-4000    banderson@partners.org    Contact: Sienna Durbin, BS    617-724-4000       Principal Investigator: Edwin Choy, MD, PhD          Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Steven Dubois, MD    617-632-5460    Steven_Dubois@dfci.harvard.edu    Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN    617-582-7162    mhohos@partners.org    Contact: Mark Morley, RN    617-632-3989    mmorley@partners.org    Principal Investigator: George Demetri, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN    617-582-7162    mhohos@partners.org    Contact: Mark Morley, RN    617-632-3989    mmorley@partners.org    Principal Investigator: George Demetri, MD          United States, Tennessee St. Jude's Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sara Federico, MD    866-278-5833    sara.federico@stjude.org Less <<
NCT02781792 Glioma Gliobl... More >>astoma Multiforme Less << Phase 1 Recruiting August 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian Campian, M.D., Ph.D.    314-747-4241    campian.jian@wustl.edu    Principal Investigator: Jian Campian, M.D., Ph.D.          Sub-Investigator: Katherine Weilbaecher, M.D.          Sub-Investigator: Joshua Rubin, M.D., Ph.D. Less <<
NCT00619112 Recurrent Central Nervous Syst... More >>em Neoplasm Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT01987830 Recurrent Glioblastoma Not Applicable Recruiting September 2020 United States, Massachusetts ... More >> Massachuesett General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Tracy Batchelor, MD    617-724-8770    tbatchelor@partners.org    Principal Investigator: Tracy Batchelor, MD Less <<
NCT01517776 Gliomas Phase 2 Terminated(due to an altered b... More >>enefit/risk assessment.) Less << - Germany ... More >> University Children´s Hospital Halle, Saxonia-Anhalt, Germany, 06120 Less <<
NCT02898012 Glioblastoma Multiforme ... More >> Primary Brain Tumor Less << Phase 2 Completed - France ... More >> Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT02446704 Small Cell Lung Cancer Phase 1 Phase 2 Recruiting August 2022 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Anna Farago, MD, PhD    617-724-4000    afarago@mgh.harvard.edu    Principal Investigator: Anna Farago, MD, PhD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: David Barbie, MD    617-632-6049    dbarbie@partners.org    Principal Investigator: David Barbie, MD          Beth Israel Deaconess Medical Center Active, not recruiting Boston, Massachusetts, United States, 02215 Less <<
NCT03633552 Glioblastoma Multiforme of Bra... More >>in|Anaplastic Astrocytoma of Brain Less << PHASE3 UNKNOWN 2021-04-03 Radiation ward of Emam Reza Ho... More >>spital, Mashhad, Razavi Khorasan, 9137913316, Iran, Islamic Republic of|Omid Hospital, Mashhad, Razavi Khorasan, 917661377, Iran, Islamic Republic of Less <<
NCT02605811 Small Cell Lung Cancer ... More >> Metastatic Carcinoma Less << Phase 2 Enrolling by invitation April 2021 China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT03514069 Glioma Gliobl... More >>astoma Less << Phase 1 Recruiting December 2020 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia, MD    866-223-8100    CancerCenterResearch@ccf.org    Principal Investigator: Manmeet Ahluwalia, MD Less <<
NCT01956734 Glioblastoma Multiforme ... More >> Recurrent Tumor Less << Phase 1 Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT01781403 Rectal Cancer PHASE1 COMPLETED 2016-05-04 Asan Medical Center, Seoul, So... More >>ngpa-gu, 138-736, Korea, Republic of Less <<
NCT01114555 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03422445 Advanced Melanoma Phase 2 Recruiting February 2019 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Jun Guo Less <<
NCT03495921 Ewing Sarcoma ... More >> Ewing Family of Tumors Ewing's Tumor Metastatic Ewing's Sarcoma Metastatic Less << Phase 3 Recruiting July 1, 2022 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Catherine Redinger, RN    501-364-4290    RedingerCatherineL@uams.edu    United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO    904-953-7292    Attia.Steven@mayo.edu    Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Coraly Diaz-Gamboa, BS    786-624-2853    coraly.diaz@NicklausHealth.org    United States, Massachusetts Dana-Farber/Boston Children's Cancer and Blood Disorders Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD    617-632-5460    Steven_Dubois@dfci.harvard.edu    United States, Missouri Washington University Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Michele Landeau    314-747-9488    landeaum@wustl.edu    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Dara Herman       schwamd@mskcc.org    Contact: Leonard H. Wexler, MD    212-639-7990       Principal Investigator: Leonard H. Wexler, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact    513-636-2799    cancer@cchmc.org    Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Peter Anderson, MD    216-445-4044    andersp@ccf.org    Contact: Stacey Zahler, MD    216-445-3588    zahlers@ccf.org    United States, Pennsylvania Fox Chase Cancer Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Sujana Movva, MD    215-728-4300    Sujana.Movva@fccc.edu    United States, Texas Texas Oncology - Pediatrics Recruiting Dallas, Texas, United States, 75230 Contact: Maurizio Ghisoli, MD    972-566-6647    Maurizio.Ghisoli@usoncology.com Less <<
NCT03213002 Glioblastoma Multiforme (GBM) ... More >> Glioblastoma Glioma of Brain Glioblastoma, Adult Brain Tumor Brain Tumor, Primary Brain Tumor Adult Cancer Brain Cancer Less << Phase 1 Phase 2 Recruiting June 2021 United States, New York ... More >> Lenox Hill Brain Tumor Center Recruiting New York, New York, United States, 10075 Contact: Tamika Wong, MPH    212-434-4836    twong4@northwell.edu    Principal Investigator: John Boockvar, MD          Sub-Investigator: David Langer, MD          Sub-Investigator: Anuj Goenka, MD          Sub-Investigator: Christopher Filippi, MD          Sub-Investigator: Lalitha Anand, MD          Sub-Investigator: Sherese Fralin, NP          Sub-Investigator: Ashley Ray, NP          Sub-Investigator: Tamika Wong, MPH Less <<
NCT02343081 - Completed - -
NCT01781403 Rectal Cancer PHASE1 COMPLETED 2016-05-04 Asan Medical Center, Seoul, So... More >>ngpa-gu, 138-736, Korea, Republic of Less <<
NCT02113007 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Terminated(Closed early due to... More >> slow accrual.) Less << - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Memorial Cancer Institute Hollywood, Florida, United States, 33021 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT01127594 Melanoma PHASE1 COMPLETED 2025-06-14 Moffitt Cancer Center, Tampa, ... More >>Florida, 33612, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02113007 - Terminated(Closed early due to... More >> slow accrual.) Less << - -
NCT03435302 Melanoma Phase 3 Recruiting February 2019 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Bin Lian, MD    +86(10)88196951    lianbin0214@126.com    Contact: Lu Si, MD    +86(10)88196951    silu.net@hotmail.com    Sub-Investigator: Bin Lian, MD Less <<
NCT03643549 Glioblastoma Phase 1 Phase 2 Recruiting August 31, 2023 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Dorota Goplen, MD, PhD    +4755974019    dgop@helse-bergen.no    Contact: Jorunn Brekke, MD    +4755970986    joub@helse-bergen.no Less <<
NCT01847235 Anaplastic Oligodendroglioma|A... More >>naplastic Oligoastrocytoma Less << PHASE2 COMPLETED 2025-03-16 Seoul National University Hosp... More >>ital, Seoul, 110-744, Korea, Republic of Less <<
NCT02343081 Brain Neoplasms, Malignant, Pr... More >>imary Less << Phase 4 Completed - Argentina ... More >> FLENI Instituto Clínico-Quirúrgico de Diagnóstico y Tratamiento Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1428AQK FLENI Instituto de Rehabilitación y Educación Terapéutica Escobar, Buenos Aires, Argentina, B1625XAS Less <<
NCT02972320 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Unknown December 2018 China, Liaoning ... More >> The First Affiliated Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: mingfang zhao, professor    13644055129 Less <<
NCT03291990 Glioblastoma Multiforme EARLY_PHASE1 COMPLETED 2020-08-19 Sibley Hospital, Washington, D... More >>istrict of Columbia, 20016, United States|Suburban Hospital, Washington, District of Columbia, 20818, United States|SKCCC at Johns Hopkins (East Baltimore), Baltimore, Maryland, 21287, United States Less <<
NCT03556384 Gastrointestinal Stromal Tumor... More >>s|Sdh|GIST|Cancer Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-06-26 UC San Diego Moores Cancer Cen... More >>ter, La Jolla, California, 92093, United States|University of Miami, Miami, Florida, 33136, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States Less <<
NCT03463733 Glioma Gliobl... More >>astoma Less << Phase 1 Recruiting June 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD    +31 (0)20 4444321    h.verheul@vumc.nl Less <<
NCT02507232 Glioma Phase 2 Recruiting April 2022 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Less <<
NCT03359005 Ewing Sarcoma Phase 2 Recruiting February 28, 2025 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu    86 15901040835    xujie_pkuph@sina.com    Principal Investigator: Wei Guo, M.D., Ph.D. Less <<
NCT02654106 Brain Metastases Phase 2 Completed - China, Beijing ... More >> Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Less <<
NCT00977431 Glioblastoma Phase 1 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN The Christie Hospital Manchester, United Kingdom, M20 4BX The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Less <<
NCT03663725 Glioblastoma Phase 3 Not yet recruiting May 1, 2023 -
NCT00994071 Medulloblastoma ... More >> Pontine Glioma Ependymoma Astrocytoma PNET Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03139331 Sarcoma Phase 1 Recruiting November 30, 2019 United States, California ... More >> UCSF Benioff Children's Hospital, Oakland Recruiting Oakland, California, United States, 94609 Contact: Jennifer Michlitsch, MD    510-428-3372    jmichlitsch@mail.cho.org    Principal Investigator: Jennifer Michlitsch, MD          UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94158 Contact: Kieuhoa Vo, MD, MAS    415-476-3831    kieuhoa.vo@ucsf.edu    Principal Investigator: Kieuhoa Vo, MD, MAS          United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD    617-632-5640    steve_dubois@dfci.harvard.edu    Principal Investigator: Steven DuBois, MD Less <<
NCT00526617 Non-hematologic Malignancies ... More >> Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma Less << Phase 1 Completed - -
NCT01506609 Metastatic Breast Cancer Phase 2 Active, not recruiting May 30, 2019 -
NCT03128047 High Grade Glioma Phase 1 Recruiting February 2019 United States, New Jersey ... More >> Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh, APN    551-996-3457    jeanette.haugh@hackensackmeridian.org Less <<
NCT00482677 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Centre hospitalier regional de Trois-Rivieres Trois-Rivieres, Quebec, Canada, G8Z 3R9 Germany Klinikum Der J.W. Goethe Universitaet Frankfurt, Germany, 60590 Universitaetsklinikum Freiburg Freiburg, Germany, 79106 Universitaetsklinikum Leipzig Leipzig, Germany, 04103 Universitaetsklinikum Tuebingen Tuebingen, Germany, 72076 Japan Hiroshima University Hospital Hiroshima, Japan, 734-8551 Netherlands Maastro - Maastricht Radiation Oncology Maastricht, Netherlands, 6201 Less <<
NCT00943826 Glioblastoma Phase 3 Completed - -
NCT02358356 Midgut Neuroendocrine Tumours ... More >> Pancreatic Neuroendocrine Tumours Less << Phase 2 Recruiting December 2020 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Kathryn Jenkins       Kathryn.Jenkins@health.nsw.gov.au    Principal Investigator: Nick Pavlakis          Australia, Queensland Royal Brisbane and Women's Hospital Recruiting Herston, Queensland, Australia, 4029 Contact: Jenny Campbell       Jenny.Campbell@health.qld.gov.au    Australia, Victoria Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 8006 Contact: Elizabeth Drummond       Elizabeth.Drummond@petermac.org    Australia, Western Australia Fiona Stanley Hospital Recruiting Murdoch, Western Australia, Australia, 6150 Contact: Kanako Ohara       kanako.ohara@health.wa.gov.au    Principal Investigator: David Ransom Less <<
NCT02617589 Brain Cancer Phase 3 Recruiting October 1, 2019 -
NCT00885534 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00609011 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> The Angeles Clinic Los Angeles, California, United States, 90025 United States, Florida Cancer Centers of Florida Ocoee, Florida, United States, 34761 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT02344355 Glioblastoma Multiforme Phase 2 Recruiting December 2023 United States, Iowa ... More >> Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Sandy Vollstedt, RN, BSN    319-353-7143    sandy-vollstedt@uiowa.edu    Contact: Heather Brown, RN, BAN    319-384-7912    heather-brown@uiowa.edu    Sub-Investigator: John M. Buatti, MD          Sub-Investigator: Joseph J. Cullen, MD          Sub-Investigator: Daniel Berg, MD          Sub-Investigator: Matthew Howard, MD          Sub-Investigator: Jeremy Greenlee, MD          Sub-Investigator: David Hasan, MD          Sub-Investigator: Patrick Hitchon, MD          Sub-Investigator: Varun Monga, MD          Sub-Investigator: Mark C. Smith, MD          Sub-Investigator: Carryn M. Anderson, MD          Sub-Investigator: Wenqing Sun, MD, PhD          Sub-Investigator: Douglas Spitz, PhD          Sub-Investigator: Mohammed Milhem, MBBA          Sub-Investigator: Garry R. Buettner, PhD Less <<
NCT03082846 Glioma Radiot... More >>herapy, Intensity-Modulated Maximum Tolerated Dose Less << Not Applicable Completed - -
NCT01141244 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT00482677 - Completed - -
NCT00895960 Glioblastoma ... More >>CNS Disease Brain Diseases Less << Phase 1 Terminated(Sponsor withdrew su... More >>pport; Study did not progress to Phase II.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00885534 - Completed - -
NCT00039494 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 2 Completed - -
NCT02975882 Childhood Solid Neoplasm ... More >> Recurrent Central Nervous System Neoplasm Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Less << Phase 1 Recruiting June 3, 2020 -
NCT01835145 Recurrent Uveal Melanoma ... More >> Stage III Uveal Melanoma AJCC v7 Stage IIIA Uveal Melanoma AJCC v7 Stage IIIB Uveal Melanoma AJCC v7 Stage IIIC Uveal Melanoma AJCC v7 Stage IV Uveal Melanoma AJCC v7 Less << Phase 2 Completed - -
NCT02179086 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 2 Recruiting May 2024 -
NCT00026494 - Completed - -
NCT02029573 Glioblastoma Multiforme Phase 2 Completed - Saudi Arabia ... More >> King Fahad Medical City Riyadh, Saudi Arabia, 11525 Less <<
NCT02831179 Functional Pancreatic Neuroend... More >>ocrine Tumor Malignant Somatostatinoma Merkel Cell Carcinoma Metastatic Adrenal Gland Pheochromocytoma Metastatic Carcinoid Tumor Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B Neuroendocrine Neoplasm Non-Functional Pancreatic Neuroendocrine Tumor Pancreatic Glucagonoma Pancreatic Insulinoma Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Gland Pheochromocytoma Recurrent Merkel Cell Carcinoma Somatostatin-Producing Neuroendocrine Tumor Stage III Adrenal Cortex Carcinoma Stage III Thyroid Gland Medullary Carcinoma Stage IIIA Merkel Cell Carcinoma Stage IIIB Merkel Cell Carcinoma Stage IV Adrenal Cortex Carcinoma Stage IV Merkel Cell Carcinoma Stage IVA Thyroid Gland Medullary Carcinoma Stage IVB Thyroid Gland Medullary Carcinoma Stage IVC Thyroid Gland Medullary Carcinoma Thymic Carcinoid Tumor VIP-Producing Neuroendocrine Tumor Well Differentiated Adrenal Cortex Carcinoma Zollinger Ellison Syndrome Less << Phase 1 Withdrawn(Loss of funding supp... More >>ort) Less << February 2020 -
NCT00943826 - Completed - -
NCT00612651 Gliosarcoma G... More >>lioblastoma Anaplastic Astrocytoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00544284 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00026494 Metastatic Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00147160 Glioma Phase 2 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 United Kingdom Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8BJ Less <<
NCT00597402 - Completed - -
NCT00597402 Glioblastoma ... More >>Gliosarcoma Brain Tumor Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00946335 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Tennessee ... More >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Less <<
NCT03746080 Glioblastoma ... More >>Glioblastoma With Primitive Neuronal Component Gliosarcoma Malignant Glioma Oligodendroglial Component Present Less << Phase 2 Recruiting January 11, 2027 United States, California ... More >> Stanford Cancer Institute Palo Alto Recruiting Palo Alto, California, United States, 94304 Contact: Lawrence Recht    650-725-8630    lrecht@stanford.edu    Principal Investigator: Lawrence Recht Less <<
NCT02770378 Glioblastoma Phase 1 Active, not recruiting March 2020 Germany ... More >> University of Ulm School of Medicine Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT00544817 Glioblastoma Multiforme Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00404495 Glioma Medull... More >>oblastoma Less << Phase 2 Completed - Australia, New South Wales ... More >> Pfizer Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Pfizer Investigational Site Herston, Queensland, Australia, 4029 Australia, Victoria Pfizer Investigational Site Parkville, Victoria, Australia, 3052 Belgium Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus N, Denmark, 8200 Pfizer Investigational Site Koebenhavn OE, Denmark, 2100 France Pfizer Investigational Site Angers, France, 49000 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Lille, France, 59020 Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Paris, France, 75005 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Padova, Italy, 35100 Poland Pfizer Investigational Site Warszawa, Poland, 04-730 Spain Pfizer Investigational Site Esplugues de Llobregat, Barcelona, Spain, 08950 Pfizer Investigational Site El Palmar, Murcia, Spain, 30120 Pfizer Investigational Site Barcelona, Spain, 08035 Pfizer Investigational Site Madrid, Spain, 28009 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46026 United Kingdom Pfizer Investigational Site Soouthampton, Hampshire, United Kingdom, SO16 6YD Pfizer Investigational Site Birmingham, United Kingdom, B4 6NH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site Manchester, United Kingdom, M27 4HA Pfizer Investigational Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Pfizer Investigational Site Nottingham, United Kingdom, NG7 2UH Pfizer Investigational Site Sutton, United Kingdom, SM2 5PT Less <<
NCT00404495 - Completed - -
NCT00104988 Melanoma (Skin) Phase 2 Completed - -
NCT00335075 Glioblastoma ... More >>Astrocytoma Less << Phase 3 Completed - -
NCT01790503 Patients With Newly Diagnosed ... More >>Glioblastoma Less << Phase 1 Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio James Cancer Hospital/Ohio State University Columbia, Ohio, United States, 43210 United States, Utah Huntsman Cancer Institute University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01085422 Prostate Cancer Phase 1 Completed - -
NCT00544817 - Completed - -
NCT00052780 Childhood Central Nervous Syst... More >>em Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Tennessee ... More >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Less <<
NCT00508456 Glioblastoma Multiforme Phase 1 Terminated(Low Accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02655601 High Grade Glioma, Glioblastom... More >>a Less << Phase 2 Recruiting September 2022 United States, North Carolina ... More >> Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring    919-684-5301    sarah.woodring@dm.duke.edu    Contact: Susan Boulton, RN    919-684-5301    susan.boulton@duke.edu Less <<
NCT00437957 Brain Metastases Phase 1 Terminated(Lack of enrollment) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01514201 Anaplastic Astrocytoma ... More >> Brain Stem Glioma Childhood Mixed Glioma Fibrillary Astrocytoma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Untreated Childhood Anaplastic Astrocytoma Untreated Childhood Brain Stem Glioma Untreated Childhood Fibrillary Astrocytoma Untreated Childhood Giant Cell Glioblastoma Untreated Childhood Glioblastoma Untreated Childhood Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01076530 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Extra-adrenal Paraganglioma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Illinois ... More >> Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States, 55455 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT00916409 Glioblastoma Multiforme Phase 3 Completed - -
NCT00591370 - Completed - -
NCT02152982 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Phase 3 Active, not recruiting - -
NCT01217437 Recurrent Childhood Medullobla... More >>stoma Recurrent Childhood Pineoblastoma Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Less << Phase 2 Active, not recruiting - -
NCT00689221 Glioblastoma Phase 3 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Less <<
NCT01543464 Malignant Melanoma Phase 2 Terminated(Diminished rectruit... More >>ment) Less << - Denmark ... More >> Trine Zeeberg Iversen Brønshøj, Copenhagen, Denmark, 2700 Less <<
NCT01977677 Adult Ependymoblastoma ... More >> Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Medulloblastoma Adult Mixed Glioma Adult Oligodendroglial Tumors Adult Pineoblastoma Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) Less << Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01649830 Astrocytoma O... More >>ligodendroglioma Oligodendroastrocytoma Less << Phase 3 Recruiting August 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Principal Investigator: Zhong-ping CHEN, MD, PhD Less <<
NCT00528437 Brain Tumors Phase 2 Active, not recruiting July 2019 United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Hawaii Hawaii Pacific Health Lihue, Hawaii, United States, 96766 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota Children's Hospital and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Steven and Alexandra Cohen Children's Medical Center of New York- North Shore LIJ New Hyde Park, New York, United States, 11040 NYU Hassenfeld Center New York, New York, United States, 10016 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical Univ. of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Univ. Nashville, Tennessee, United States, 37240 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 MD Anderson Cancer Center (MDACC) Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth Univ. Richmond, Virginia, United States, 23284 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00068666 Melanoma (Skin) ... More >> Metastatic Cancer Less << Phase 2 Terminated - -
NCT00689221 - Completed - -
NCT00731731 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Cognitive Side Effects of Cancer Therapy Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01977677 - Completed - -
NCT01139970 Accelerated Phase of Disease ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With PML-RARA Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult T Acute Lymphoblastic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase Chronic Myelomonocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT01638546 - Completed - -
NCT03212742 Malignant Gliomas ... More >> Radiotherapy PARP Inhibitor Less << Phase 1 Phase 2 Recruiting June 30, 2022 France ... More >> CHU Not yet recruiting Bordeaux, France Contact: Aymeri HUCHET, MD          Principal Investigator: Aymeri HUCHET, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Dinu STEFAN, MD    33 2 31 45 50 50    d.stefan@baclesse.unicancer.fr    Contact: Jean-Michel GRELLARD          Principal Investigator: Dinu STEFAN, MD          Sub-Investigator: Julien GEFFRELOT, MD          Sub-Investigator: Ioana HRAB, MD          Centre léon Bérard Not yet recruiting Lyon, France Contact: Marie-Pierre SUNYACH, MD          Principal Investigator: Marie-Pierre SUNYACH, MD          Hôpitaux universitaires La Pitié Salpétrière - Charles Foix Not yet recruiting Paris, France Contact: Loic FEUVRET, MD          Principal Investigator: Loic FEUVRET, MD          Sub-Investigator: Florence LAIGLE-DONADEY, MD          Sub-Investigator: Khe HOANG-XUAN, MD          Sub-Investigator: Ahmed IBDAIH, Pr          Institut Curie Not yet recruiting Paris, France Contact: Hamid MAMMAR, MD          Principal Investigator: Hamid MAMMAR, MD          Sub-Investigator: Laurence BOZEC LE MOAL, MD          Sub-Investigator: Coraline DUBOT, MD          Sub-Investigator: Patricia TRESCA, MD          Sub-Investigator: Patricia MOISSON, MD          Institut Claudius Regaud Not yet recruiting Toulouse, France Contact: Elisabeth MOYAL COHEN-JONATHAN, Pr          Principal Investigator: Elisabeth MOYAL COHEN-JONATHAN, Pr          Sub-Investigator: Ioana CARPUC, MD          Sub-Investigator: Jean-Pierre DELORD, MD          Sub-Investigator: Cécile GANDY, MD          Sub-Investigator: Carlos Alberto GOMEZ-ROCA, MD          Sub-Investigator: Anouchka MODESTO, MD          Sub-Investigator: Thibaud VALENTIN, MD Less <<
NCT00591370 Melanoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03567135 - Recruiting April 1, 2019 China, Fujian ... More >> Fuzhou General Hospital Recruiting Fuzhou, Fujian, China, 350025 Contact: Wenmin Ying, Bachelor    15080015210    18352770@qq.com Less <<
NCT01638546 Recurrent Small Cell Lung Carc... More >>inoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT03204032 Extrapancreatic Neuroendocrine... More >> Tumor Less << Phase 2 Recruiting September 2018 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi, doctor       yihebalichi@yahoo.com.cn Less <<
NCT00831545 Metastases of Central Nervous ... More >>System|Melanoma|Breast Neoplasm|Carcinoma, Non-Small-Cell Lung Less << PHASE2 COMPLETED 2006-10-20 -
NCT00383851 Melanoma Phase 2 Unknown September 2008 United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Pacific Oncology and Hematology Encinitas, California, United States, 92024 Hematology - Oncology Group of Orange, Inc. Orange, California, United States, 92868 UCI Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 The Angeles Clinic Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Health Science Center Denver, Colorado, United States, 80262 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Louisiana Hematology and Oncology Specialists, LLC Metairie, Louisiana, United States, 70006 United States, Maryland The Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore, Maryland, United States, 21237 Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Montana Billings Clinic Billings, Montana, United States, 59101 United States, New Jersey Mountainside Hospital Cancer Center - The Melanoma Center Montclair, New Jersey, United States, 07042 United States, Ohio Oncology Hematology Care Cincinati, Ohio, United States, 45242 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29605 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Less <<
NCT00731731 - Active, not recruiting - -
NCT00433381 - Completed - -
NCT01285414 Glioblastoma Multiforme Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Texas University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT00900757 Malignant Glioma Phase 2 Completed - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT02502708 Glioblastoma Multiforme ... More >> Glioma Gliosarcoma Malignant Brain Tumor Ependymoma Medulloblastoma Diffuse Intrinsic Pontine Glioma Primary CNS Tumor Less << Phase 1 Recruiting December 2019 United States, Georgia ... More >> Children's Heathcare of Atlanta Recruiting Atlanta, Georgia, United States, 30342 Contact: Amy Autry-Bush    404-785-6011    amy.autry-bush@choa.org    Principal Investigator: Tobey MacDonald, MD          Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Robin Dobbins    706-721-2154    RDOBBINS@augusta.edu    Principal Investigator: Theodore Johnson, MD Less <<
NCT00433381 Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 2 Completed - -
NCT00900757 - Completed - -
NCT01505608 Neuroblastoma Phase 1 Phase 2 Terminated(Lack of Enrollment) - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States United States, California Rady Children's Hospital San Diego, California, United States, 92123 United States, Connecticut Connecticut Children's Hospital Hartford, Connecticut, United States, 06106 United States, Florida Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States, 32806 United States, Michigan Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Missouri Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, North Carolina Levine Children's Hospital Charlotte, North Carolina, United States, 28204 Less <<
NCT00301067 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting May 2020 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01735747 Central Nervous System Tumors Phase 2 Unknown November 2013 China, Shandong ... More >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT03405792 Glioblastoma ... More >>Glioblastoma, WHO Grade IV Less << Phase 2 Recruiting February 2023 United States, Florida ... More >> University of Florida Health Recruiting Gainesville, Florida, United States, 32610 Less <<
NCT02023905 Low Grade Glioma ... More >> WHO Grade II Astrocytomas Oligodendrogliomas Mixed Oligoastrocytomas Less << Phase 2 Recruiting January 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0372 Contact: Jennifer Clarke, MD, MPH    415-353-2966    Jennifer.Clarke@ucsf.edu    Contact: Tiffany Jones    415-353-9641    Tiffany.Jones@ucsf.edu    Principal Investigator: Jennifer Clarke, MD Less <<
NCT00521001 Melanoma (Skin) Phase 2 Completed - -
NCT00521001 - Completed - -
NCT01505608 - Terminated(Lack of Enrollment) - -
NCT02052648 Glioblastoma Multiforme ... More >> Glioma Gliosarcoma Malignant Brain Tumor Less << Phase 1 Phase 2 Active, not recruiting October 2018 United States, California ... More >> Eden Medical Center Castro Valley, California, United States, 94546 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia University Cancer and Blood Center Athens, Georgia, United States, 30607 Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30342 Georgia Regents University Augusta, Georgia, United States, 30912 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky University of Kentucy Lexington, Kentucky, United States, 40536 United States, Minnesota John Nasseff Neuroscience Institute Minneapolis, Minnesota, United States, 55407 United States, New Mexico University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States, 87131 United States, North Carolina Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Texas Texas Oncology Austin, Texas, United States, 78705 United States, Utah Huntsman Cancer Center Salt Lake City, Utah, United States, 84112 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Less <<
NCT00091572 Melanoma Phase 3 Completed - -
NCT00091572 - Completed - -
NCT00109798 Central Nervous System Tumors ... More >> Lymphoma Less << Not Applicable Withdrawn(Sub-Investigator rel... More >>oacted to another institution) Less << - -
NCT00881595 Soft Tissue Sarcomas Phase 2 Withdrawn(No patients accrued ... More >>since study opened) Less << - -
NCT00077207 Brain Tumor C... More >>entral Nervous System Tumor Less << Not Applicable Completed - United States, Pennsylvania ... More >> Childrens Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00385853 Glioblastoma Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00077207 - Completed - -
NCT03323034 Recurrent Central Nervous Syst... More >>em Neoplasm Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Lymphoma Refractory Malignant Solid Neoplasm Less << Phase 1 Recruiting December 1, 2021 -
NCT02667587 Brain Neoplasms Phase 3 Recruiting August 1, 2023 -
NCT00022711 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Kimball Medical Center Lakewood, New Jersey, United States, 08701 South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 Community Medical Center Toms River, New Jersey, United States, 08755 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania Bon Secours-Holy Family Health System Altoona, Pennsylvania, United States, 16602 Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026-1186 Pinnacle Health Hospitals Harrisburg, Pennsylvania, United States, 17105-8700 Conemaugh Memorial Hospital Johnstown, Pennsylvania, United States, 15905 Saint Mary Regional Center Langhorne, Pennsylvania, United States, 19047 Central Montgomery Medical Center Lansdale, Pennsylvania, United States, 19446-1200 Paoli Memorial Hospital Paoli, Pennsylvania, United States, 19301-1792 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Pottstown Memorial Regional Cancer Center Pottstown, Pennsylvania, United States, 19464 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT00998010 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting June 30, 2019 United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT00072163 Recurrent Melanoma ... More >> Stage IV Melanoma Tumors Metastatic to Brain Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00705198 - Completed - -
NCT01812603 Cancer Phase 1 Phase 2 Completed - United Kingdom ... More >> The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Guy's and St Thomas NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT01355445 RHABDOMYOSARCOMA Phase 2 Active, not recruiting September 2023 France ... More >> Centre Hospitalier Universitaire Nord Amiens, France, 80000 Hôpital des Enfants, Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU Morvan Brest, France CHU Estaing Clermont ferrand, France, 63003 Centre Oscar Lambret Lille cedex, France, 59020 Centre Léon Bérard Lyon, France CHU, Hôpital d'Enfants de la Timone Marseille, France Hôpital Arnaud de Villeneuve - CHU Montpellier, France CHU, Hôpital Mère enfants Nantes, France Hôpital Armand Trousseau Paris, France Institut Curie Paris, France Hôpital Jean Bernard Poitiers, France CHU - Hôpital Américain Reims, France CHU Rennes - Hôpital Sud Rennes, France CHU St Etienne - Hôpital Nord Saint-Etienne, France Hôpital de Hautepierre Strasbourg, France Hôpital des enfants Toulouse, France CHRU Tours, France CHRU Hôpital d'Enfants Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France Less <<
NCT01043536 Glioblastoma Phase 1 Completed - France ... More >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Less <<
NCT00804908 Melanoma Meta... More >>static Melanoma Skin Cancer Less << Phase 2 Completed - -
NCT00804908 - Completed - -
NCT00194766 Breast Cancer|Soft Tissue Sarc... More >>oma Less << PHASE2 COMPLETED 2025-12-06 University of Washington/Seatt... More >>le Cancer Care Alliance, Seattle, Washington, 98109-1023, United States Less <<
NCT01005472 Metastatic Melanoma Phase 1 Completed - United States, California ... More >> University of California Los Angeles (UCLA) Los Angeles, California, United States, 90095 Less <<
NCT02272270 Newly Diagnosed High Grade Gli... More >>oma Less << Phase 1 Active, not recruiting October 2019 United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00304200 Metastatic Malignant Melanoma Phase 1 Phase 2 Terminated(Funding was inadequ... More >>ate to continue; Companies requested closure.) Less << - United States, California ... More >> Northern California Melanoma Center San Francisco, California, United States, 94109 Less <<
NCT00616005 Glioblastoma Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT03426891 Glioblastoma ... More >>Brain Tumor GBM Less << Phase 1 Recruiting April 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Melissa Wicklund    813-745-3620    melissa.wicklund@moffitt.org    Contact: Solmaz Sahebjam, M.D.    813-745-6101    solmaz.sahebjam@moffitt.org Less <<
NCT03079440 Neuroendocrine Tumors ... More >> Neuroendocrine Carcinoma Temozolomide Capecitabine Less << Phase 2 Recruiting October 2020 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD    +82-2-3010-1727    yooc@amc.seoul.kr Less <<
NCT00311584 Neuroblastoma Phase 2 Completed - -
NCT01465659 Pancreatic Alpha Cell Carcinom... More >>a Pancreatic Beta Islet Cell Carcinoma Pancreatic Delta Cell Carcinoma Pancreatic G-cell Carcinoma Recurrent Islet Cell Carcinoma Less << Phase 1 Phase 2 Recruiting August 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Halla null. Nimeiri    312-695-4381    h-nimeiri@northwestern.edu    Principal Investigator: Halla null. Nimeiri          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Mark M. Zalupski    734-615-3969    zalupski@med.umich.edu    Principal Investigator: Mark M. Zalupski          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Steven J. Cohen    215-728-2570    Steven.Cohen@fccc.edu    Principal Investigator: Steven J. Cohen          United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jordan D. Berlin    615-936-8422    jordan.berlin@Vanderbilt.edu    Principal Investigator: Jordan D. Berlin          United States, Washington University of Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Gabriela Chiorean, MD    855-557-0555 Less <<
NCT00704808 - Completed - -
NCT00311584 - Completed - -
NCT00182819 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00704808 - Completed - -
NCT00725010 - Completed - -
NCT00725010 - Completed - -
NCT00612989 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01480479 Glioblastoma ... More >>Small Cell Glioblastoma Giant Cell Glioblastoma Gliosarcoma Glioblastoma With Oligodendroglial Component Less << Phase 3 Completed - -
NCT00006043 Ovarian Cancer ... More >> Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00005955 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00887146 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Recruiting - -
NCT02311920 Gliosarcoma S... More >>upratentorial Glioblastoma Less << Phase 1 Active, not recruiting - United States, California ... More >> UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Cancer Center/Fairview Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00038493 Glioblastoma Multiforme Phase 2 Completed - United States, Texas ... More >> UTMD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00555399 Glioblastoma Multiforme ... More >> Anaplastic Glioma Less << Phase 1 Phase 2 Active, not recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00004204 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Florida Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Cancer Center of Albany Medical Center Albany, New York, United States, 12208 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Nalitt Institute for Cancer And Blood Related Diseases Staten Island, New York, United States, 10305 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Neurological Clinic Portland, Oregon, United States, 97210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00527761 Metastatic Melanoma Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006024 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 1 Completed - -
NCT02805179 Glioma Phase 2 Recruiting June 2020 United States, Michigan ... More >> University of Michigan Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jody Sharp    734-615-4909    sharpjd@umich.edu    Principal Investigator: Michelle Kim, M.D. Less <<
NCT01450826 Nausea Vomiti... More >>ng Glioma Less << Phase 2 Completed - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT00003062 Lung Cancer Phase 2 Completed - Italy ... More >> Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Poland Medical University of Gdansk Gdansk, Poland, 80-211 South Africa Medical Oncology Centre of Rosebank Johannesburg, South Africa, 2193 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT01450826 - Completed - -
NCT00076856 Carcinoma, Non-Small-Cell Lung... More >>|Neoplasm Metastasis|Brain Neoplasms Less << PHASE2 COMPLETED 2006-03-31 -
NCT00248534 - Terminated(slow accrual/lack o... More >>f resources/low priority due to combining 2 consortia) Less << - -
NCT00248534 Lymphoma Phase 2 Terminated(slow accrual/lack o... More >>f resources/low priority due to combining 2 consortia) Less << - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00960492 Glioblastoma ... More >>Giant Cell Glioblastoma Gliosarcoma Less << Phase 1 Completed - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Beth Israel Medical Center New York, New York, United States, 10003 United States, North Carolina Duke University Medical Center; The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System/Division of Neuro-Oncology Charlottesville, Virginia, United States, 22908 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00006877 Lung Cancer Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00004113 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01236560 Brain Stem Glioma ... More >> Cerebral Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Spinal Cord Neoplasm Untreated Childhood Brain Stem Glioma Untreated Childhood Cerebral Astrocytoma Less << Phase 2 Phase 3 Completed - -
NCT00003731 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre Hospitalier Regional de Lille Lille, France, 59037 CHU de la Timone Marseille, France, 13385 CHU de Nancy - Hopital Neurologique Nancy, France, 54035 Hopital Pasteur Nice, France, 06002 Centre Antoine Lacassagne Nice, France, 06189 Institut Gustave Roussy Villejuif, France, F-94805 Germany Nervenklinik Bamberg Bamberg, Germany, D-96049 Universitaetsklinikum Benjamin Franklin Berlin, Germany, D-12200 Klinikum der Universitat Regensburg Regensburg, Germany, DOH-9-3053 Italy Azienda Ospedaliera di Padova Padova (Padua), Italy, 35128 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Netherlands University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1093 Slovakia Postgraduate Medical Institute Bratislava, Slovakia, 833 03 Switzerland Kantonspital Aarau Aarau, Switzerland, 5001 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Less <<
NCT00003718 Endometrial Cancer ... More >> Ovarian Cancer Sarcoma Less << Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00703859 Glioblastoma Phase 1 Withdrawn - -
NCT00257205 Melanoma Phase 3 Completed - -
NCT01186406 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 2 Active, not recruiting January 2019 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 Less <<
NCT02595424 Gastric Neuroendocrine Carcino... More >>ma Intestinal Neuroendocrine Carcinoma Pancreatic Neuroendocrine Carcinoma Less << Phase 2 Recruiting January 1, 2029 -
NCT01430351 Brain Cancer Phase 1 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01186406 - Active, not recruiting - -
NCT01124240 Newly Diagnosed Non Methylated... More >> Glioblastoma Multiforme Grade 4 Less << Phase 2 Unknown January 2014 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia, 2065 Contact: Sally McCowatt, Rn    61299265049    smccowat@nsccahs.health.nsw.gov.au    Contact: Helen Wheeler, MBBS    61299267111    hrwheeler@optusnet.com.au    Principal Investigator: Helen Wheeler, MBBS Less <<
NCT00338130 Melanoma Phase 2 Completed - -
NCT01193140 Solid Tumor Cancers Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 43022 Encinitas, California, United States, 92024 Site Reference ID/Investigator# 42662 Santa Monica, California, United States, 90404 Less <<
NCT01957956 Giant Cell Glioblastoma ... More >> Glioblastoma Gliosarcoma Less << Early Phase 1 Active, not recruiting November 15, 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03477110 Glioblastoma Early Phase 1 Recruiting March 2020 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Wenyin Shi, MD    215-955-6702    wenyin.shi@jefferson.edu Less <<
NCT00978458 Brain and Central Nervous Syst... More >>em Tumors Neurotoxicity Less << Phase 3 Active, not recruiting December 31, 2026 -
NCT02343549 Cancer of Brain and Nervous Sy... More >>stem Less << Phase 2 Recruiting June 2021 United States, North Carolina ... More >> Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Sylvia Rushing Less <<
NCT01812616 Cancer Phase 1 Phase 2 Completed - Germany ... More >> Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Universitätsklinikum Aachen RWTH Aachen, Germany, 52074 Neurologie des Klinikums Altenburger Land Altenburg, Germany, 04600 Zentrum für Neuroonkologie der Universität Duesseldorf Duesseldorf, Germany, 40225 Strahlenklinik der Universität Erlangen Erlangen, Germany, 91054 United Kingdom The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Queen's Centre for Haematology & Oncology, Castle Hill Hospital Cottingham, United Kingdom, HU16 5JQ West of Scotland Beatson Cancer Centre Glasgow, United Kingdom, G12 0YN Guy's & St Thomas' NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00003304 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT03181477 Glioblastoma, Adult Not Applicable Recruiting August 4, 2020 France ... More >> CHU Besançon Not yet recruiting Besançon, France Principal Investigator: Patrick Dr Bontemps, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21850 Principal Investigator: Dr Gille TRUC, MD          Centre d'oncologie et de radiothérapie Not yet recruiting Mâcon, France Principal Investigator: Valérie Dr POUCHARD, MD          Institut de cancérologie de Lorraine Recruiting Nancy, France Principal Investigator: valérie Dr Bernier, MD          Paul Strauss Not yet recruiting Strasbourg, France, 67000 Principal Investigator: Delphine Dr Antoni, MD          Centre de Cancérologie Des Dentellières Not yet recruiting Valenciennes, France Principal Investigator: niolas Dr BLANCHARD, MD Less <<
NCT00884741 Glioblastoma ... More >>Gliosarcoma Supratentorial Glioblastoma Less << Phase 3 Completed - -
NCT00884741 - Completed - -
NCT00970996 Melanoma Phase 1 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03776071 Glioblastoma Phase 2 Not yet recruiting December 2022 -
NCT00629343 Soft Tissue Sarcoma ... More >> Mesothelioma Less << Phase 1 Unknown August 2014 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00049387 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Maryland ... More >> Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Less <<
NCT00100802 - Unknown - -
NCT00262730 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01013285 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown January 2017 United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT02490930 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Early Phase 1 Completed - United States, Maryland ... More >> The Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT00262730 - Completed - -
NCT00612638 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01107522 Solid Tumors, Glioblastoma, Re... More >>current Malignant Gliomas Less << Phase 1 Active, not recruiting - United States, New York ... More >> New York University New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10017 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 Oregon Health and Sciences University Portland, Oregon, United States, 97239 Less <<
NCT01055314 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Metastatic Childhood Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT00100802 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Unknown - -
NCT00276679 Neuroblastoma Phase 2 Completed - France ... More >> Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Ireland Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT02599090 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Withdrawn(Multi phase study di... More >>d not progress to Phase II. Phase I registered as NCT00734526.) Less << - -
NCT01115491 Glioblastoma Multiforme Phase 2 Completed - Spain ... More >> Barcelona, Spain, 08025 Barcelona, Spain, 08907 Barcelona, Spain, 08916 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Valencia, Spain, 41014 Valencia, Spain, 46026 Less <<
NCT01115491 - Completed - -
NCT01830101 Recurrent Glioblastoma Phase 3 Withdrawn(This study will not ... More >>be proceeding due to lack of funding from anticipated sources) Less << November 2017 Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT02871843 Glioblastoma ... More >>Oligodendroglioma Anaplastic Oligodendroglioma Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California San Francisco (UCSF) Recruiting San Francisco, California, United States, 94143 Contact: Jane Rabbitt    415-353-2652    Jane.Rabbitt@ucsf.edu    Contact: Thelma Munoz    415-353-2523    Thelma.Munoz@ucsf.edu    Principal Investigator: Nicholas Butowski, MD          United States, New Jersey The Cancer Institute of New Jersey (Rutgers University) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Ling Zheng    732-235-8865    Zhengl1@cinj.rutgers.edu    Principal Investigator: Robert Aiken, MD          United States, New York Weill Cornell Brain Tumor Center Recruiting New York, New York, United States, 10021 Contact: Kate Carbonell    646-962-6137    kac2051@med.cornell.edu    Principal Investigator: Howard A Fine, MD Less <<
NCT00302159 High Grade Gliomas ... More >> Brain Tumors Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-6056 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23284 Less <<
NCT01525082 Gastrinoma Gl... More >>ucagonoma Insulinoma Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Recurrent Pancreatic Cancer Somatostatinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Active, not recruiting July 2019 United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Florida Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01055314 - Completed - -
NCT00302159 - Completed - -
NCT00304031 - Completed - -
NCT00768911 Glioblastoma Multiforme Phase 1 Unknown June 2011 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Kentucky University of Kentucky Hospital Lexington, Kentucky, United States, 40536 United States, Missouri Washington University Cancer Center St. Louis, Missouri, United States, 63110 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03149575 Glioblastoma Multiforme ... More >> Glioblastoma Glioma GBM Brain Cancer Less << Phase 3 Active, not recruiting August 2019 United States, California ... More >> Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 University of California, San Francisco - Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Atlantic Neuroscience Institute - Brain Tumor Center of NJ Summit, New Jersey, United States, 07901 United States, New York Dent Neurosciences Research Center Amherst, New York, United States, 14226 Less <<
NCT00316849 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Iowa Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Capitol Des Moines, Iowa, United States, 50307 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Altru Cancer Center Grand Forks, North Dakota, United States, 58201 Less <<
NCT01364064 Glioblastoma PHASE3 COMPLETED 2025-06-08 -
NCT02343406 Glioblastoma Multiforme Phase 2 Recruiting December 13, 2020 -
NCT01044966 Glioblastoma Multiforme ... More >> Glioma Astrocytoma Brain Tumor Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated due to lack of adequate patient enrollment into trial.) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00304031 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00613028 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00004106 Lymphoma Phase 2 Terminated(Per Data Monitoring... More >> Committee given the poor/inadequate accrual.) Less << - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00734526 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00817284 Glioblastoma Multiforme Phase 2 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Odense Hospital Odense, Denmark Århus Hospital Århus, Denmark Less <<
NCT01019434 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> UZ Leuven Leuven, Belgium France Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Nantes-Saint Herblain, France, 44805 CHU Pitie-Salpetriere AP-HP Paris, France, FR 75651 Germany Universitaetsklinikum Freiburg Freiburg, Germany, DE 79106 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Italy Ospedale Bellaria Bologna, Italy, I-40139 Netherlands Medisch Centrum Haaglanden - Westeinde Den Haag, Netherlands, NL 2501 Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands, NL 3008 Spain ICO Badalona - Hospital Germans Trias i Pujol Badalona, Spain, ES 08916 Switzerland Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 United Kingdom Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom Western General Hospital Edinburgh, United Kingdom Less <<
NCT00813943 Glioblastoma Phase 2 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Less <<
NCT00813943 - Completed - -
NCT00187486 - Completed - -
NCT00613028 - Completed - -
NCT00187486 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 2 Completed - United States, California ... More >> UCSF Department of Neurological Surgery San Francisco, California, United States, 94143-0372 Less <<
NCT00481455 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Completed - United States, North Carolina ... More >> The Brain Tumor Center, Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01907165 Glioblastoma Early Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00003466 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT00033280 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT02044120 Ewing Sarcoma Phase 1 Active, not recruiting April 2021 United States, California ... More >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, Washington Seattle's Children Cancer Center Seattle, Washington, United States, 98101 United Kingdom University College London Hospital London, United Kingdom, W1T 7HA Less <<
NCT01105702 Brain Cancer Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, New Jersey ... More >> Overlook Hospital Summit, New Jersey, United States, 07902 United States, New York New York University Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT01105702 - Terminated(Due to slow accrual... More >>) Less << - -
NCT00617539 Breast Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT01143402 - Completed - -
NCT00717210 Anaplastic Astrocytoma ... More >> Oligodendroglioma Oligoastrocytoma Less << Phase 3 Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurology and Radiotherapy Tübingen, Baden-Württemberg, Germany, 72076 Klinikum Aschaffenburg Aschaffenburg, Germany Nervenklinik Bamberg, Germany Charite Berlin, Germany Neurosurgery Düsseldorf, Germany Radiotherapy Erlangen, Germany Neurology Essen, Germany Neurosurgery Frankfurt, Germany Neurosurgery Kiel, Germany Neurosurgery Mainz, Germany County District Hospital Regensburg, Germany Less <<
NCT00138216 Brain and Central Nervous Syst... More >>em Tumors Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Oregon Health and Science University Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania, United States, 18107 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-9786 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT01143402 Iris Melanoma ... More >> Medium/Large Size Posterior Uveal Melanoma Ocular Melanoma With Extraocular Extension Recurrent Uveal Melanoma Small Size Posterior Uveal Melanoma Stage IV Uveal Melanoma Less << Phase 2 Completed - -
NCT00512798 - Terminated(This study was term... More >>inated due to lack of efficacy) Less << - -
NCT03554473 Carcinoma, Small Cell ... More >> Lung Cancer Small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting January 15, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00503594 Lymphoma Phase 2 Unknown July 2012 France ... More >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD    + 33(0) 1 42 16 41 60    antonio.omuro@psl.aphp.fr Less <<
NCT00617539 - Completed - -
NCT00077454 Previously Treated Childhood R... More >>habdomyosarcoma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma Less << Phase 1 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00505635 Melanoma Phase 2 Terminated(Slow accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00512798 Brain and Central Nervous Syst... More >>em Tumors Melanoma Solid Tumor Less << Phase 1 Phase 2 Terminated(This study was term... More >>inated due to lack of efficacy) Less << - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00905060 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> UCSF Department of Neurosurgery San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, New Jersey The Valley Hospital Paramus, New Jersey, United States, 07652 United States, New York Northern Westchester Hospital Mount Kisco, New York, United States, 10549 Columbia University New York, New York, United States, 10032 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00505635 - Terminated(Slow accrual) - -
NCT00615186 Glioblastoma Multiforme Phase 3 Terminated(Due to delay in sit... More >>e initiation and funding considerations) Less << December 2013 -
NCT00875355 Breast Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - France ... More >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Youlia Kirova    33-44-32-4000 Less <<
NCT02308527 Neuroblastoma Phase 2 Recruiting January 2022 Austria ... More >> St Anna Children's Hospital and CCRI/Studies and Statistics Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43 1 40470 4750    ruth.ladenstein@ccri.at    Principal Investigator: Ruth Ladenstein, MD          Denmark University Hospital Rigshospitalet Recruiting Copenhagen, Denmark, DK-2100 Contact: Karsten Nysom, MD    45 35 45 08 09    Karsten.Nysom@regionh.dk    Principal Investigator: Karsten Nysom, MD          France Hopital des Enfants Recruiting Toulouse, France, 31059 Contact: Herve Rubie, MD    33 534 55 86 11    rubie.h@chu-toulouse.fr    Principal Investigator: Herve Rubie, MD          Ireland Our Ladys Children's Hospital Dublin Recruiting Dublin, Ireland, Dublin 12 Contact: Cormac Owens, MD    35 31 409 6659    cormac.owens@olchc.ie    Principal Investigator: Cormac Owens, MD          Italy Ospedale Pediatrico Bambino Gseu Recruiting Rome, Italy, 00165 Contact: Aurora Castellano, MD       aurora.castellano@opbg.net    Principal Investigator: Aurora Castellano, MD          Spain Instituto de Investigacion Sanitaria Recruiting Valencia, Spain, 46026 Contact: Victoria Castel, MD    34 963 862 758    castel_vic@gva.es    Principal Investigator: Victoria Castel, MD          Switzerland Swiss Paediatric Oncology Group Recruiting Bern, Switzerland, 3008 Contact: Nicolas Gerber    +41 (0)31 508 42 38    'nicolas.gerber@kispi.uzh.ch'    Contact: TuMy DiepLai    +41 (0)31 508 42 38    Tu-My.Diep@spog.ch    Principal Investigator: Nicolas Gerber`          United Kingdom The Royal Marsden NHS Foundation Trust and Institute of Cancer Research Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Andrew DJ Pearson, MD          Contact: Lucas Moreno, MD          Principal Investigator: Andrew DJ Pearson, MD Less <<
NCT01767194 Ganglioneuroblastoma ... More >> Recurrent Neuroblastoma Less << Phase 2 Completed - -
NCT00274833 CNS Tumor, Adult Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01009515 - Terminated(Low accrual; target... More >> accrual not met) Less << - -
NCT00548938 Glioblastoma Multiforme ... More >> High-Grade Glioma Less << Phase 2 Terminated(Principal Investiga... More >>tor has left the institution) Less << October 2010 United States, Tennessee ... More >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Less <<
NCT00498927 - Completed - -
NCT01196416 Recurrent Melanoma ... More >> Stage IV Skin Melanoma Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00892385 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT01196416 - Completed - -
NCT01009515 Melanoma Phase 2 Terminated(Low accrual; target... More >> accrual not met) Less << - United States, New Mexico ... More >> Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Less <<
NCT01845675 Advanced Well-differentiated P... More >>ancreatic Neuroendocrine Tumor Less << Phase 2 Completed - China ... More >> Division of Medical Oncology, Peking Union Medical College Hospital Beijing, China, 100730 Less <<
NCT00724841 Metastatic Melanoma Phase 1 Phase 2 Terminated(Study terminated pr... More >>ematurely due to financial contraints.) Less << - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00498927 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01478854 Glioblastoma Multiforme Not Applicable Active, not recruiting July 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT03119064 Glioblastoma Multiforme ... More >> Glioblastoma GBM Less << Phase 1 Phase 2 Recruiting July 2020 United States, Rhode Island ... More >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Heinrich Elinzano, MD Less <<
NCT01213407 Glioblastoma Multiforme Phase 2 Completed - Austria ... More >> Landesnervenklinik Wagner-Jauregg Linz, Oberösterreich, Austria, 4020 Landeskrankenhaus Feldkirch Feldkirch, Austria, 6807 Department of Neurosurgery, Medical University Graz Graz, Austria, 8036 Clinical Department of Neurology, Medical University Innsbruck Innsbruck, Austria, 6020 Department of Neurosurgery, Christian Doppler Klinik, Paracelsus Medizinische Privatuniversität Salzburg, Austria, 5020 Neuroonkologisches Tumorboard KFJ-KA; Rudolfsstiftung Vienna, Austria, 1030 Department of Paediatrics, Medical University Vienna Vienna, Austria, 1090 Medical Department of Oncology, Donauspital, SMZ-Ost Vienna, Austria, 1220 Less <<
NCT00662506 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00086879 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 CHU Pitie-Salpetriere Paris, France, 75651 Institut Gustave Roussy Villejuif, France, F-94805 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Medisch Centrum Haaglanden 's-Gravenhage, Netherlands, 2501 CK University Medical Center Rotterdam at Erasmus Medical Center Rotterdam, Netherlands, 3000 CA United Kingdom Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00283543 Newly Diagnosed Supratentorial... More >> Malignant Glioma Less << Phase 2 Unknown April 2008 United States, Kentucky ... More >> Kentuckiana Cancer Institute Louisville, Kentucky, United States, 40202 Less <<
NCT00072345 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00993044 - Completed - -
NCT01127178 Solid Tumors Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States United States, New Hampshire Lebanon, New Hampshire, United States United States, South Carolina Greensville, South Carolina, United States United States, Texas San Antonio, Texas, United States United States, Virginia Charlottesville, Virginia, United States Less <<
NCT00525525 - Completed - -
NCT00993044 Refractory Solid Tumors in Chi... More >>ldren Less << Phase 1 Completed - United States, California ... More >> Childrens Hospital los Angeles Los angeles, California, United States, 90027 Less <<
NCT00525525 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT00763750 Brain Tumor Phase 2 Completed - United States, Rhode Island ... More >> Lifespan Hospitals Providence, Rhode Island, United States, 02906 Less <<
NCT00763750 - Completed - -
NCT00003464 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT03018288 Glioblastoma Phase 2 Recruiting January 9, 2024 United States, Arizona ... More >> Barrow Neurological Institute Recruiting Phoenix, Arizona, United States, 85013 Contact: Kathryn Gilbert    602-406-6274       United States, Florida UF Health Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Helen Tran    321-841-3812    helen.tran@orlandohealth.com    United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke    312-695-4772    anne.mendelke@nm.org    Northshore University Health System Recruiting Glenview, Illinois, United States, 60026 Contact: Patricia Lada    847-570-2025    plada@northshore.org    Advocate Health Care Recruiting Park Ridge, Illinois, United States, 60068 Contact: Sheri Velez    847-723-5579    sherri.velez@advocate.com    United States, Maryland National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937       United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Francesca Picotte, M.D.    313-916-3181    fpicott1@hfhs.org    United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Michael Roxas    919-962-8834    michael_roxas@med.unc.edu    United States, South Carolina MUSC Hollings Cancer Center Recruiting Charleston, South Carolina, United States, 29425 Contact: Michele DeCandio    843-792-9016    decandio@musc.edu    United States, Texas Texas Oncology-Austin Brain Tumor Center Recruiting Austin, Texas, United States, 78705 Contact: Michele Harris    972-490-2963    michelle.harris2@usoncology.com    Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Amy Solis    214-820-8685    amy.solis@BSW.edu    United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Lisa Angelos    801-587-4702    Lisa.Angelos@hci.uah.edu    United States, Washington University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Valeria Martin    206-221-1538    avmartin@uw.edu    United States, Wisconsin Aurora Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Gary Dennison    414-385-7129    gary.dennison@aurora.org Less <<
NCT00869401 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01313884 - Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - -
NCT00869401 - Active, not recruiting - -
NCT00499798 - Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT02455557 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Active, not recruiting May 30, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01119599 Acoustic Schwannoma ... More >> Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma Adult Brain Stem Glioma Adult Choroid Plexus Neoplasm Adult Craniopharyngioma Adult Diffuse Astrocytoma Adult Ependymoblastoma Adult Ependymoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Grade I Meningioma Adult Grade II Meningioma Adult Medulloblastoma Adult Mixed Glioma Adult Myxopapillary Ependymoma Adult Oligodendroglioma Adult Papillary Meningioma Adult Pilocytic Astrocytoma Adult Pineal Gland Astrocytoma Adult Pineoblastoma Adult Pineocytoma Adult Primary Melanocytic Lesion of Meninges Adult Subependymal Giant Cell Astrocytoma Adult Subependymoma Adult Supratentorial Primitive Neuroectodermal Tumor Malignant Adult Intracranial Hemangiopericytoma Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT01313884 Bone Cancer E... More >>wing's Sarcoma Less << Phase 2 Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00601289 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Withdrawn(funding term ended) - -
NCT02137759 Glioblastoma Multiforme of Bra... More >>in Less << Phase 2 Recruiting June 2022 United States, Georgia ... More >> Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Rikesh Patel    404-778-2981    rikesh.b.patel@emory.edu    Contact: Lily Masoumy    404-778-1960    lily.masoumy@emory.edu    United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Matthias Holdhoff, MD, PhD    410-955-8837    mholdho1@jhmi.edu Less <<
NCT00027742 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00004200 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Agouron Pharmaceuticals, Inc. La Jolla, California, United States, 92037 Less <<
NCT00354068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00096265 Metastatic Malignant Neoplasm ... More >>in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Terminated - -
NCT02270034 Glioblastoma Multiforme (Grade... More >> IV) of Cerebellum Less << Phase 1 Recruiting February 2019 Spain ... More >> Institut Català D'Oncologia L'Hospitalet (Ico) Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Ana Márquez, Pharmacist    +34934344412    ana.marquez@mfar.net    Principal Investigator: Miguel Gil, MD          Hospital Del Mar Active, not recruiting Barcelona, Spain, 08003 Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Estela Pineda, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Ana Márquez, Pharmacist    +934344412    ana.marquez@mfar.net    Principal Investigator: Juan Sepulveda, MD Less <<
NCT00096265 - Terminated - -
NCT00027625 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75390-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT02663440 Glioblastoma Multiforme Phase 2 Unknown - China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    86-571-88122098    cxzfyun@sina.com    Principal Investigator: Xiaozhong Chen, MD Less <<
NCT00112502 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Florida University of Texas MD Anderson Cancer Center at Orlando Orlando, Florida, United States, 32806-2134 United States, Georgia CCOP - Atlanta Regional Atlanta, Georgia, United States, 30342-1701 United States, Illinois CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Grand Rapids Grand Rapids, Michigan, United States, 49503 CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, South Carolina CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02378532 Glioblastoma Multiforme Phase 1 Recruiting June 2019 Netherlands ... More >> Maastricht Radiation Oncology Recruiting Maastricht, Netherlands, 6202 AZ Less <<
NCT03234595 Recurrent High Grade Glioma Phase 1 Phase 2 Recruiting December 31, 2021 Taiwan ... More >> Hualien Tzu Chi Hospital Recruiting Hualien City, Taiwan, 970 Contact: Jui-Hao Lee, Ph.D.    +886-3-863-0108    juihaolee@efbiotech.com Less <<
NCT01328535 - Active, not recruiting - -
NCT01217398 Intraocular Melanoma Phase 2 Unknown - France ... More >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Contact Person    33-1-4432-4068    sophie.piperno-neumann@curie.net Less <<
NCT00003747 Melanoma (Skin) Phase 1 Unknown - United Kingdom ... More >> Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Less <<
NCT01502241 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Phase 3 Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 University of Frankfurt Frankfurt, Hessen, Germany, 60528 Charite Berlin Berlin, Germany University of Bochum Bochum, Germany University of Bonn Bonn, Germany University of Dresden Dresden, Germany University of Düsseldorf Düsseldorf, Germany University of Erlangen Erlangen, Germany University of Essen Essen, Germany University of Freiburg Freiburg, Germany University of Hamburg Hamburg, Germany University of Hannover II Hannover, Germany University of Hannover Hannover, Germany University of Homburg Homburg, Germany University of Kiel Kiel, Germany University of Leipzig Leipzig, Germany University of Mainz Mainz, Germany University of Heidelberg Mannheim, Germany University of Marburg Marburg, Germany University of Regensburg Regensburg, Germany University of Tübingen Tübingen, Germany University of Ulm Ulm, Germany Switzerland University of Zurich Zurich, Switzerland, 8091 Less <<
NCT00014261 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New Hampshire ... More >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756-0002 Less <<
NCT00020150 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01864109 Newly Diagnosed Ewing Sarcoma Phase 2 Recruiting May 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Paul Meyers, MD    212-639-5952       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul Meyers, MD    212-639-5952       Contact: Emily Slotkin, MD    212-639-8856       Principal Investigator: Paul Meyers, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Paul Meyers, MD    212-639-5952 Less <<
NCT01328535 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Active, not recruiting December 15, 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03008148 Glioblastoma Phase 2 Phase 3 Not yet recruiting October 2023 Taiwan ... More >> Taipei Veterans General Hospital Not yet recruiting Taipei City, Taiwan, 11217 Principal Investigator: Yu-Ming Liu          Tri-Service General Hospital Not yet recruiting Taipei City, Taiwan, 11490 Principal Investigator: Hsin-I Ma Less <<
NCT00601614 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Withdrawn(no enrollment) - -
NCT00006025 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00021307 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Withdrawn(Study not activated.... More >>) Less << - -
NCT00006358 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Neuro-Oncology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01390571 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United Kingdom ... More >> Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 0QQ Christie Hospital Manchester, England, United Kingdom Royal Marsden Hospital Sutton, England, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH Western General Hospital Edinburgh, United Kingdom, EH4 2XU Less <<
NCT00458601 Malignant Glioma Phase 2 Completed - -
NCT00033709 Sarcoma Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT02661282 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Phase 2 Recruiting June 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00003176 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01062425 Adult Glioblastoma ... More >> Adult Gliosarcoma Less << Phase 2 Active, not recruiting - -
NCT02991456 Chemo-radiation Induced Nausea... More >> and Vomiting Less << Phase 2 Recruiting April 27, 2021 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Mary Lou Affronti, DNP, RN, ANP, MHSc    919-684-5301       Contact: Edythe Parker, BS, MBA    919-684-5301       Principal Investigator: Katherine Peters, MD, PhD Less <<
NCT01851369 Lymphomas Sol... More >>id Tumors NSCLC Metastatic Colon Carcinoma Granulosa Cell Ovarian Cancer Less << Phase 1 Phase 2 Recruiting February 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01062425 - Active, not recruiting - -
NCT00412503 Refractory Tumors ... More >> Malignant Tumors Less << Phase 1 Completed - France ... More >> Institut Gustave Roussy Villejuif, Ille de France, France, 94805 Less <<
NCT02903069 Glioblastoma ... More >>Malignant Glioma Less << Phase 1 Recruiting May 31, 2020 United States, California ... More >> University of California, Irvine Medical Center Comprehensive Brain Tumor Program Recruiting Irvine, California, United States, 92697 Contact: Jinah Chung    714-456-8442    jinahec@uci.edu    Principal Investigator: Daniela Bota, MD, PhD          University of California, San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92037 Contact: Brian Churas    858-534-7996    bchuras@ucsd.edu    Principal Investigator: David Piccioni, MD, PhD          John Wayne Cancer Institute at the Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher    310-582-7460    najee.boucher@providence.org    Principal Investigator: Santosh Kesari, MD, PhD          United States, Illinois Northwestern Brain Tumor Institute at Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke       anne.mendelke@northwestern.edu    Contact: Roger Stupp, MD    (855) 695-6284       United States, North Carolina Duke University Medical Center, Preston Robert Tisch Brain Tumor Center Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring    919-684-2527    sarah.woodring@duke.edu    Contact: Denise Jaggers    919-613-6803    denise.jaggers@dm.duke.edu    Principal Investigator: Annick Desjardins, MD          United States, Pennsylvania Penn State Health Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Scott Murphy    717-531-0003 ext 283114    smurphy6@pennstatehealth.psu.edu    Principal Investigator: Dawit G Aregawi, MD          Canada, Ontario Princess Margaret Hospital, Gerry and Nancy Pencer Brain Tumour Centre Recruiting Toronto, Ontario, Canada Contact: Mariya Bakalets    416-946-4603    mariya.bakalets@uhn.ca    Contact: Elena Chizhov    416-946-4624    elena.chizhov@uhn.ca    Principal Investigator: Warren Mason, MD          Switzerland University Hospital Zurich Brain Tumor Center Recruiting Zurich, Switzerland, 8091 Contact: Carola Keding    +41 44 255 55 00    carola.keding@usz.ch    Principal Investigator: Patrick Roth, MD Less <<
NCT00083096 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - France ... More >> Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT01149850 Giant Cell Glioblastoma ... More >> Glioblastoma Gliosarcoma Less << Phase 2 Active, not recruiting January 1, 2019 United States, California ... More >> Kaiser Foundation Hospital Los Angeles, California, United States, 90027 University of California, Los Angeles Los Angeles, California, United States, 90095 Kaiser Permanente at San Diego San Diego, California, United States, 92120 Less <<
NCT01822275 Histologically Proven Diagnosi... More >>s of Glioblastoma or Gliosarcoma (WHO Grade IV) Less << Phase 2 Recruiting December 2018 United States, Maryland ... More >> Ummc Msgcc Recruiting Baltimore, Maryland, United States, 21201 Contact: Caroline Poff, RN    410-369-5264    caroline.poff@umm.edu Less <<
NCT00085254 - Completed - -
NCT00003708 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 San Antonio Cancer Institute San Antonio, Texas, United States, 78229 Less <<
NCT00006353 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 British Columbia Cancer Agency - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Doctor Leon Richard Oncology Centre Moncton, New Brunswick, Canada, E1C 8X3 Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 Less <<
NCT03189706 Neuroblastoma (NB) Early Phase 1 Recruiting June 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Shakeel Modak, MD    212-639-7623       Contact: Brian Kushner, MD    212-639-6793       Principal Investigator: Shakeel Modak Less <<
NCT00272415 Melanoma Phase 1 Terminated - -
NCT01740258 Malignant Glioma ... More >> Grade 4 Malignant Glioma Glioblastoma Gliosarcoma Less << Phase 2 Active, not recruiting December 2019 United States, North Carolina ... More >> Duke Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00626405 Melanoma (Skin) Phase 2 Completed - -
NCT00165230 Neuroendocrine Tumor Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconness Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00385398 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Withdrawn(lack of funding and ... More >>drug supply) Less << - -
NCT01480050 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00876993 Central Nervous System Tumors Phase 1 Completed - United States, Florida ... More >> Johns Hopkins All Children's Hospital Saint Petersburg, Florida, United States, 33701 Less <<
NCT00085254 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02085304 Glioblastoma Phase 1 Phase 2 Unknown December 2017 United States, Arizona ... More >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Recruiting Phoenix, Arizona, United States, 85013 Contact: Norissa Honea, PhD, RN    602-406-6267    Norissa.Honea@dignityhealth.org    Contact: Charlotte Myers, MS, ANP-C    602-406-5157    Charlotte.Myers@bnaneuro.net    Principal Investigator: Kris A Smith, MD Less <<
NCT03345095 Newly Diagnosed Glioblastoma Phase 3 Recruiting July 2023 Belgium ... More >> GasthuisZusters Antwerpen - Sint-Augustinus Recruiting Antwerpen, Belgium Principal Investigator: Paul Meijnders, Dr          Grand Hopital de Charleroi - Grand Hôpital de Charleroi - Site Notre Dame Recruiting Charleroi, Belgium Principal Investigator: Vincent Verschaeve, Dr          Canada, Ontario Windsor Regional Cancer Centre Recruiting Windsor, Ontario, Canada Principal Investigator: Kay Amin, Dr          Canada CHUM - Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame Recruiting Montréal, Canada Principal Investigator: Laura Masucci Giuseppina          CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Québec, Canada Principal Investigator: Andre Blaise          Allan Blair Cancer Centre Recruiting Regina, Canada Principal Investigator: Ibrahim Chalchal Haji          Odette Cancer Centre - Sunnybrook Health Sciences Centre Recruiting Toronto, Canada Principal Investigator: James Perry          University Health Network - Oci / Princess Margaret Hospital Recruiting Toronto, Canada Principal Investigator: Mason Warren          Centre hospitalier regional de Trois-Rivieres Recruiting Trois-Rivières, Canada Principal Investigator: Anouk Tremblay, Dr          France CHRU de Lille Recruiting Lille, France Principal Investigator: Emilie Le Rhun, Dr          Institut de Cancerologie de l'Ouest Recruiting Nantes, France Principal Investigator: Jean-Sebastien Frenel          Netherlands Spaarne Gasthuis - Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Netherlands Principal Investigator: Myra van Linde          Universitair Medisch Centrum - Academisch Ziekenhuis Recruiting Utrecht, Netherlands, 3584 Contact       f.devos@umcutrecht.nl    Principal Investigator: Filip De Vos          Norway Oslo University Hospital - Radiumhospitalet Recruiting Oslo, Norway Contact       petter.brandal@ous-hf.no    Principal Investigator: Petter Brandal          Spain Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) Recruiting Badalona, Spain Contact       cbalana@iconcologia.net    Principal Investigator: Carmen Balana          Clinica Universidad de Navarra - Clinica Universitaria De Navarra Recruiting Pamplona, Spain Principal Investigator: Gallego Jaime          Switzerland University Hospital of Geneva Recruiting Geneva, Switzerland Contact: Anna Patrikidou, MD          Principal Investigator: Anna Patrikidou          Centre Hospitalier Universitaire Vaudois Not yet recruiting Lausanne, Switzerland Contact: Andreas Hottinger, MD          Principal Investigator: Andreas Hottinger          Kantonsspital Not yet recruiting Saint Gallen, Switzerland Principal Investigator: Thomas Hundsberger          UniversitaetsSpital Recruiting Zürich, Switzerland Contact: Patrick Roth, MD          Principal Investigator: Patrick Roth Less <<
NCT02715609 Glioblastoma Multiforme Phase 1 Phase 2 Suspended(Waiting to see if a ... More >>dose expansion phase will be added) Less << February 28, 2022 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01026493 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Hawaii Leeward Radiation Oncology 'Ewa Beach, Hawaii, United States, 96706 Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States, 96813 Hawaii Medical Center - East Honolulu, Hawaii, United States, 96817 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Kansas CCOP - Kansas City Prairie Village, Kansas, United States, 66208 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503-9985 Louisville Oncology at Norton Cancer Institute - Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Regional Cancer Center at Singing River Hospital Pascagoula, Mississippi, United States, 39581 United States, Nevada Renown Institute for Cancer at Renown Regional Medical Center Reno, Nevada, United States, 89502 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Legacy Good Samaritan Hospital & Comprehensive Cancer Center Portland, Oregon, United States, 97210 Less <<
NCT00003465 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01026493 - Completed - -
NCT00805961 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00626405 - Completed - -
NCT01062399 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT02780024 Glioblastoma Multiforme Phase 2 Recruiting December 2021 Canada, Quebec ... More >> Montreal Neurological Institute - McGill University Health Centre Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Marianna Perna, CCRP,CCRC    514-934-1934 ext 43191    marianna.perna@muhc.mcgill.ca    Contact: Tatiana Carvalho, CCRP    514-934-1934 ext 43698    tatiana.carvalho@muhc.mcgill.ca    Sub-Investigator: Bassam Abdulkarim, M.D.          Sub-Investigator: Marie-Christine Guiot, M.D.          Sub-Investigator: Scott Owen, M.D.          Sub-Investigator: Kevin Petrecca, M.D.          Sub-Investigator: Valerie Panet-Raymond, M.D.          Sub-Investigator: Luis Souhami, M.D. Less <<
NCT03190967 Breast Cancer ... More >> Brain Metastasis Brain Cancer Less << Phase 1 Phase 2 Recruiting June 30, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00401180 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01062399 - Active, not recruiting - -
NCT02836028 Ovarian Cancer Phase 2 Withdrawn - -
NCT00005954 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00471653 - Terminated(low accrual) - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00394628 Glioblastoma Multiforme Phase 1 Phase 2 Unknown - United States, California ... More >> University of California, Los Angeles Recruiting Los Angeles, California, United States Contact: Emese Filka    310-794-3521       Principal Investigator: Tim Clughsey, MD          United States, Illinois Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Lilia Gallot    312-695-1363       Principal Investigator: Jeffrey Raizer, MD          United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Ruth Ann Beasse    313-916-3731    rbeasse1@hfhs.org    Principal Investigator: Tom Mikkelsen, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Velmeca McCrea    919-684-5632    velmeca.mccrea@duke.edu    Principal Investigator: David Reardon, MD          United States, Texas Baylor Research Institute Recruiting Dallas, Texas, United States Contact: Stephanie Peschka, RN    214-820-8685       Principal Investigator: Karen Fink, MD Less <<
NCT01220271 Glioma Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Jolla, California, United States, 92093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States, 94143 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durham, North Carolina, United States, 27710 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69120 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Less <<
NCT00805961 - Completed - -
NCT01452854 - Terminated(Low recruitment, sp... More >>onsor withdrew funding.) Less << - -
NCT00602576 Melanoma (Skin) Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00238251 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT03480867 Glioblastoma Multiforme, Adult Phase 1 Recruiting July 31, 2022 Canada, Québec, Canada ... More >> McGill University Health Centre-Cedars Cancer Centre Recruiting Montréal, Québec, Canada, Canada, H4A 3J1 Contact: Valerie Panet-Raymond, M.D.    514-934-4440    valerie.panet-raymond@mcgill.ca    Contact: Marianna Perna, CCRP    514-934-1934 ext 43191    marianna.perna@muhc.mcgill.ca    Sub-Investigator: Bassam Abdulkarim, M.D.          Sub-Investigator: Kevin Petrecca, M.D.          Sub-Investigator: Scott Owen, M.D.          Sub-Investigator: Donatella Tampieri, M.D.          Sub-Investigator: Marie-Christine Guiot, M.D. Less <<
NCT01729260 Newly Diagnosed High-Grade Gli... More >>oma Less << Phase 1 Active, not recruiting September 2020 United States, Maryland ... More >> The Johs Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT01452854 - Terminated(Low recruitment, sp... More >>onsor withdrew funding.) Less << - United States, California ... More >> UCSF Center for Reproductive Health San Francisco, California, United States, 94115 Less <<
NCT00547131 Brain and Central Nervous Syst... More >>em Tumors Metastatic Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00005054 Breast Cancer Phase 2 Unknown - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00920595 Solid Tumor Phase 1 Completed - France ... More >> Cephalon Investigational Site Nantes, France, 44805 United Kingdom Cephalon Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT00098436 Leukemia Phase 1 Completed - United States, Indiana ... More >> American Health Network - North Illinois Street Indianapolis, Indiana, United States, 46202 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT03150810 Locally Advanced or Metastatic... More >> Solid Tumors Less << Phase 1 Phase 2 Recruiting August 1, 2020 United States, Michigan ... More >> START Midwest Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Kathy Estkowski, BS, CCRP          Contact: Yvette C. Cole, RN, BSN, OCN          Principal Investigator: Nehal Lakhani, MD, PhD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Melissa Meredith, MD          Principal Investigator: Haesong Park, MD          United States, New York Mount Sinai - PRIME Recruiting New York, New York, United States, 10029 Principal Investigator: Matthew Galsky, MD          Montefiore Medical Center PRIME Recruiting New York, New York, United States, 10461 Principal Investigator: Sanjay Goel, MD          United States, Tennessee Sarah Cannon Research Institute (Tennessee Oncology) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Melissa Johnson, MD          United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 Contact: Angela Streck          Contact: Jessica Bondurant          Principal Investigator: John Nemunaitis, MD Less <<
NCT01478321 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Less << Phase 2 Active, not recruiting November 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 Northwestern Lake Forest Hospital Lake Forest, Illinois, United States, 60045 Edward Cancer Center Naperville, Illinois, United States, 60540 Central Dupage Hospital Warrenville, Illinois, United States, 60555 Less <<
NCT00305864 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - -
NCT00034697 Metastases, Neoplasm ... More >> Carcinoma, Non-Small-Cell Lung Brain Neoplasms Less << Phase 2 Terminated(Slow Enrollment) - -
NCT01700569 Grade IV Astrocytoma ... More >> Glioblastoma Less << Phase 1 Unknown March 2018 France ... More >> ICO site Gauducheau Recruiting Nantes, France, 44805 Contact: Mario Campone, MD, PhD    +33240679900    mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD, PhD          Sub-Investigator: Jean S FRESNEL, MD Less <<
NCT00268684 Carcinoma, Non-Small-Cell Lung... More >> Neoplasm Metastasis Less << Phase 3 Unknown - Israel ... More >> Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 63409 Contact: Felix Bokstein, M.D.    972-524266532    fbok@netvision.net.il    Contact: Debora Blumenthal, M.D.    972-524266403    dvorab@tasmc.gov.il Less <<
NCT00639262 Brain Metastases ... More >> Primary Brain Tumors Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00516607 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - United Kingdom ... More >> Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Less <<
NCT00305864 - Completed - -
NCT03623347 - Completed - -
NCT01345370 - Completed - France ... More >> CHRU Hautepierre Strasbourg, Alsace, France, 67 CHU de Bordeaux Bordeaux, Aquitaine, France, 33000 CHU Cote de Nacre Caen, Basse Normandie, France, 14000 Center Eugene Marquis Rennes, Brittany, France, 35000 CHU La Salpetriere Paris, Ile de France, France, 75000 CHRU de Lille Lille, Nord Pas-de-Calais, France, 59000 CHU La Timone Marseille, Paca, France, 13000 CHU de Poitiers Poitiers, Poitou-Charentes, France, 86000 CHU de Grenoble Grenoble, Rhone-Alpes, France, 38000 CHU de Lyon Lyon, Rhone-Alpes, France, 69000 Less <<
NCT01260103 Optic Nerve Glioma Phase 3 Withdrawn(Withdrawn study halt... More >>ed prematurely, prior to enrollment of first participant) Less << December 2018 -
NCT02943733 Neuroendocrine Tumors ... More >> Neoplasms Cancer Tumors Less << Phase 1 Recruiting August 2020 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu    Principal Investigator: Nataliya Uboha Less <<
NCT00504660 Anaplastic Glioma of Brain ... More >> Glioblastoma Multiforme Brain Cancer Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01467986 Neuroblastoma Recurrent Phase 2 Recruiting December 2019 Germany ... More >> University Hospital Regensburg, Department of Pediatric Hematology and Oncology Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD    +49(0)941 944-2101    selim.corbacioglu@ukr.de    Principal Investigator: Selim Corbacioglu, MD Less <<
NCT00720356 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida M.D. Anderson Cancer Center at Orlando Orlando, Florida, United States, 32806-2134 United States, Illinois Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611-3013 Evanston Hospital Evanston, Illinois, United States, 60201-1781 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Neuro-Oncology Associates at Baylor University Medical Center, Dallas Dallas, Texas, United States, 75246 M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 The Methodist Hospital Neurological Institute Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 19024 Less <<
NCT00005815 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02799238 Glioblastoma Phase 2 Recruiting January 2022 Sweden ... More >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden Contact: Katja Werlenius, Dr. Med          Principal Investigator: Katja Werlenius          Sub-Investigator: Marie Sjögren          Ryhov hospital Recruiting Jönköping, Sweden, 55185 Contact: Mickael Stradeus, MD       mickael.stradeus@rjl.se    Skånes university hospital Recruiting Lund, Sweden, 221 85 Contact: Sara Kinhult, MD       sara.kinhult@skane.se    Karolinska University hospital Recruiting Stockholm, Sweden, 171 76 Contact: Giuseppe Stragliotto, MD       giuseppe.stragliotto@karolinska.se    Contact: Sofia Hylin, MD       sofia.hylin@karolinska.se Less <<
NCT00504660 - Completed - -
NCT00720356 - Completed - -
NCT00222443 Lymphomas Tum... More >>ors Less << Phase 1 Completed - United States, Oklahoma ... More >> Oklahoma University Health Sciences Center-Jimmy Everest Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00121680 Metastatic Melanoma Phase 1 Completed - United States, Texas ... More >> Dallas, Texas, United States Houston, Texas, United States Less <<
NCT02815410 Glioblastoma Multiforme Phase 2 Not yet recruiting June 2022 -
NCT00016055 Melanoma (Skin) Phase 1 Unknown - United States, Wisconsin ... More >> Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT02227576 Thrombocytopenia ... More >> Glioblastoma Less << Phase 2 Terminated(Study halted for ef... More >>ficacy following the results of the interim analysis provided for in the protocol on 20 patients.) Less << - France ... More >> CHRU de Lille, Hôpital Roger Salengro,Clinique de Neurochirurgie Lille, France, 59037 Cedex Hôpital Neurologique Pierre Wertheimer, Lyon, Lyon, France AP-HM,Hôpital La Timone, AP-HM, Marseille Marseille, France AH-HP, Hôpital Pitié-Salpêtrière, Service de Neurologie 2 Paris, France, 75013 Less <<
NCT03393000 Glioblastoma Phase 3 Recruiting June 23, 2022 United States, California ... More >> University of California Recruiting Irvine, California, United States, 92868 Contact: Ricardo Avalos    714-509-2495    ravalos2@uci.edu    Contact: Mohamad Alsharif    714-509-2371    alsharim@uci.edu    Principal Investigator: Daniela Bota, MD, PhD          Scott Peak, M.D. Recruiting Redwood City, California, United States, 94063 Contact: Nancy Mendelssohn    650-299-4165    nancy.d.mendelssohn@kp.org    John Wayne Cancer Institute @ Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Naj Boucher    310 582 7460    Najee.Boucher@Providence.Org    Principal Investigator: Santosh Kesari, MD, PhD, FANA, FAAN          United States, Georgia Piedmont Cancer Recruiting Atlanta, Georgia, United States, 30318 Contact: Jane R Myrie    404-425-7927    jacene.myrie@piedmont.org    Principal Investigator: Erin Dunbar, MD          John B. Amos Cancer Center Recruiting Columbus, Georgia, United States, 31904 Contact: Felicia Irvin    706-478-7968    firvin@iacthealth.com    Contact: Katrina Quidley    706-321-0495       Principal Investigator: Douglas Ciuba, M.D.          United States, Minnesota Abbott Northwestern Hospital Recruiting Minneapolis, Minnesota, United States, 55407 Contact: Amy Ellenberger, CCRC    612-863-6562       Contact: Emily Shoemaker, MPH    612-863-0324       Principal Investigator: John Trusheim, M.D.          United States, New Jersey John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello, RN, BSN, CCRP    551-996-5098    lori.cappello@hackensackmeridian.org    Principal Investigator: Samuel A Goldlust, MD          United States, New Mexico UNM Comprehensive Cancer Center Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Melissa Gibson    505-272-5237    mngibson@salud.unm.edu    Contact: Sariat Ibrahim    505-272-7412    SIbrahim@salud.unm.edu    Principal Investigator: Ben Liem, MD          United States, New York North Shore University Hospital Recruiting Manhasset, New York, United States, 11030 Contact: Louise A Purcell, NP    516-941-1260    LPurcell@Northwell.edu    Principal Investigator: Michael Schulder, MD          Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Angela Stangarone    212-241-9843    Angela.stangarone@mssm.edu    Principal Investigator: Adilia Hormingo, MD, PhD          United States, Oregon Providence Portland Medical Center Recruiting Portland, Oregon, United States, 97213 Contact: Larisa Lindgren    503-215-2614       Principal Investigator: Herschel D Wallen, M.D.          United States, South Carolina Scott Lindhorst, M.D. Recruiting Charleston, South Carolina, United States, 29425 Contact: John "Bo" Keller    843-792-2209    kellej@musc.edu    Contact: Michele DeCandio    843-792-9016    decandio@musc.edu    United States, Texas Neuro Oncology Associates Recruiting Dallas, Texas, United States, 75246 Contact: Oghenevovwero Sido    214-820-6168    Oghenevovwero.sido@BSWhealth.org    Contact: Carolyn Nwankwo    214-865-4978    carolyn.nwankwo@BSWhealth.org    Principal Investigator: Karen Fink, MD, PhD Less <<
NCT02065466 Metastatic Melanoma ... More >> Brain Metastases Less << Phase 1 Phase 2 Withdrawn(lack of accrual) - United States, Arizona ... More >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 University of Arizona Cancer Center Tucson, Arizona, United States, 85742 Less <<
NCT02203526 Primary Central Nervious Syste... More >>m Lymphoma Less << Phase 1 Recruiting June 15, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01044225 Glioblastoma Phase 2 Terminated(Results of the phas... More >>e III RTOG0525 trial made the manufacturer of cilengitide decide to end their support to the trial) Less << - Belgium ... More >> Onze-Lieve-Vrouwziekenhuis Aalst, Belgium, 9300 ZNA Middelheim Antwerpen, Belgium, 2020 GHdC Charleroi Charleroi, Belgium, 6000 ZOL Campus Sint-Jan Genk, Belgium, 3600 UZ Gent Gent, Belgium, 9000 UCL de Mont-Godinne Yvoir, Belgium, 5530 Less <<
NCT02681705 Medulloblastoma Phase 2 Unknown December 2016 China, Shanghai ... More >> The Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Chuanying zhu, MD    862125076994    sdnanhai123@163.com    Principal Investigator: Mawei Jiang, MD Less <<
NCT00944801 Glioblastoma Phase 1 Phase 2 Completed - Germany ... More >> University of Regensburg, Department of Neurology Regensburg, Germany, 93053 Less <<
NCT03396575 Diffuse Intrinsic Pontine Glio... More >>ma (DIPG) Less << Phase 1 Recruiting June 2022 United States, Florida ... More >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Contact: Marcia Hodik, RN    352-273-6971    marcia.hodik@neurosurgery.ufl.edu    Principal Investigator: Sridharan Gururangan, FRCP          University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 Less <<
NCT01702610 Glioblastoma Mutliforme Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Center Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT00311857 Glioblastoma Multiforme Phase 1 Phase 2 Unknown - Germany ... More >> University of Heidelberg Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Daniela Schulz-Ertner, MD    +49-6221-56 ext 8201    Daniela.Ertner@med.uni-heidelberg.de    Contact: Stephanie E Combs, MD    +49-6221-56 ext 8201    Stephanie.Combs@med.uni-heidelberg.de    Principal Investigator: Daniela Schulz-Ertner, MD          Sub-Investigator: Stephanie E Combs, MD Less <<
NCT01605162 Wild Type BRAF Stage IV Melano... More >>ma Unresectable Stage III Melanoma Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Pittsburgh, Pennsylvania, United States Less <<
NCT02970448 High Grade Glioma Early Phase 1 Recruiting January 2020 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Jennifer Yu, MD, PhD    216-445-9799    yuj2@ccf.org Less <<
NCT00080054 Glioma Gliobl... More >>astoma Astrocytoma Oligodendroglioma Brain Neoplasm Less << Phase 1 Completed - United States, Arizona ... More >> Barrow Neurological Institute Phoenix, Arizona, United States, 85013 Less <<
NCT01310868 Glioblastoma Phase 2 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Royal Preston Hospital Preston, Lancashire, United Kingdom Ninewells Hospital Dundee, United Kingdom Southern General Hospital Glasgow, United Kingdom Hull Royal Infirmary Hull, United Kingdom Leeds General Infirmary Leeds, United Kingdom The Walton Centre Liverpool, United Kingdom King's College Hospital London, United Kingdom University College London Hospital/ National Hospital for Neurology and Neurosurgery London, United Kingdom Royal Hallamshire Hospital Sheffield, United Kingdom Less <<
NCT00626483 Malignant Neoplasms Brain Phase 1 Active, not recruiting June 2019 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01310868 - Completed - -
NCT02520635 Glioblastoma Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100005 Less <<
NCT00267592 Glioblastoma Multiforme Phase 2 Completed - -
NCT00369590 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00369590 - Completed - -
NCT01465347 - Completed - -
NCT00154375 Glioblastoma Multiforme ... More >> Astrocytoma Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Duelmen, Germany Less <<
NCT02976441 Astrocytoma B... More >>rainstem Glioma Ependymoma Mixed Glioma Oligodendroglioma Optic Nerve Glioma Less << Early Phase 1 Withdrawn(Physician decided no... More >>t to go through with study) Less << February 2018 -
NCT01465347 Glioblastoma ... More >>GBM Glioma Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> St. Joseph's Medical Center Barrow Neurology Clinics Phoenix, Arizona, United States, 85013 United States, Arkansas University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States, 72205 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, District of Columbia The George Washington University Medical Center Washington, D.C., District of Columbia, United States, 20037 United States, Florida University of Florida McKnight Brain Institute Gainesville, Florida, United States, 32611 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 United States, North Carolina Forsyth Regional Cancer Center Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania Penn State University Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 University of Texas Health Science Center Memorial Hermann Medical Center Houston, Texas, United States, 77030 United States, Virginia UVA Health Sciences Center Emily Couric Clinical Cancer Center Charlottesville, Virginia, United States, 22908 United States, Wisconsin Froedtert & Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00667953 Melanoma Adva... More >>nced Melanoma Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00473408 - Terminated(Moved to another co... More >>untry, not possible to recruit from abroad.) Less << - Norway ... More >> Dept. of Oncology & Dept. of Radiology, Haukeland University Hospital Bergen, Norway, Hordaland, Norway, 5021 Less <<
NCT00687765 Glioblastoma Phase 1 Phase 2 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States, 35294 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Georgia Research Site Atlanta, Georgia, United States, 30322 United States, Maryland Research Site Baltimore, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States, 92114 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, North Carolina Research Site Winston Salem, North Carolina, United States, 27157 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00154375 - Completed - -
NCT01528046 Solid Tumors ... More >>Primary Brain Tumors Less << Phase 1 Recruiting December 2020 United States, Connecticut ... More >> Connecticut Children's Medical Center Recruiting Hartford, Connecticut, United States, 06106 Contact: Robin Arens    860-545-9637    Rarens@ccmckids.org    Principal Investigator: Michael Isakoff, M.D.          Sub-Investigator: Donna Boruchov, M.D.          Sub-Investigator: Kerry Moss, M.D.          Sub-Investigator: Andrea Orsey, M.D.          Sub-Investigator: Nehal Parikh, M.D.          Sub-Investigator: Arnold Altman, M.D.          United States, Delaware Nemours/Alfred I. duPont Hospital for Children, Delaware Recruiting Wilmington, Delaware, United States, 19803 Contact: Debra J. Bertz    302-651-5757    debra.bertz@nemours.org    Principal Investigator: Edward A. Kolb, M.D.          Sub-Investigator: Andrew Walter, M.D.          Sub-Investigator: Jonathan Powell, M.D.          Sub-Investigator: Emi Caywood, M.D.          Sub-Investigator: Robin Miller, M.D.          Sub-Investigator: Gregory Griffin, M.D.          United States, Florida University of Florida Terminated Gainesville, Florida, United States, 32611 Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Ingrid Ingram    904-697-3985    iingram@nemours.org    Principal Investigator: Scott Bradfield, M.D.          Sub-Investigator: Eric Sandler, M.D.          Sub-Investigator: Michael Joyce, M.D.          Sub-Investigator: Cynthia Gauger, M.D.          Sub-Investigator: Manisha Bansal, M.D.          Sub-Investigator: Paul Pitel, M.D.          Holtz Children's Hospital at the University of Miami Recruiting Miami, Florida, United States, 33124 Contact: Myriam Zayas    305-243-7846    MZayas2@med.miami.edu    Principal Investigator: John Goldberg, M.D.          Sub-Investigator: Cristina Fernandes, M.D.          Sub-Investigator: Joanna Davis, M.D.          Sub-Investigator: Antonello Podda, M.D.          Sub-Investigator: Martin Andreansky, M.D.          Sub-Investigator: Julio Barredo, M.D.          Sub-Investigator: Ofelia Alvarez, M.D.          Johns Hopkins All Children's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Ashley Repp, RN    727-767-4784    Ashley.Repp@allkids.org    Contact: Frances Hamblin    727-767-2423    frances.hamblin@allkids.org    Principal Investigator: Damon Reed, M.D.          Sub-Investigator: Irmel Ayala, M.D.          Sub-Investigator: Gregory Hale, M.D.          Sub-Investigator: Nanette Grana, M.D.          Sub-Investigator: Stacie Stapleton, M.D.          Sub-Investigator: Kelly Sawczyn, M.D.          Sub-Investigator: Jennifer Mayer, M.D.          Sub-Investigator: Jody Kerr, M.D.          Tampa General Hospital Recruiting Tampa, Florida, United States, 33606 Contact: Denise Fife    813-844-7829    dafife@tgh.org    Principal Investigator: Cameron Tebbi, M.D.          H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Tiffany Smith    813-745-6250    tiffany.smith@moffitt.org    Principal Investigator: Damon Reed, M.D.          United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Tammy Taylor    859-323-6975    tammy.taylor@uky.edu    Principal Investigator: Lars Wagner, M.D.          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: David Loeb, M.D.    410-502-7247    loebda@jhmi.edu    Principal Investigator: David Loeb, M.D.          United States, New York The Children's Hospital at Montefiore Recruiting Bronx, New York, United States, 10467 Contact: Noam Zeffren    718-741-2356    nzeffren@montefiore.org    Principal Investigator: Jonathan Gill, M.D.          United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Sharon Guerry    919-966-1178       Contact: Patrick Thompson, M.D    919-966-1178    patom@email.unc.edu    Principal Investigator: Patrick Thompson, M.D.          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Amy Yekisa    614-722-6570    Amy.Yekisa@nationwidechildrens.org    Principal Investigator: Bhuvana Setty, M.D.          United States, Utah Primary Children's Medical Center/Utah Recruiting Salt Lake City, Utah, United States, 84113 Contact: Melissa Bolton    801-213-3909    melissa.bolton@hsc.utah.edu    Principal Investigator: Holly Spraker-Perlman, M.D.          Sub-Investigator: Richard Lemons, M.D., Ph.D.          Sub-Investigator: Jennifer Wright, M.D. Less <<
NCT00004068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Tennessee ... More >> Saint Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT00390403 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01022918 Naive Unresectable Glioblastom... More >>a Less << Phase 2 Completed - France ... More >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Less <<
NCT00974987 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Japan ... More >> Osaka Medical College Takatsuki, Osaka, Japan, 569-8686 Less <<
NCT01866449 Glioblastoma Multiforme (GBM) ... More >>WHO Grade IV Less << Phase 2 Completed - Germany ... More >> Hämatologisch onkologische Praxis Augsburg, Germany, 86150 Stiftungsklinikum Mittelrhein GmbH Koblenz, Germany, 56068 Lars Bullinger, MD Ulm, Germany, 89081 Less <<
NCT01020292 Glioma Phase 1 Active, not recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03763422 Low-grade Glioma ... More >> Temozolomide Phase III Wait or Treat Less << Phase 3 Not yet recruiting October 2031 -
NCT00052455 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00734864 Glioblastoma Multiforme ... More >> Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioma Less << Phase 1 Withdrawn(Study drug supplier ... More >>withdrew support for the study. Study was withdrawn from the Duke IRB.) Less << June 2012 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00068250 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville Beach, Florida, United States, 32250 Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207 Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States, 32207 Baptist Medical Center South Jacksonville, Florida, United States, 32258 Integrated Community Oncology Network - Orange Park Orange Park, Florida, United States, 32073 Florida Cancer Center - Palatka Palatka, Florida, United States, 32177 Flagler Cancer Center Saint Augustine, Florida, United States, 32086 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49001 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Bronson Methodist Hospital Kalamazoo, Michigan, United States, 49007 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nevada CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey John F. Kennedy Medical Center Edison, New Jersey, United States, 08818 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Providence Milwaukie Hospital Milwaukie, Oregon, United States, 97222 Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 Providence St. Vincent Medical Center Portland, Oregon, United States, 97225 United States, Pennsylvania Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray, Utah, United States, 84157 Utah Valley Regional Medical Center - Provo Provo, Utah, United States, 84604 United States, Washington Southwest Washington Medical Center Cancer Center Vancouver, Washington, United States, 98668 United States, Wisconsin Community Memorial Hospital Cancer Care Center Menomonee Falls, Wisconsin, United States, 53051 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00409383 Melanoma Phase 1 Unknown June 2013 United States, New York ... More >> New York University Cancer Center New York, New York, United States, 10016 Less <<
NCT01777919 Glioblastoma Multiforme Phase 2 Not yet recruiting January 2020 Greece ... More >> Olympion Medical Center Not yet recruiting Patras, Greece, 26443 Contact: Petros N Karamanakos, MD, PhD          Principal Investigator: Petros N Karamanakos, MD, PhD Less <<
NCT00884416 Glioblastoma ... More >>Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Less << Phase 1 Completed - Switzerland ... More >> Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, GE, Switzerland, 1211 Less <<
NCT00936052 Glioblastomas ... More >> Gliosarcoma Less << Phase 2 Unknown December 2010 United States, New York ... More >> Long Island Brain Tumor Center at Neurological surgery P.C. Recruiting Commack, New York, United States, 11725 Contact: Julia Trojanowski, RN    631-864-3900 ext 18    neurooncologyli2@gmail.com    Contact: Kerry E McConie, RN    516-478-0010 ext 14    neurooncologyli@gmail.com    Principal Investigator: J Paul Duic, MD          Principal Investigator: Jai Grewal, MD          Long Island Brain Tumor Center at Neurological Surgery P.C. Recruiting Great Neck, New York, United States, 11021 Contact: Kerry E McConie, RN    516-478-0010 ext 14    neurooncologyli@gmail.com    Contact: Julia Trojanowski, RN    631-864-3900 ext 18    neurooncologyli2@gmail.com    Principal Investigator: J Paul Duic, MD          Principal Investigator: Jai Grewal, MD Less <<
NCT03687034 Glioblastoma Phase 1 Not yet recruiting December 31, 2019 -
NCT02046187 Glioblastoma (GBM) Phase 1 Phase 2 Terminated(excessive protocol ... More >>deviations due to strict nature of diet requirements) Less << - United States, Arizona ... More >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 Less <<
NCT01342757 - Completed - -
NCT01342757 Adult Glioblastoma ... More >> Depression Recurrent Adult Brain Tumor Less << Not Applicable Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00068250 - Completed - -
NCT00943462 - Withdrawn(No eligible patients... More >> could be recruited.) Less << June 2011 -
NCT00360945 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Middlesex Hospital London, England, United Kingdom, W1T 3AA Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00486603 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Unknown - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT02092038 Glioblastoma Phase 1 Completed - United States, Florida ... More >> Tampa General Hospital Tampa, Florida, United States, 33606 Less <<
NCT00673361 Melanoma Phase 2 Terminated - -
NCT01402063 Glioblastoma Multiforme Phase 2 Completed - United States, California ... More >> UCSD Cancer Center La Jolla, California, United States, 92093 United States, Maine Maine Medical Center Scarborough, Maine, United States, 04074 United States, Massachusetts UMASS Medical Center Cancer Center Worcester, Massachusetts, United States, 01605 United States, New York SUNY Medical Center Syracuse, New York, United States, 13210 United States, Pennsylvania PSU Hershey, Pennsylvania, United States, 17033 Thomas Jefferson University Cancer Center Philadelphia, Pennsylvania, United States, 19107 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02906 United States, Texas UT Southwestern Cancer Center Dallas, Texas, United States, 75235 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00626990 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Active, not recruiting January 2024 -
NCT01402063 - Completed - -
NCT00714181 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00006474 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00492687 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00402116 Glioblastoma ... More >>Glioblastoma Multiforme Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician San Francisco, California, United States Less <<
NCT00770471 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, California UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00673361 - Terminated - -
NCT01247623 Malignant Melanoma Phase 1 Phase 2 Completed - Norway ... More >> Oslo University Hospital Oslo, Postbox 4953, Norway, 0424 Less <<
NCT00811759 Melanoma (Skin) Phase 1 Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03709680 Solid Tumors ... More >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma Less << Phase 1 Not yet recruiting September 27, 2023 -
NCT03519412 Colorectal Neoplasms ... More >> Microsatellite Instability Less << Phase 2 Not yet recruiting June 2022 Italy ... More >> Grande Ospedale Metropolitano Niguarda Not yet recruiting Milano, Italy Contact: Andrea Sartore Bianchi, MD          Istituto Nazionale Tumori di Milano Not yet recruiting Milano, Italy Contact: Filippo Pietrantonio, MD          Istituto oncologico Veneto Not yet recruiting Padova, Italy Contact: Sara Lonardi, MD Less <<
NCT02331498 Glioblastoma Multiforme Phase 1 Phase 2 Recruiting December 2018 France ... More >> Centre Antoine Lacassagne Recruiting Nice, Cedex 2, France, 06189 Contact: Esma SAADA BOUZID, Md    +33492031618    esma.saada-bouzid@nice.unicancer.fr    Contact: Christine LOVERA    +33492031618    christine.lovera@nice.unicancer.fr    Principal Investigator: Esma SAADA BOUZID, Dr          Sub-Investigator: Jérôme BARRIERE, Pr.          Sub-Investigator: Pierre Yves BONDIAU, Dr. Less <<
NCT00068952 Glioblastoma Phase 3 Completed - -
NCT00047294 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Virginia Cancer Center at the University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00099125 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00720564 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT02942264 Brain Tumor A... More >>strocytoma Astroglioma Glioblastoma Gliosarcoma Less << Phase 1 Phase 2 Recruiting August 2, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03150862 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Recruiting October 31, 2021 -
NCT03705351 Glioblastoma ... More >>Cancer of Brain Glioblastoma Multiforme Brain Tumor Less << Phase 1 Not yet recruiting December 1, 2024 United States, Oregon ... More >> Providence St. Vincent Medical Center Not yet recruiting Portland, Oregon, United States, 97225 Contact: Tiffany Gervasi-Follmar    503-216-1023    tiffany.gervasi@providence.org Less <<
NCT01164189 Central Nervous System Tumors Phase 2 Unknown - -
NCT00005952 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Head and Neck Cancer Kidney Cancer Neuroblastoma Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00020839 Melanoma (Skin) ... More >> Metastatic Cancer Less << Phase 3 Terminated(low accrual) - -
NCT00568451 - Terminated(Slow accrual.) - -
NCT02880410 Glioblastoma Phase 1 Active, not recruiting December 2020 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00568451 Melanoma (Skin) Phase 2 Terminated(Slow accrual.) - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00005951 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00006263 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Withdrawn - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00093353 Diarrhea Drug... More >>/Agent Toxicity by Tissue/Organ Neuroblastoma Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0718 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT03243461 Glioblastoma WHO Grade IV ... More >> Diffuse Midline Glioma Histone 3 K27M WHO Grade IV Anaplastic Astrocytoma WHO Grade III Diffuse Intrinsic Pontine Glioma Gliomatosis Cerebri Less << Phase 3 Recruiting June 1, 2023 Germany ... More >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Michael Frühwald, Prof.          Evangelisches Krankenhaus Bielefeld Recruiting Bielefeld, Germany Contact: Norbert Jorch, Dr.          Universitätsklinikum Bonn Recruiting Bonn, Germany Contact: Carola Weber, Dr.          Klinikum Bremen-Mitte gGmbH Recruiting Bremen, Germany Contact: Arnulf Pekrun, Prof.          Klinikum Chemnitz gGmbH Recruiting Chemnitz, Germany Contact: André Hofmann, Dr.          Carl-Thiem-Klinikum Cottbus gGmbH Recruiting Cottbus, Germany Contact: Georg Schwabe, PD Dr.          Sana Kliniken Duisburg GmbH - Wedau Kliniken Recruiting Duisburg, Germany Contact: Tanja Höll, Dr.          Universitätsklinikum Erlangen Recruiting Erlangen, Germany Contact: Markus Metzler, Prof.          Universitätsklinikum Freiburg Recruiting Freiburg, Germany Contact: Charlotte Niemeyer, Prof.          Universitätsmedizin Greifswald Recruiting Greifswald, Germany Contact: Holger Lode, Prof.          Universitätsmedizin Göttingen Recruiting Göttingen, Germany Contact: Christof Kramm, Prof.          Universitätsklinikum Halle Recruiting Halle, Germany Contact: Toralf Bernig, Dr.          Universitätsklinikum des Saarlandes Recruiting Homburg, Germany Contact: Norbert Graf, Prof.          Gesundheit Nordhessen - Klinikum Kassel Recruiting Kassel, Germany Contact: Michaela Nathrath, Prof.          Universitätsklinikum Leipzig Recruiting Leipzig, Germany Contact: Holger Christiansen, Prof.          UMM Universitätsmedizin Mannheim Recruiting Mannheim, Germany Contact: Matthias Dürken, PD Dr.          Johannes Wesling Klinikum Minden Recruiting Minden, Germany Contact: Bernhard Erdlenbruch, Prof.          Universitätsklinikum Münster Recruiting Münster, Germany Contact: Ronald Sträter, PD Dr.          Klinikum Oldenburg gGmbH Recruiting Oldenburg, Germany Contact: Hermann Müller, Prof.          Universitätsklinikum Regensburg Recruiting Regensburg, Germany Contact: Marcus Jakob, Dr.          ASKLEPIOS Klinik St. Augustin Recruiting Sankt Augustin, Germany Contact: Harald Reinhard, PD Dr.          Klinikum Stuttgart - Olgahospital Recruiting Stuttgart, Germany Contact: Stefan Bielack, Prof.          Universitätsklinikum Tübingen Recruiting Tübingen, Germany Contact: Martin Ebinger, PD Dr. Less <<
NCT03332355 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 1 Recruiting June 30, 2019 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Oana C Danciu, M.D.          United States, Maryland Johns Hopkins Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Matthias Holdhoff, M.D.          United States, Minnesota Regions Hospital Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Richard Peterson, MD    651-254-3572    Richard.A.Peterson@HealthPartners.Com    Principal Investigator: Richard Peterson, MD          Sub-Investigator: Daniel Anderson, MD          Sub-Investigator: Kurt Demel, MD          Sub-Investigator: Randolph Hurley, MD          Sub-Investigator: Balkrishna Jahagirdar, MD          Sub-Investigator: Pryia Kumar, MD          Sub-Investigator: Steven McCormack, MD          Sub-Investigator: Gary Shapiro, MD          Sub-Investigator: Peter Hurley, MD          Sub-Investigator: Stephanie Kroon, PA-C          Sub-Investigator: Angela Martizna, RN          Sub-Investigator: Joanna Hill Less <<
NCT00303940 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00715793 Malignant Melanoma Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00514397 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Contact Person    44-353-1-409-6659       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B4 6NH Contact: Martin W. English, MD    44-121-333-8412    martin.english@bch.nhs.uk    Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: Contact Person    44-117-342-0205       Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Amos Burke, MD    44-1223-348-151       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Adam Glaser, MD    44-113-206-4984    adam.glaser@leedsth.nhs.uk    Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Contact Person    44-151-252-5294       University College Hospital Recruiting London, England, United Kingdom, NW1 2BU Contact: Contact Person    44-20-7380-9950       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person    44-20-7829-7924       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Contact Person    44-113-206-4985       Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person    44-115-823-0620       Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Contact Person    44-1865-234-205       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Contact Person    44-114-271-7366       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-2380-794-101       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-20-8661-3455       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Veronica Neefjes    44-1224-550-217       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Heidi Traunecker, MD, PhD    44-29-2074-2285    heidi.traunecker@cardiffandvale.wales.nhs.uk Less <<
NCT00089427 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Oligoastrocytoma Less << Phase 1 Completed - United States, California ... More >> University of California San Francisco - Dept. of Neurological Surgery San Francisco, California, United States, 94143 United States, North Carolina Carolina Neurosurgery & Spine Assoc. Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Department of Neurological Surgery Cleveland, Ohio, United States, 44195 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health Systems - Department of Neurological Surgery Charlottesville, Virginia, United States, 22908 Less <<
NCT00387400 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT01587144 Glioblastoma Multiforme Phase 2 Terminated(Sponsor's decision) - United States, California ... More >> UCSD Moores Cancer Center La Jolla, California, United States, 92093 UCI Medical Center Orange, California, United States, 92868 United States, New York Dent Neurologic Institute Amherst, New York, United States, 14226 United States, Ohio Fairview Hospital Moll Cancer Center/Cleveland Clinic Cleveland, Ohio, United States, 44111 Cleveland Clinic Cleveland, Ohio, United States, 44195 Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic Mayfield, Ohio, United States, 44124 India Gujarat Cancer Research Institute Ahmedabad, Gujarat, India, 380016 Jaslok Hospital & Research Centre Mumbai, Maharashtra, India, 400062 Bhagwan Mahaveer Cancer Hospital & Reseach Centre Jaipur, Rajasthan, India, 302017 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Less <<
NCT00715793 - Completed - -
NCT00238277 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Terminated(Terminated - due to... More >> low accrual) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00128700 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Germany Klinikum der Universitaet Regensburg Regensburg, Germany, D-93053 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3075 EA Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT02772107 Extensive-stage Small Cell Lun... More >>g Cancer Less << Phase 2 Phase 3 Unknown January 2018 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: haitao tao, PhD    +861066937875    whatyouknow@126.com Less <<
NCT00376103 Glioblastoma Multiforme Phase 1 Phase 2 Terminated(Loss of funding fro... More >>m sponsor) Less << - United States, Tennessee ... More >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Less <<
NCT00049361 Brain and Central Nervous Syst... More >>em Tumors Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Illinois ... More >> CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, North Carolina CCOP - Southeast Cancer Control Consortium Goldsboro, North Carolina, United States, 27534-9479 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1030 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 Less <<
NCT00650923 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Recurrent Adult Brain Tumor Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles (UCLA ) Los Angeles, California, United States, 90095 UCSF-Mount Zion San Francisco, California, United States, 94115 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00807027 Glioblastoma Phase 3 Completed - Korea, Republic of ... More >> Hanyang University Guri Hospital Guri, Gyeonggi-Do, Korea, Republic of Gyunghee University Medical Center Seoul, Korea, Republic of Konkuk University Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Samsung Seoul Medical Center Seoul, Korea, Republic of Seoul Asan Medical Center Seoul, Korea, Republic of Yeonsei University Medical Center Seoul, Korea, Republic of Less <<
NCT02049593 Metastatic Cancer ... More >> Unspecified Adult Solid Tumor Less << Phase 1 Active, not recruiting June 30, 2019 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT01014767 Brain Cancer ... More >>Choroid Plexus Tumors Less << Phase 3 Suspended(PI departure from co... More >>ordinating institution) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT00694837 Glioblastoma Phase 1 Completed - Netherlands ... More >> Maastricht Radiation Oncology Maastricht, Netherlands, 6202 AZ Less <<
NCT02590263 Malignant Glioma ... More >> Glioblastoma Multiforme Less << Phase 1 Phase 2 Recruiting December 31, 2020 Japan ... More >> Nagoya University Hospital /ID# 138559 Completed Nagoya-shi, Aichi, Japan, 466-8560 Iwate Medical University Hospital /ID# 149145 Recruiting Morioka-shi, Iwate, Japan, 020-8505 Kitasato University Hospital /ID# 148493 Recruiting Sagamihara-shi, Kanagawa, Japan, 252-0375 Kyoto Prefect Univ Med /ID# 149093 Recruiting Kyoto-shi, Kyoto, Japan, 602-8566 Tohoku University Hospital /ID# 138464 Recruiting Sendai-shi, Miyagi, Japan, 980-8574 Okayama University Hospital /ID# 148674 Recruiting Okayama-shi, Okayama, Japan, 700-8558 Osaka University Hospital /ID# 140438 Recruiting Suita-shi, Osaka, Japan, 565-0871 Shizuoka Cancer Center /ID# 148673 Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 National Cancer Center Hospital /ID# 140435 Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Kyorin University Hospital /ID# 140360 Recruiting Mitaka-shi, Tokyo, Japan, 181-8611 Tokyo Women's Medical University Hospital /ID# 140436 Recruiting Shinjuku-ku, Tokyo, Japan, 162-8666 Chiba Cancer Center /ID# 164375 Recruiting Chiba, Japan, 260-0801 Saitama Med Univ Int Med Ctr /ID# 140361 Recruiting Hidaka, Japan, 350-1241 Hiroshima University Hospital /ID# 139399 Recruiting Hiroshima, Japan, 734-8551 Kumamoto University Hospital /ID# 138558 Recruiting Kumamoto, Japan, 860-0862 NHO Kyoto Medical Center /ID# 140437 Recruiting Kyoto, Japan, 612-0861 Osaka Inter. Cancer Institute /ID# 148494 Recruiting Osaka, Japan, 541-8567 Kyoto University Hospital /ID# 163206 Recruiting Sakyo-ku, Japan, 606-8507 Hokkaido University Hospital /ID# 150589 Recruiting Sapporo, Japan, 060-8648 Dokkyo Medical University Hosp /ID# 150990 Recruiting Shimotsuga, Japan, 321-0293 Nihon University Itabashi Hosp /ID# 149385 Recruiting Tokyo, Japan, 173-0032 Tsukuba University Hospital /ID# 140433 Recruiting Tsukuba, Japan, 305-8576 Less <<
NCT00431561 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Phase 2 Completed - Austria ... More >> Universitätsklinik Innsbruck; Abteilung für Neurochirurgie Innsbruck, Austria, 6020 Landes-Nervenklinik Wagner-Jauregg Linz, Austria, 4020 Kaiser Franz Josef Spital, Abteilung für Neurologie Wien, Austria, 1100 Georgia Sarajishvili Institute of Clinical Neurology and Neurosurgery Tbilisi, Georgia, 0114 Germany Medizinische Klinik und Poliklinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte Berlin, Germany, 10117 Klinik und Poliklinik für Neurologie Cottbus, Germany, 03048 Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany, 01307 Universitätsklinikum Gießen, Neurochirurgische Universitätsklinik Gießen, Germany, 35392 Universitätsklinikum Kiel, Klinik für Neurochirurgie Kiel, Germany, 24106 Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie Leipzig, Germany, 04103 Universitätsklinik Magdeburg, Klinik für Neurochirurgie Magdeburg, Germany, 39120 Universitätskliniken Mainz, Neurochirurgische Klinik und Poliklinik Mainz, Germany, 55131 Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie Münster, Germany, 48149 Klinikum und Poliklinik für Neurologie, Universität Regensburg Regensburg, Germany, 93053 Klinikum Saarbrücken, Neurochirurgie Saarbrücken, Germany, 66119 Neurologische Universitätsklinik Tübingen Tübingen, Germany, 72076 India Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre Cochin, Kerala, India, 682026 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Department of Neurosurgery Trivandrum, Kerala, India, 695011 Manipal Hospital; Manipal Institute for Neurological Disorders Bangalore, India, 560017 Department of Neurosurgery, National Institute of Mental Health and Neurosciences Bangalore, India, 560029 Department of Medical Oncology, Nizam's Institute of Medical Sciences Hyderabad, India, 500082 Department of Neurosurgery, LTMG Hospital & LTM Medical College Mumbai, India, 400022 Department of Neurosurgery, Neurosciences Center New Dehli, India, 110029 Department of Neurological Sciences, Christian Medical College & Hospital Vellore, India, 632004 Israel Soroka Medical Center, Neurosurgery Department Beer Sheva, Israel Rambam Medical Center, Neurosurgery Department Haifa, Israel, 31096 Rabin Medical Center, Neurosurgery Department Petach Tikva, Israel, 49100 Russian Federation Sverdlovsk Regional Oncological Clinic Ekaterinburg, Russian Federation, 620036 Republican Clinical Hospital of Ministry of Health of Tatarstan Republic Kazan, Russian Federation, 420064 Burdenko Neurosurgery Research Institute Moscow, Russian Federation, 125047 Omsk State Medical Academy; State Educational Institution of Higher Professional Education Omsk, Russian Federation, 644099 State Institution of Healthcare, Samara Regional Clinical Hospital in the name of M.I. Kalinin Samara, Russian Federation, 443095 Polenov Neurosurgery Research Institute St. Petersburg, Russian Federation, 191104 Military Medical Academy named after I.S.M. Kirov, Neurosurgery Department St. Petersburg, Russian Federation, 194175 Medical Center "XXI century" St. Petersburg, Russian Federation, 194354 Tcheliabinsk Regional Clinical Hospital; State Medical Institution for Prophylaxis and Treatment Tcheliabinsk, Russian Federation, 454076 Less <<
NCT00761280 Anaplastic Astrocytoma ... More >> Glioblastoma Less << Phase 3 Terminated(Unable to recruit t... More >>he projected patient number. All analyses are descriptive, only.) Less << - -
NCT01991977 Malignant Glioma Phase 2 Suspended(per study design) July 1, 2019 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00761280 - Terminated(Unable to recruit t... More >>he projected patient number. All analyses are descriptive, only.) Less << - -
NCT00915694 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00272870 Glioblastoma Multiforme (WHO G... More >>rade IV) Anaplastic Astrocytoma (WHO Grade III) Less << Phase 1 Terminated(Slow accrual; drug ... More >>availability) Less << - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00639639 Malignant Neoplasms of Brain Phase 1 Active, not recruiting December 2019 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03495960 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Not yet recruiting October 31, 2023 Italy ... More >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD          Principal Investigator: Benjamin Kasenda          IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland Less <<
NCT02685605 Glioblastoma Phase 3 Recruiting February 2021 United States, Arizona ... More >> Barrow Neurological Institute (SJHMC) Not yet recruiting Phoenix, Arizona, United States, 85013 Contact: Rima Woo       Rima.Woo@barrowbrainandspine.com    Principal Investigator: Peter Nakaji, MD          United States, Illinois Stritch School of Medicine Loyola University Recruiting Maywood, Illinois, United States, 60153 Contact: Beth A Chiappetta, RN, BSN, CCRP    708-216 ext 2568    BCHIAPPETTA@lumc.edu    Principal Investigator: William Small Jr, MD, FACRO, FACR, FASTRO          United States, New York Long Island Jewish Medical Center, North Shore University Hospital Recruiting Lake Success, New York, United States, 11042 Contact: Louise A Purcell, MS ANP-C CCRN-CMC    +1 516-941 ext 1263    LPurcell@northwell.edu    Sub-Investigator: Michael Schulder, MD          Lenox Hill Hospital, Hofstra Northwell School of Medicine Recruiting New York, New York, United States, 10028 Contact: Tamika A Wong, MPH    212-434-4836    twong4@northwell.edu    Principal Investigator: John A. Boockvar, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506-9260 Contact: Joseph Brunetti    304-293-7360       Principal Investigator: Christopher P Cifarelli, MD, PhD, FAANS, FACS          Canada, Quebec Montreal Neurological Institute and Hospital Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Anna Pietromonaco    +1-514-398- ext 2591    anna.pietromonaco@mcgill.ca    Contact: Gregory Ringkamp    +1-514-398- ext 2667    gregory.ringkamp@mcgill.ca    Principal Investigator: Kevin Petrecca, MD          Sub-Investigator: Luis Souhami, MD          Germany Klinikum Augsburg Recruiting Augsburg, Germany, 86156 Contact: Sabine Schill, PhD    +49 821 400 25 42    Sabine.Schill@klinikum-augsburg.de    Principal Investigator: Klaus H Kahl, MD          University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Anke Keller, MSc    00496213834960    anke.keller@medma.uni-heidelberg.de    Principal Investigator: Frank A Giordano, MD          Sub-Investigator: Daniel Haenggi, MD          Sub-Investigator: Michael Platten, MD          Technical University of Munich (TUM), Department of Radiation Oncology Recruiting Munich, Germany, 81675 Contact: Carmen Kessel, PhD    +49 89 4140-4501    carmen.kessel@tum.de]    Principal Investigator: Stephanie E Combs, MD          Klinikum Stuttgart Recruiting Stuttgart, Germany, 70174 Contact: Ulrike Arzbach    +49 711/ 278-33700    u.arzbach@klinikum-stuttgart.de    Principal Investigator: Oliver Ganslandt, MD          Sub-Investigator: Marc Münter, MD          Spain Catalan Institute of Oncology (ICO) Recruiting Barcelona, Spain, 08908 Contact: Montserrat Ventura Bujalance    + 34 93 260 77 22    montseventura@iconcologia.net    Principal Investigator: Ferran Guedea, MD, PhD          United Kingdom The London Clinic Not yet recruiting London, United Kingdom, W1G 6BW Contact: Christine Topham    020 3219 3570 ext 8389    C.Topham@thelondonclinic.co.uk    Contact: Alistair Gifford-Moore    020 3219 3570 ext 8384    A.Gifford-Moore@thelondonclinic.co.uk    Principal Investigator: n.n. n.n. Less <<
NCT03137888 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Recruiting September 2019 United States, Florida ... More >> University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Lilly Sanchez    305-243-0974    lsanchez@med.miami.edu    Contact: Eric Mellon, MD, PhD       eric.mellon@med.miami.edu    Principal Investigator: Eric Mellon, MD, PhD          United States, Georgia Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Lily Masoumy    404-778-1960    lily.masoumy@emory.edu    Contact: Hui-Kuo Shu, MD, PhD       hgshu@emory.edu    Principal Investigator: Hui-Kuo Shu, MD, PhD          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Deborah Epstein    410-955-8866    epstede@jhmi.edu    Contact: Lawrence Kleinberg, MD       kleinla@jhmi.edu    Principal Investigator: Lawrence Kleinberg, MD Less <<
NCT03276286 Glioblastoma Multiforme Not Applicable Recruiting December 31, 2019 United States, Alabama ... More >> University of Alabama at Birmingham (UAB) Not yet recruiting Birmingham, Alabama, United States, 35233 Contact: Thiru Pillay, RN BSN    205-934-1842    tpillay@uab.edu    Principal Investigator: Burt Nabors, MD          United States, Arizona Center for Neurosciences Recruiting Tucson, Arizona, United States, 85718 Contact: Margie Pazzi, RN, MSN    520-320-2147    mpazzi@neurotucson.com    Contact    520.795.7750       Principal Investigator: Michael Badruddoja, MD          United States, California California Cancer Care Associates Recruiting Encinitas, California, United States, 92024 Contact: Beth Kimball, RN OCN    760-452-3909    bkimball@ccare.com    Principal Investigator: Edward McClay, MD          John Wayne Cancer Institute @ Providence St Johns Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Anand Moses    310-582-7097    mosesa@jwci.org    Principal Investigator: Garni Barkhoudarian, MD          United States, Connecticut Associated Neurologists of Southern CT, PC Recruiting Fairfield, Connecticut, United States, 06824 Contact: Tori Pascoe, CRC    203-333-1151 ext 4    tpascoe@anscneuro.com    Principal Investigator: Nicholas Blondin, MD          United States, District of Columbia George Washington University Not yet recruiting Washington, District of Columbia, United States, 20037 Contact: Lindsey Covington          Principal Investigator: Jonathan Sherman          United States, Florida Boca Raton Regional Hospital Recruiting Boca Raton, Florida, United States, 33486 Contact: Pilar Zuniga, MD    561-955-4800    pzuniga@brrh.com    Principal Investigator: Sajeel Chowdhary, MD          United States, Kansas University of Kansas Medical Center (KUMC) Not yet recruiting Kansas City, Kansas, United States, 66205 Contact: Sasha Moores    913-588-5520    smoores@kumc.edu    Principal Investigator: Michael Salacz, MD          United States, Texas Cancer Care Collaborative Recruiting Austin, Texas, United States, 78705 Contact: Heidi Herndon, RN    512-324-7000 ext 77713    hherndon@ascension.org    Principal Investigator: Brian D Vaillant, MD          Baylor Scott and White Health Recruiting Temple, Texas, United States, 98101 Contact: Dedra Preece    254-724-5939    dedra.preece@bswhealth.org    Contact: Gates Anderson    254.724.5889    Gates.Anderson@bswhealth.org    Principal Investigator: Ekokobe Fonkem, DO Less <<
NCT01752491 Glioblastoma ... More >>GBM Glioblastoma Multiforme Less << Phase 1 Active, not recruiting December 31, 2021 United States, Iowa ... More >> Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT01400958 Malignant Glioma Phase 2 Terminated(Slow Accrual, Initi... More >>ating Principal Investigator (PI) left Moffitt) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02099487 Glioma Phase 2 Completed - Italy ... More >> ICH Humanitas Cancer Center Milan, Lombardia, Italy, 20090 Less <<
NCT03344250 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 1 Recruiting December 1, 2020 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Melissa Otoya, RN, MSN-CNL    434-982-3365    mo9w@virginia.edu    Principal Investigator: Camilo Fadul, MD Less <<
NCT02796261 Anaplastic Astrocytoma ... More >> Recurrent Anaplastic Astrocytoma Less << Phase 3 Recruiting August 2019 -
NCT02853565 Glioblastoma Multiforme Phase 1 Completed - Taiwan ... More >> Chang Gung Memorial Hospital, Linkou Taipei, Taiwan, 100 National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01800695 Glioblastoma Multiforme Phase 1 Completed - -
NCT02223884 Malignant Melanoma Phase 2 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT03506139 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 2 Not yet recruiting December 31, 2026 -
NCT01400958 - Terminated(Slow Accrual, Initi... More >>ating Principal Investigator (PI) left Moffitt) Less << - -
NCT03351296 Pancreatic Cancer Phase 2 Not yet recruiting June 2023 France ... More >> Gustave Roussy Not yet recruiting Villejuif, Val De Marne, France, 94805 Contact: Michel Ducreux, MD, PhD    0142116017 ext +33    michel.ducreux@gustaveroussy.fr    Contact: Dune Lemettre    0142116643 ext +33    dune.lemettre@gustaveroussy.fr Less <<
NCT00643097 - Completed - -
NCT01952886 Malignant Glioma Phase 2 Withdrawn(Lack of approval and... More >> funding from company) Less << - United States, North Carolina ... More >> Duke Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT03197506 Glioblastoma ... More >>Gliosarcoma Supratentorial Glioblastoma Less << Phase 2 Suspended(The study is tempora... More >>rily closed to enrollment per study design. Patients currently on study are being followed according to the protocol.) Less << July 31, 2022 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03246113 Glioblastoma Phase 1 Recruiting December 31, 2019 United States, New York ... More >> Columbia University Medical Center- Department of Radiation Oncology Recruiting New York, New York, United States, 10032 Contact: Tony J Wang, MD    212-305-7077    tjw2117@cumc.columbia.edu    Contact: Mariamne Reyna    646-317-4244    mo2213@cumc.columbia.edu    New York State Psychiatric Institute Recruiting New York, New York, United States, 10032 Contact: Margaret Haney, PhD    646-774-6153    Meg.Haney@nyspi.columbia.edu Less <<
NCT02313389 Primary Central Nervous System... More >> Lymphoma Less << Phase 3 Recruiting June 2021 France ... More >> Groupe Hospitalier Pitie Salpetriere Recruiting Paris, France, 75013 Contact: Khe HOANG-XUAN, MD, PhD    +33 - 1.42.16.03.81    khe.hoang-xuan@psl.aphp.fr Less <<
NCT00820963 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - France ... More >> Centre Leon Berard Lyon, France, 69373 Less <<
NCT00643097 Malignant Neoplasms of Brain Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT02208336 - Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT03387592 Neuroendocrine Carcinoma Phase 2 Recruiting January 2021 Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Recruiting Meldola, FC, Italy, 47014 Contact: Toni Ibrahim, MD    0543739100    toni.ibrahim@irst.emr.it    Principal Investigator: Toni Ibrahim, MD          Sub-Investigator: Albero Bongiovanni, MD          Istituto Nazionale Tumori Milano Recruiting Milano, MI, Italy Contact: Sara Pusceddu          Azienda Ospedaliera-Universitaria di Modena Recruiting Modena, MO, Italy Contact: Gabriele Luppi, MD          Ospedale Civile degli Infermi Recruiting Faenza, RA, Italy Contact: Stefano Tamberi          Ospedale di Bolzano Recruiting Bolzano, Italy Contact: Giovanni Di Meglio, MD          IRCCS "Saverio De Bellis" Recruiting Castellana Grotte, Italy Contact: Ivan Lolli          Ospedale "Vito Fazzi" Recruiting Lecce, Italy Contact: Silvana Leo          Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Francesca Bergamo, MD          Azienda Ospedaliera-Universitaria di Parma Recruiting Parma, Italy Contact: Francesca Pucci, MD          Ospedale S.Chiara - AOU Pisana Recruiting Pisa, Italy Contact: Sergio Ricci, MD Less <<
NCT02254954 Glioblastoma Phase 1 Terminated(Sponsor decision du... More >>e to low recruitment) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03739411 Glioma Phase 1 Recruiting August 1, 2020 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94115 Contact: Susan M. Chang    415-353-2383    ChangS@neurosurg.ucsf.edu    Principal Investigator: Susan M. Chang Less <<
NCT02189109 Glioblastoma Multiforme Phase 1 Unknown December 2017 Australia, New South Wales ... More >> St. Vincents Hospital Sydney Darlinghurst, New South Wales, Australia, 2010 Australia, South Australia Flinders Medical Centre Adelaide, South Australia, Australia, 5042 Australia, Victoria Nucleus Network Melbourne, Victoria, Australia, 3004 Epworth Center Melbourne, Victoria, Australia, 3121 Less <<
NCT02510950 Glioblastoma Multiforme ... More >> Astrocytoma, Grade IV Less << Phase 1 Terminated(Low accrual) - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02458508 - Completed - Italy ... More >> Division of Radiotherapy, Department Of Oncology, University Hospital of Pisa Pisa, Italy, 56126 Less <<
NCT00025558 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, New York ... More >> NYU Cancer Institute at New York University Medical Center New York, New York, United States, 10016 United States, Ohio Columbus Children's Hospital Columbus, Ohio, United States, 43205-2696 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Less <<
NCT01409174 Melanoma Phase 1 Terminated(Slow accrual, close... More >>d in Phase I.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02206230 Glioblastoma Phase 2 Recruiting August 2020 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Samir Patel, MD    780-432-8518    samir.patel2@albertahealthservices.ca Less <<
NCT02511132 Ewing's Sarcoma Phase 2 Active, not recruiting December 2018 United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, Florida Nicklaus Children's Hospital (Miami Children's Health System) Miami, Florida, United States, 33155 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Children's Cleveland, Ohio, United States, 44195 United States, Texas Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75230 TOPA - Medical City Dallas Pediatric Hematology-Oncology Dallas, Texas, United States, 75230 Less <<
NCT03688178 Glioblastoma Phase 2 Not yet recruiting March 1, 2025 United States, North Carolina ... More >> Duke University Medical Center Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Stevie Threatt    919-684-5301    dukebrain1@dm.duke.edu    Contact: Susan Boulton, RN, BSN    919-684-5301    dukebrain1@dm.duke.edu Less <<
NCT01390948 High Grade Glioma Phase 2 Active, not recruiting March 10, 2020 -
NCT01939574 Glioblastoma Not Applicable Unknown September 2016 China, Shandong ... More >> Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT03650257 Glioma of Brain Phase 2 Not yet recruiting August 20, 2023 China, Beijing ... More >> Beijing Tiantan Hospital Affiliated to Capital Medical University Not yet recruiting Beijing, Beijing, China, 100050 Contact: hua Gao    18600678822    gh2004518@163.com Less <<
NCT00028795 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT02414165 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 2 Phase 3 Active, not recruiting March 2023 -
NCT01390948 - Active, not recruiting - -
NCT02287428 Glioblastoma ... More >>Gliosarcoma Glioblastoma With Oligodendroglial Features Giant Cell Glioblastoma Glioblastoma Multiforme MGMT-unmethylated Glioblastoma MGMT-methylated Glioblastoma GBM Less << Phase 1 Active, not recruiting August 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02113 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03548571 Glioblastoma Phase 2 Phase 3 Recruiting May 1, 2023 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: Einar O Vik-Mo, MD, PhD    +47 23074340    uxvieb@ous-hf.no    Contact: Solveig Bringsli       solbri@ous-hf.no Less <<
NCT01507506 Glioblastoma Phase 3 Active, not recruiting March 2023 France ... More >> Clinique Claude Bernard Albi, France, 81000 Centre Jean Perrin Clermont-ferrand, France, 63011 Centre Georges François Leclerc Dijon, France, 21000 Hospices Civils de Lyon (Hôpital Lyon Sud/Hôpital P. Wertheimer) Lyon, France, 69002 Centre Leon Berard Lyon, France, 69373 AP HM - Hôpital La Timone Marseille, France, 13385 Centre Val d'Aurelle Montpellier, France, 34298 Institut de Cancerologie Lucien Neuwirth Saint-Priest-En-Jarez, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 CHU de Strasbourg Strasbourg, France, 67065 Institut Claudius REGAUD Toulouse, France, 31052 Centre Marie Curie Valence, France, 26953 Less <<
NCT00897377 Astrocytomas ... More >>Oligodendrogliomas Oligoastrocytoma Less << Phase 3 Terminated(Difficulty in recru... More >>iting patients) Less << - China, Guangdong ... More >> Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00253487 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - -
NCT00014092 Melanoma (Skin) Phase 2 Completed - United States, California ... More >> Saint Francis Memorial Hospital San Francisco, California, United States, 94109 John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 Less <<
NCT03212235 Glioblastoma Multiforme Phase 2 Recruiting June 1, 2020 Brazil ... More >> Instituto do Cancer do Estado de São Paulo (ICESP) - FMUSP Recruiting São Paulo, Sao Paulo, Brazil, 01246-000 Contact: Gustavo N Marta, PhD    55+11+38934538    gustavo.marta@hc.fm.usp.br Less <<
NCT01458730 Central Nervous System Lymphom... More >>a Less << Phase 2 Active, not recruiting October 2020 Denmark ... More >> Elisa Jacobsen Pulczynski Aarhus, Denmark, DK-8000 Less <<
NCT00004259 - Completed - -
NCT00004259 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00005637 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03395587 Glioblastoma Phase 2 Recruiting June 6, 2023 Germany ... More >> Klinik für Neurologie, Knappschaftskrankenhaus Bochum Recruiting Bochum, Northrhine Westphalia, Germany, 44829 Contact: Uwe Schlegel, Prof. MD    00492342993719    neurologie@kk-bochum.de    Contact: Rekowski Sylvia    00492342993719    sylvia.rekowski@kk-bochum.de    Sub-Investigator: Thomas Kowalski          Principal Investigator: Uwe Schlegel, Prof. MD          Klinik für Neurochirurgie, Sana Kliniken Duisburg Not yet recruiting Duisburg, Northrhine Westphalia, Germany, 47055 Contact: Jung Su Zin, Dr. med.    00492037332401    suzin.jung@sana.de    Principal Investigator: Catharina Junghans, Dr. med.          Sub-Investigator: Lutz Schreiber, Dr. med.          Neurochirurgische Klinik, Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Northrhine Westphalia, Germany, 40225 Contact: Michael C. Sabel, Prof. MD    00492118116276    michael.sabel@med.uni-duesseldorf.de    Contact: Natalie Sevens    00492118117881       Sub-Investigator: Marion Rapp, PD MD          Principal Investigator: Michael Sabel, Prof. MD          Klinik für Allgemeine Neurologie, Universitätsklinikum Münster Recruiting Münster, Northrhine Westphalia, Germany, 48149 Contact: Oliver Grauer, PD Dr. med.    0492518346814    oliver.grauer@ukmuenster.de    Principal Investigator: Oliver Grauer, PD Dr. med.          Sub-Investigator: Ole Simon, Dr. med. Less <<
NCT00867568 Neuroblastoma ... More >> Medulloblastoma Relapse Less << Phase 1 Completed - United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123 United States, Florida Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States, 32806 United States, Missouri Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, North Carolina Levine Children's Hospital Charlotte, North Carolina, United States, 28204 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Vermont UVM/FAHC Burlington, Vermont, United States, 05401 Less <<
NCT02288897 Cutaneous Melanoma Phase 3 Active, not recruiting April 2019 -
NCT00867568 - Completed - -
NCT03660761 Efficacy and Safety Phase 2 Completed - China, Shandong ... More >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT00890786 Newly Diagnosed High-Grade Gli... More >>omas Diffuse Intrinsic Pontine Glioma Less << Early Phase 1 Completed - United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60614 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT03180502 1p/19q Co-deletion ... More >> Anaplastic Astrocytoma Diffuse Astrocytoma Glioma IDH1 Gene Mutation IDH2 Gene Mutation Oligoastrocytoma Oligodendroglioma WHO Grade III Glioma Less << Phase 2 Recruiting August 31, 2027 United States, Illinois ... More >> Northwestern Medicine Cancer Center Delnor Recruiting Geneva, Illinois, United States, 60134 Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org    Principal Investigator: Vinai Gondi          Northwestern Medicine Cancer Center Warrenville Recruiting Warrenville, Illinois, United States, 60555 Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org    Principal Investigator: Vinai Gondi          United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact    877-726-5130       Principal Investigator: Helen A. Shih          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Anita Mahajan          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Christina I. Tsien          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: David R. Grosshans          United States, Washington Seattle Cancer Care Alliance at Northwest Hospital Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact    206-606-5800       Principal Investigator: Yolanda D. Tseng          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact    800-804-8824       Principal Investigator: Yolanda D. Tseng Less <<
NCT01182350 Diffuse Intrinsic Pontine Glio... More >>ma Less << Phase 2 Completed - -
NCT03257618 Glioma Not Applicable Recruiting December 2020 France ... More >> Institut regional du Cancer - Val d Aurelle Recruiting Montpellier, France, 34298 Contact: Bleuse Jean Pierre    +33467612344    jean-pierre.bleuse@icm.unicancer.fr    Principal Investigator: darlix amelie Less <<
NCT02010606 Glioblastoma ... More >>Glioblastoma Multiforme Glioma Astrocytoma Brain Tumor Less << Phase 1 Active, not recruiting January 2021 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00416819 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Not Applicable Completed - -
NCT01269424 Glioblastoma Multiforme Phase 1 Terminated(Revisions due - Enr... More >>oll to cohort 2) Less << - United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5047 Less <<
NCT01222221 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ UCL Cancer Institute London, England, United Kingdom, WC1E 6DD Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Western General Hospital Edinburgh, United Kingdom, EH4 2XU St James' University Hospital Leeds, United Kingdom, LS9 7TF The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00660543 Adult Brain Glioblastoma Not Applicable Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01618136 Malignant Solid Tumour ... More >> Ovarian Cancer Triple Negative Breast Cancer Advanced Melanoma B-cell Malignancy, Low-grade Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> King's College London Guy's Hospital Campus London, United Kingdom, SE1 9RT Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom, NE7 7DN Less <<
NCT00660543 - Completed - -
NCT02364206 Adult Glioblastoma Phase 1 Phase 2 Active, not recruiting June 2019 France ... More >> CHU Amiens Sud-Salouel Amiens, France Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont-Ferrand, France Centre Georges François Leclerc Dijon, France Centre Paul Strauss Strasbourg, France Less <<
NCT01670890 Malignant Gliomas Phase 2 Unknown - China, Beijing ... More >> Beijing Tiantan Hospital Affiliated to Capital Medial University Recruiting Beijing, Beijing, China, 100050 Contact: Jiang tao, MD    86-010-67021832    jiangtao369@sohu.com    Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: wang ren zhi, MD    86-010-69156071    wangrz@126.com    Principal Investigator: Ma wen bin, MD          Sub-Investigator: wang yu, MD          China, Tianjin Tianjin medical university general university Recruiting Tianjin, Tianjin, China, 300052 Contact: Yang xue jun, MD       ydenny@yahoo.com Less <<
NCT00014105 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Unknown - United States, New Jersey ... More >> Overlook Hospital Summit, New Jersey, United States, 07902-0220 Less <<
NCT00455286 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Unknown November 2011 Taiwan ... More >> Changhua Christian Hospital Recruiting Changhua, Taiwan Contact: Cheng-Shyong Chang, M.D.    886-4-7238595    15120@cch.org.tw    China Medical University Hospital Recruiting Taichung, Taiwan Contact: Chang-Fang Chiu Chiu, M.D.    886-4-22052121    d5686@www.cmuh.org.tw    National Cheng Kung University Hospital Recruiting TaiNan, Taiwan Contact: Wu-Chou Su, M.D.    886-6-2353535    sunnysu@mail.ncku.edu.tw    Mackay Memorial Hospital Recruiting Taipei, Taiwan Contact: Ming-Chih Chang, M.D.    886-2-25433535 ext 3454    mmhdonald@yahoo.com.tw    Contact: Ming-Jer Huang Less <<
NCT03168919 Glioma Not Applicable Terminated(PI is leaving insti... More >>tution) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 Less <<
NCT00961844 Metastatic Malignant Melanoma Phase 1 Phase 2 Terminated(Logistical problems... More >>) Less << - Norway ... More >> The Norwegian Radium Hospital, Department of Clinical Cancer Research Oslo, Montebello, Norway, NO-0310 Less <<
NCT02546102 Glioblastoma Multiforme Phase 3 Suspended(Company at this time... More >> unable to secure sufficient financial resources to complete) Less << December 2021 -
NCT02193347 Brain Cancer ... More >>Brain Neoplasm, Primary Brain Neoplasms, Recurrent Brain Tumor Cancer of the Brain Less << Phase 1 Active, not recruiting June 2019 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02573324 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 3 Recruiting February 13, 2021 -
NCT00588523 CNS Cancer CN... More >>S BRAIN Less << Phase 2 Active, not recruiting September 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center Commack, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01860638 Glioblastoma Phase 2 Completed - -
NCT02617745 Glioblastoma Phase 2 Recruiting December 2020 France ... More >> Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Frederic Di Fiore, MD, PhD    +33232082554    frederic.difiore@chb.unicancer.fr    Contact: Doriane Richard, PhD    +33232082985    doriane.richard@orange.fr    Sub-Investigator: Isabelle Tennevet, MD          Sub-Investigator: Cristina Alexandru, MD          Sub-Investigator: Ovidiu Veresezan, MD          Sub-Investigator: Chantal Hanzen, MD          Sub-Investigator: Bernard Dubray, MD, PhD Less <<
NCT00395070 Metastatic Melanoma Phase 3 Completed - -
NCT03425292 Newly Diagnosed Glioblastoma Phase 1 Recruiting February 1, 2020 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jaya Gill, RN    310-582-7437    jaya.gill@providence.org    Principal Investigator: Santosh Kesari, MD, PhD Less <<
NCT02758366 Glioblastoma (GBM) ... More >> DIPG Brainstem Glioma, Pediatric Diffuse Spinal Glioma Bilateral Thalamic Glioma Gliomatosis Cerebri Anaplastic Astrocytoma Midline Diffuse Glioma Less << Phase 2 Recruiting July 2020 Italy ... More >> Meyer Children's Hospital Recruiting Florence, Italy, 50145 Contact: Iacopo Sardi, MD, PhD    +390555662631    iacopo.sardi@meyer.it Less <<
NCT02977780 Glioblastoma Phase 2 Recruiting May 2021 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: L. Burt Nabors, MD    205-934-1432    bnabors@uab.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Isabel Arrillaga-Romany, MD PhD    617-724-8770    iarrillaga@mgh.harvard.edu    Principal Investigator: Isabel Arrillaga-Romany, MD PhD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Brian Alexander, MD MPH    617-732-7560    Brian_Alexander@dfci.harvard.edu    Contact: Lisa Doherty, NP    617-632-2166    lisa_doherty@dfci.harvard.edu    Principal Investigator: Brian Alexander, MD MPH          United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Eva Galanis, MD    507-284-2511    galanis.evanthia@mayo.edu    United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Mary Welch, MD    212-342-0571    mw2517@cumc.columbia.edu    United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia,, MD    216-444-6145    ahluwam@ccf.org    United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Jan Drappatz, MD    412-864-7791    drappatzj@upmc.edu    United States, Texas UT MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: John DeGroot, MD    713-745-3072    jdegroot@mdanderson.org    United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Howard Colman, MD    801-587-4042    Howard.colman@hci.utah.edu    United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: David Schiff, MD    434-924-5610    Ds4jd@virginia.edu Less <<
NCT00786669 Solid Tumor Phase 1 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT03631823 - Not yet recruiting May 1, 2020 -
NCT03338075 - Completed - -
NCT02850744 Glioblastoma Multiforme Phase 2 Terminated - Switzerland ... More >> University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Less <<
NCT00967330 Glioblastoma Multiforme Phase 2 Completed - Germany ... More >> Aachen, Germany, 52074 Berlin, Germany, 13353 Bochum, Germany, 44892 Bonn, Germany, 53127 Chemnitz, Germany, 09113 Dresden, Germany, 01307 Düsseldorf, Germany, 40225 Erfurt, Germany, 99089 Erlangen, Germany, 91054 Frankfurt am Main, Germany, 60528 Freiburg, Germany, 79106 Göttingen, Germany, 37075 Idar-Oberstein, Germany, 55743 Kiel, Germany, 24105 Köln, Germany, 50937 Leipzig, Germany, 04103 Mannheim, Germany, 68167 Marburg, Germany, 35043 Muenchen, Germany, 81377 München, Germany, 81675 Münster, Germany, 48149 Regensburg, Germany, 93053 Tübingen, Germany, 72076 Ulm, Germany, 89081 Less <<
NCT01920191 CNS Tumor, Adult Phase 1 Phase 2 Completed - Switzerland ... More >> Geneva University Hospitals, Centre of Oncology Geneva, Switzerland, CH-1211 Less <<
NCT00967330 - Completed - -
NCT02082119 Glioma Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Milan, Italy, 20100 Less <<
NCT00991250 Malignant Melanoma Phase 2 Unknown September 2011 Sweden ... More >> Lunds Universitetssjukhus Recruiting Lund, Skåne, Sweden, 22185 Contact: Christian Ingvar, MD    +46 (0)46-17 10 00    christian.ingvar@skane.se    Principal Investigator: Christian Ingvar, MD          Södersjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 11883 Contact: Peter Gillgren, MD    +46 (0)8-616 23 84    peter.gillgren@sodersjukhuset.se    Principal Investigator: Peter Gillgren, MD          Karolinska Sjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 17176 Contact: Johan Hansson, MD    +46 (0)8-5177 36 40    johan.hansson@karolinska.se    Principal Investigator: Johan Hansson, MD          Norrlands Universitetssjukhus Recruiting Umeå, Västerbottens Län, Sweden, 90185 Contact: Peter Naredi, MD    +46 (0)90- 785 00 00    peter.naredi@surgery.umu.se    Principal Investigator: Peter Naredi, MD          Sahlgrenska Universitetssjukhuset Not yet recruiting Göteborg, Västra Götalands Län, Sweden, 41685 Contact: Jan E Mattsson, MD    +46 (0)31-342 84 58    jan.e.mattsson@vgregion.se    Principal Investigator: Jan E Mattsson, MD Less <<
NCT02832635 Brain Metastasis ... More >> Radiation Therapy Complication Less << Phase 2 Unknown December 2017 China, Guangdong ... More >> Department of Radiation Oncology, Sun Yat-Sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Yun-fei Xia, Professor    86-13602805461    xiayf@sysucc.org.cn    Contact: Xiaohui Wang, MD    86-18826260661    wangxh@sysucc.org.cn    Principal Investigator: Yun-fei Xia, Professor          Sub-Investigator: Xiaohui Wang, MD          Guangdong Three Nine Brain Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Lin-bo Cai, Prof.    86-13503030491       Principal Investigator: Linbo Cai, Prof.          Guangzhou First People's Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Guo-long Liu, Prof.    86-13802527172       Principal Investigator: Guo-long Liu, Prof.          Guangzhou People's Liberation Army Hospital 421 Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Si-Lang Zhou, Prof.    86-13189099597       Principal Investigator: Si-Lang Zhou, Prof.          Panyu Central Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Xiao-long Cao, Prof.    86-18922238053       Principal Investigator: Xiao-long Cao, Prof.          The First Affiliated Hospital, Jinan University Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Yi-ou Wang, Prof.    86-13602751067       Principal Investigator: Yi-ou Wang, Prof.          The Affiliated Cancer Hospital Of Guangzhou Medical Collage Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: Xun-fan Shao, Prof.    +86-13902770926    xunfanshao@yahoo.com.cn    Principal Investigator: Xun-fan Shao, Prof.          Guangdong Provincial Hospital Of Chinese Medicine Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Gong Li, Prof.    +86-13802915171    leegong@21cn.com    Principal Investigator: Gong Li, Prof.          The First Affiliated Hospital Of Guangzhou Medical Collage Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Dao-li Niu, Prof.    +86-13711101855    daoliniu@163.com    Principal Investigator: Dao-li Niu, Prof.          The Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting Zhuhai, Guangdong, China, 519000 Contact: Zhibin Cheng, Professor    86-13926946708       Principal Investigator: Zhibin Cheng, Professor Less <<
NCT01837862 Pilomyxoid Astrocytoma ... More >> Pilocytic Astrocytoma Glioma, Astrocytic Optic Nerve Glioma Pleomorphic Xanthoastrocytoma Glioblastoma Multiforme Anaplastic Astrocytoma Gliosarcoma Diffuse Intrinsic Pontine Glioma DIPG Low-grade Glioma Brainstem Glioma Less << Phase 1 Phase 2 Recruiting April 2020 United States, New York ... More >> Cohen Children's Medical Center of New York Recruiting New Hyde Park, New York, United States, 11040 Contact: Mark P Atlas, MD    718-470-3460    matlas@nshs.edu    Contact: Derek R Hanson, MD    551-996-5437    DHanson@hackensackumc.org    Principal Investigator: Mark P Atlas, MD          Sub-Investigator: Derek R Hanson, MD          Sub-Investigator: Arlene Redner, MD          Sub-Investigator: Mohamad Badawi, MD          Sub-Investigator: Avery Wright, DO Less <<
NCT00250211 Glioblastoma ... More >>Glioma Less << Phase 1 Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT02672241 Childhood Brain Stem Neoplasm Phase 2 Recruiting August 2019 China, Shanghai ... More >> he Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: chuanying zhu, MD    862125076994    sdnanhai123@163.com Less <<
NCT02329795 - Terminated(Slow accrual) - Denmark ... More >> Department of Oncology, Section for Radiotherapy, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00539591 Malignant Melanoma Phase 2 Completed - United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas The Children's Cancer Hospital at UT M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02375334 - Terminated(Support Staff Left ... More >>Institution) Less << - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00539591 - Completed - -
NCT02813135 Children, Adolescents and Youn... More >>g Adults With Refractory or Recurrent Malignancies Less << Phase 1 Phase 2 Recruiting January 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Birgit Geoerger, MD    1 42 11 4661 ext +33    birgit.geoerger@gustaveroussy.fr    Contact: Xavier Paoletti, MD    1 42 11 6564 ext +33    xavier.paoletti@gustaveroussy.fr    Principal Investigator: Birgit Geoerger, MD          Germany University Children's Hospitalermany Not yet recruiting Heidelberg, Germany Contact: Olaf Witt, MD    6221 56 4555 ext +49    O.Witt@Dkfz-Heidelberg.de    Italy Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Michela Casanova, MD    02 23 90 25 94 ext +39    Michela.Casanova@istitutotumori.mi.it    Netherlands Erasmus MC, Sophia Children's Hospital Not yet recruiting Rotterdam, Netherlands Contact: Michel Zwaan, MD    10 703 6691 ext +31    c.m.zwaan@erasmusmc.nl    Spain Unidad de Oncología Pediátrica Hospital Niño Jesús Not yet recruiting Madrid, Spain, 28009 Contact: Francisco Bautista, MD    915 035 900 ext +43    franciscojose.bautista@salud.madrid.org    United Kingdom Pediatric and Adolescent Oncology The Royal Marsden Hospital Not yet recruiting Sutton, United Kingdom Contact: Lynley Marshall, MD    208 661 3678 ext +44    Lynley.Marshall@icr.ac.uk Less <<
NCT02310451 Metastatic Melanoma Not Applicable Unknown December 2016 France ... More >> CHU de Nice ^Hôpital de l'Archet Recruiting Nice, France, 06200 Contact: Vanina OLIVERI, CRA    0033 4 92 03 42 54    oliveri.v@chu-nice.fr Less <<
NCT02820857 Neuroendocrine Carcinomas Phase 2 Recruiting March 4, 2022 France ... More >> Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Sud, CHU d'Amiens Recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          Service d'Hépatogastroentérologie, CHU d'Angers Recruiting Angers, France, 49933 Contact: Guillaume ROQUIN, MD          Principal Investigator: Guillaume ROQUIN, MD          Service de Gastroentérologie et Pancréatologie, Hôpital Beaujon, APHP Recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Service d'Hépato-Gastroentérologie et Oncologie Digestive, CHU de Dijon Recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Service d'Hépatogastroentéologie, Hôpital Michallon, CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Département de Cancérologie Urologique et Digestive, Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Farid EL HAJBI, MD          Principal Investigator: Farid EL HAJBI, MD          Service d'Oncologie Médicale - Hôpital Edouard Herriot - Hospices Civils de Lyon Recruiting Lyon, France, 69437 Contact: Thomas WALTER, MD    4 72 11 73 98 ext +33    thomas.walter@chu-lyon.fr    Principal Investigator: Thomas WALTER, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Timone, APHM Recruiting Marseille, France, 13365 Contact: Laetitia DAHAN, MD          Principal Investigator: Laetitia DAHAN, MD          Service d'Oncologie Médicale, Hôpital Saint Eloi, CHU de Montpellier Recruiting Montpellier, France, 34298 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Salpêtrière, APHP Recruiting Paris, France, 75013 Contact: Olivier DUBREUIL, MD          Principal Investigator: Olivier DUBREUIL, MD          Service de Gastroentérologie, Hôpital Cochin, APHP Recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Européen Georges Pompidou, APHP Recruiting Paris, France, 75015 Contact: Céline LEPERE, MD          Principal Investigator: Céline LEPERE, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital Haut Lévêque, CHU Bordeaux Recruiting Pessac, France, 33604 Contact: Denis SMITH, MD          Principal Investigator: Denis SMITH, MD          Pôle Régional de Cancérologie, CHU de Poitiers Recruiting Poitiers, France, 86021 Contact: Aurélie FERRU, MD          Principal Investigator: Aurélie FERRU, MD          Service d'Hépato-Gastroentérologie et Cancérologie, Hôpital Robert Debré, CHU de Reims Recruiting Reims, France, 51100 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Service d'Hépatogastroentérologie, Hôpital Pontchaillou, CHU de Rennes Recruiting Rennes, France, 35000 Contact: Astrid LIEVRE, MD          Principal Investigator: Astrid LIEVRE, MD          Service de Gastroentérologie, CHU de Rouen Recruiting Rouen, France, 76031 Contact: Alice GANGLOFF, MD          Principal Investigator: Alice GANGLOFF, MD          Service de Gastro-Entérologie, Hôpital Nord, CHU de ST-Etienne Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nadia BOUARIOUA, MD          Principal Investigator: Nadia BOUARIOUA, MD          Service d'Oncologie Médicale, Hôpital Civil, CHU de Strasbourg Recruiting Strasbourg, France, 67200 Contact: Jean-Emmanuel KURTZ, MD          Principal Investigator: Jean-Emmanuel KURTZ, MD          Service d'Oncologie Endocrinienne, Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT00094653 Melanoma Meta... More >>stases Less << Phase 3 Completed - -
NCT02663271 Glioblastoma Multiforme ... More >> Glioblastoma Malignant Glioma GBM Less << Phase 2 Recruiting March 2019 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32611 Contact: David Tran, MD, PhD    352-294-8137    david.tran@neurosurgery.ufl.edu    Principal Investigator: David D Tran, MD, PhD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Grayson Talcott, BS    314-273-0656    wu-grayson@wustl.edu    Principal Investigator: George Ansstas, M.D. Less <<
NCT03631836 Glioblastoma Phase 1 Not yet recruiting January 1, 2022 France ... More >> Assistance Publique des Hôpitaux de Marseille Not yet recruiting Marseille, France, 13354 Contact: Olivier CHINOT, PU-PH    491385500 ext +33    olivier.chinot@ap-hm.fr    Principal Investigator: Olivier CHINOT, PU-PH Less <<
NCT03632135 Recurrent Glioblastoma Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Mark D. Anderson, MD    601-984-5517    manderson4@umc.edu    United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Nicholas Marko, MD    513-558-3559    nicholas.marko@uc.edu    Contact: , RN          Toledo University Recruiting Toledo, Ohio, United States, 43614 Contact: Jason Schroeder, MD    419-383-4000    Jason.Schroeder5@UToledo.edu    Contact: Stephanie Smiddy, RN    419-383-6962    stephanie.smiddy@UToledo.edu    United States, Pennsylvania The Penn State Univeristy College of Medicine Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Dawit Aregawi, MD    717-531-3828    daregawi@PennStateHealth.psu.edu    Allegheny Health Network Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Tulika Ranjan, MD    412-770-3039    Tulika.RANJAN@ahn.org    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Steven Jubelirer, MD    304-388-8380    steven.jubelirer@camc.org    Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org Less <<
NCT03185780 Quality of Life ... More >> Chemotherapeutic Toxicity Radiation Toxicity Less << Not Applicable Withdrawn(Unable to attain fun... More >>ding) Less << December 31, 2019 -
NCT01403285 Glioblastoma Phase 1 Terminated(Due to poor accrual... More >>. This decision was taken without any safety reasons. Since beginning of the study (June 2011) only six patients were enrolled.) Less << - United States, Maryland ... More >> Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT00094653 - Completed - -
NCT03672721 Glioblastoma Multiforme ... More >> Relapse Less << Phase 1 Phase 2 Recruiting July 10, 2021 Canada, Quebec ... More >> CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: David Fortin, MD    819-346-1110 ext 13895    david.fortin@usherbrooke.ca    Contact: marie-André Roy, nurse    819-346-1110 ext 13895    maroy.chus@ssss.gouv.qc.ca Less <<
NCT02466828 Glioblastoma ... More >>Hypoxia Less << Early Phase 1 Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00800917 Glioblastoma Multiforme Phase 2 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT02664363 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Active, not recruiting February 2024 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT02062372 Glioblastoma Not Applicable Terminated(Expectation that wi... More >>thin the set time period insufficient patients will be included, so endpoints will not be achieved) Less << - Netherlands ... More >> Maastricht Radiation Oncology (MAASTRO clinic) Maastricht, Limburg, Netherlands, 6229ET Less <<
NCT01308632 Glioblastoma Phase 2 Phase 3 Unknown June 2012 -
NCT02751138 - Recruiting September 1, 2019 Germany ... More >> Department of Neurosurgery Recruiting Ulm, Germany, 89081 Contact: Monika Deininger    +4982219622504    monika.deininger@bkh-guenzburg.de Less <<
NCT02067156 Glioblastoma Multiforme Phase 2 Completed - United States, California ... More >> University of California, San Diego Moores Cancer Center La Jolla, California, United States, 92093 Less <<
NCT03370926 - Recruiting October 31, 2019 France ... More >> CHRU de Brest Recruiting Brest, France, 29609 Contact: Ulrike SCHICK       ulrike.schick@chu-brest.fr Less <<
NCT02876003 Glioblastoma Phase 2 Withdrawn(This study has been ... More >>withdrawn prior to enrollment.) Less << October 2020 United States, California ... More >> John Wayne Cancer Institute Santa Monica, California, United States, 90404 Less <<
NCT01854099 Glioblastoma Phase 1 Withdrawn(Investigator decided... More >> not to open study.) Less << - -
NCT03607643 Cancer of Pancreas ... More >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Less << Phase 1 Phase 2 Not yet recruiting December 15, 2020 United States, Florida ... More >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO    407-426-8660    sarahfk1978@yahoo.com    Contact: Philip Arlen, PhD    407-443-0656    parlen@leafvertical.com Less <<
NCT00111007 Melanoma Phase 3 Completed - -
NCT03582514 Glioblastoma Multiforme Phase 1 Phase 2 Not yet recruiting July 1, 2022 Netherlands ... More >> The Netherlands Cancer Institute Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 1066CX Contact: Gerben R Borst, MD,PhD          Medisch Centrum Slotervaart Active, not recruiting Amsterdam, Noord-Holland, Netherlands, 1066EC Less <<
NCT03311542 - - - Belarus ... More >> N.N. Alexandrov National Cancer Centre Minsk, Belarus, 223040 Hong Kong The Hong Kong Cancer Institute Hong Kong, Hong Kong, 518031 Tajikistan "Cancer Research Center" of the Ministry of Health of the Republic of Tajikistan Dushanbe, Tajikistan, 734026 Uzbekistan Republican Cancer Research Center of the Ministry of Health of the Republic of Uzbekistan (RENTC MH RUz) Tashkent, Uzbekistan, 100049 Less <<
NCT02986815 Glioma Not Applicable Recruiting December 2021 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75063 Contact: Sarh McNeil, RN    214-645-8166    sarah.mcneil@utsouthwestern.edu    Principal Investigator: Robert Bachoo, MD Less <<
NCT01827384 Advanced Malignant Solid Neopl... More >>asm Less << Not Applicable Suspended(Scheduled Interim Mo... More >>nitoring) Less << - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Maryland National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01737346 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Unknown April 2014 Korea, Republic of ... More >> Ajou University Hospital Recruiting Wonchon-dong, Suwon, Korea, Republic of, 443-721 Contact: Se-Hyuk Kim, Doctor    82-31-219-5235    nsksh@ajou.ac.kr    Principal Investigator: Se-Hyuk Kim, Doctor Less <<
NCT03616860 Glioblastoma Not Applicable Recruiting December 2021 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Maheleth          Contact    416-480-6100 ext 2476    maheleth.llinas@sunnybrook.ca    Principal Investigator: Nir Lipsman, MD Less <<
NCT00392886 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - -
NCT00111007 - Completed - -
NCT03291314 Recurrent Glioblastoma (WHO-Gr... More >>ade IV Glioma) Less << Phase 2 Recruiting September 30, 2018 Belgium ... More >> UZ Brussel Recruiting Brussel, Belgium, 1090 Contact: Bart Neyns, Phd,Md    +32 2 477 ext 54 47    bart.neyns@uzbrussel.be    Principal Investigator: Bart Neyns, Phd,Md Less <<
NCT00813566 - Recruiting July 2022 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Less <<
NCT03217097 Neuroendocrine Tumors Phase 4 Not yet recruiting October 2021 France ... More >> Hôpital Sud - CHU Amiens Not yet recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sandrine LABOUREAU, MD          Principal Investigator: Sandrine LABOUREAU, MD          Hôpital Beaujon - APHP Not yet recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Hôpital François Mitterrand - CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Hôpital André Michalon - CHU Grenoble Alpes Not yet recruiting La Tronche, France, 38700 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Eric DANSIN, MD          Principal Investigator: Eric DANSIN, MD          Hôpital Claude Hurriet - CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Christine DO CAO, MD          Principal Investigator: Christine DO CAO, MD          Hôpital Edouard Herriot - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69003 Contact: Thomas WALTER, MD          Principal Investigator: Catherine LOMBARD BOHAS, MD          Sub-Investigator: Thomas WALTER, MD          Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Jérôme DESRAMES, MD          Principal Investigator: Jérôme DESRAMES, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Matthieu SARABI, MD          Principal Investigator: Matthieu SARABI, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Patricia NICCOLI, MD          Principal Investigator: Patricia NICCOLI, MD          Hôpital Saint Eloi - CHU Montpellier Not yet recruiting Montpellier, France, 34090 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Hôpital Saint Louis - APHP Not yet recruiting Paris, France, 75010 Contact: Thomas APARICIO, MD          Principal Investigator: Thomas APARICIO, MD          Hôpital Cochin - APHP Not yet recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Mathieu BACONNIER, MD          Principal Investigator: Mathieu BACONNIER, MD          Hôpital Robert Debré - CHU Reims Not yet recruiting Reims, France, 51092 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Hôpital Nord - CHU Saint Etienne Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nicolas WILLIET, MD          Principal Investigator: Nicolas WILLIET, MD          Institut de Cancérologie de la Loire Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Léa SABAN-ROCHE, MD          Principal Investigator: Léa SABAN-ROCHE, MD          Hôpital Rangueil - CHU Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Rosine GUIMBAUD, MD          Principal Investigator: Rosine GUIMBAUD, MD          Hôpital Trousseau - CHU Tours Not yet recruiting Tours, France, 37044 Contact: Thierry LECOMTE, MD          Principal Investigator: Thierry LECOMTE, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT00846430 Neurofibromatosis 1 Phase 2 Unknown December 2017 United States, Michigan ... More >> Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 Less <<
NCT00422682 Tumors Phase 1 Completed - United States, Connecticut ... More >> Research Site New Haven, Connecticut, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York City, New York, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Houston, Texas, United States Research Site San Antonio, Texas, United States Less <<
NCT01666600 Glioblastoma Multiforme Phase 1 Phase 2 Terminated(Interim Analysis fo... More >>r Feasibility) Less << - Germany ... More >> University Hospital Heidelberg, Department of Neurooncology Heidelberg, Baden-Württemberg, Germany, 69120 University Hospital Heidelberg, Department of Pharmacology Heidelberg, Baden-Württemberg, Germany, 69120 Less <<
NCT02596828 Pineoblastoma Phase 2 Recruiting April 2020 Germany ... More >> University Hospital of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD    0043 (0)941 944 ext 2101    kinderonkologie@ukr.de    Contact: Susanne Ellinger    0043 (0)941 944 ext 2063    susanne.ellinger@ukr.de Less <<
NCT01861990 Pediatric Brain Tumor ... More >> Glioma Anaplastic Astrocytoma Medulloblastoma Glioblastoma Less << Phase 1 Withdrawn(Feasibility of the t... More >>rial was proven to be absent.) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00084838 Central Nervous System Tumor, ... More >>Pediatric Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT01933815 Glioblastoma Multiforme Phase 1 Phase 2 Suspended(Temporarily suspende... More >>d for financial reasons) Less << March 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York The Long Island Brain Tumor Center at Neurological Surgery, P.C. Commack, New York, United States, 11725 The Long Island Brain Tumor Center at Neurological Surgery, P.C. Lake Success, New York, United States, 11042 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Texas Memorial Hermann Hospital Houston, Texas, United States, 77030 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT00084838 - Completed - -
NCT01105988 Glioblastoma Early Phase 1 Terminated(Funding ended) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00098774 Lymphoma Phase 2 Completed - -
NCT00098774 - Completed - -
NCT03047473 Glioblastoma Multiforme of Bra... More >>in Less << Phase 2 Recruiting March 2020 Canada, Quebec ... More >> Clinique Neuro-Outaouais Recruiting Gatineau, Quebec, Canada, J9J 0A5 Contact: Victorine Sikati-Foko, RN Msc    819-777-2500 ext 3    victorine.sikatifoko@neuro-outaouais.ca Less <<
NCT00936156 Metastatic, Cerebral Primitive... More >> Neuroectodermal Tumors Less << Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01856933 GBM Glioblast... More >>oma Multiforme Gliosarcoma Less << Phase 2 Completed - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 United States, Texas UT Southwestern Dallas, Texas, United States, 75235 Less <<
NCT02047214 Glioblastoma Multiforme Phase 2 Terminated(Due to lack of clin... More >>ical benefit in the 17 subjects enrolled in the trial to date) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, Florida H Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States, 33612 United States, Illinois Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 United States, Missouri Washington University, School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Texas Memorial Hermann Hospital Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT02727387 Ewing's Sarcoma (ES) Phase 2 Recruiting May 2020 Italy ... More >> Centro di Riferimento Oncologico - Unit of Medical Oncology Not yet recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD    +390434659 ext 536    mascarin@cro.it    Principal Investigator: Maurizio Mascarin, MD          I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD    +39.011.9933 ext 628    massimo.aglietta@ircc.it    Principal Investigator: Massimo Aglietta, MD          Sub-Investigator: Giovanni Grignani, MD          Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366199 ext 199    stefano.ferrari@ior.it    Principal Investigator: Stefano Ferrari, MD          Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD    +39070504208       Principal Investigator: Rosamaria Mura, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Carla Manzitti, MD    0105636 2431       Principal Investigator: Carla Manzitti, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Rossella Bertulli, MD    +390223903 ext 287    rossella.bertulli@istitutotumori.mi.it    Principal Investigator: Rossella Bertulli, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Roberto Luksch, MD    +390223903       Principal Investigator: Roberto Luksch, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD    +39065266919       Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT01856933 - Completed - -
NCT02015728 Recurrent Childhood Brain Tumo... More >>r Less << Not Applicable Unknown December 2017 United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less <<
NCT01653834 Glioblastoma Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT02302235 Glioblastoma Multiforme of Bra... More >>in Less << Phase 2 Recruiting December 2018 United States, Maryland ... More >> MidAtlantic Epilepsy and Sleep Center Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD    301-530-9744    tyrlikovai@epilepsydc.com    Contact: Pavel Klein, MD    301-704-4925    kleinp@epilepsydc.com    Principal Investigator: Pavel Klein, MD Less <<
NCT00753246 Adults With Glioblastoma Multi... More >>forma Less << Phase 3 Completed - Germany ... More >> Dep. Neurosurgery, Univ. Hamburg Hamburg, Germany, 20246 Less <<
NCT02854228 - Recruiting December 2020 France ... More >> Groupement Hospitalier Est, Lyon, France Recruiting Bron, France, 69500 Contact: Gerald Raverot, MD PhD    (0)472119325 ext +33    gerald.raverot@chu-lyon.fr    Contact: Emmanuel Jouanneau, MD PhD    (0)472357411 ext +33    emmanuel.jouanneau@chu-lyon.fr Less <<
NCT00584883 Brain Tumor Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00323115 - Completed - -
NCT03334305 Malignant Glioma Phase 1 Recruiting May 2026 United States, Florida ... More >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32608 Contact: Marcia Hodik, RN    352-273-6971    marcia.hodik@neurosurgery.ufl.edu    Principal Investigator: Elias Sayour, MD, PhD Less <<
NCT00039000 Malignant Melanoma Phase 3 Completed - -
NCT00323115 Glioblastoma Multiforme Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01873469 - Active, not recruiting October 2018 Germany ... More >> Dresden University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Oncology; and DKTK partner site Dresden Dresden, Saxony, Germany, 01307 Less <<
NCT02432417 Glioblastoma ... More >>Astrocytoma, Grade IV Less << Phase 2 Not yet recruiting January 2024 -
NCT01805453 Newly-diagnosed Glioblastoma Phase 3 Active, not recruiting May 15, 2017 France ... More >> Neurology Department - Avicenne Hospital Bobigny, France, 93000 Less <<
NCT02501551 Melanoma Phase 2 Recruiting June 2019 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 120-752 Contact: Sang Joon Shin Less <<
NCT02678975 Glioma Gliobl... More >>astoma Less << Phase 2 Phase 3 Recruiting September 2020 Norway ... More >> Cancer Clinic, St.Olavs University Hospital Recruiting Trondheim, Norway Contact: Tora S Solheim, MD, PhD          Principal Investigator: Tora S Solheim, MD, PhD          Sweden Dept. of Oncology, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Katja Werlenius, MD          Principal Investigator: Katja Werlenius, MD          Ryhov County Hospital Recruiting Jönköping, Sweden Contact: Michael Strandéus, MD          Principal Investigator: Michael Strandéus, MD          Linköping University Hospital Recruiting Linkoping, Sweden Contact: Munila Mudaisi, MD          Principal Investigator: Munila Mudaisi, MD          Lund University Hospital Recruiting Lund, Sweden Contact: Sara Kinhult, MD, PhD          Principal Investigator: Sara Kinhult, MD, PhD          Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Sofia Hylin, MD          Principal Investigator: Sofia Hylin, MD          Uppsala University Hospital Recruiting Uppsala, Sweden Contact: Magnus Lindskog, MD, PhD          Principal Investigator: Magnus Lindskog, MD, PHD          Örebro University Hospital Recruiting Örebro, Sweden Contact: David Löfgren, MD          Principal Investigator: David Löfgren, MD Less <<
NCT03526822 Brain Tumor Not Applicable Recruiting May 1, 2022 France ... More >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Emeline TABOURET, PH    491385500 ext +33    emeline.tabouret@ap-hm.fr    Contact: Dominique FIGARELLA, PU-PH    413429011 ext +33    dominique.figarella-branger@ap-hm.fr    Principal Investigator: Emeline TABOURET, PH          Sub-Investigator: Olivier CHINOT, PU-PH          Sub-Investigator: Philippe METELLUS, PU-PH Less <<
NCT00669669 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Phase 2 Active, not recruiting December 31, 2027 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01091792 Glioblastoma Multiforme Early Phase 1 Completed - United States, New Hampshire ... More >> Dartmouth Hithcock Medcial Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT02666066 - Completed - Netherlands ... More >> Maastricht Radiation Oncology (MAASTRO clinic) Maastricht, Limburg, Netherlands, 6229ET Less <<
NCT00412542 Glioblastoma Multiforme ... More >> Glioma Less << Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02843230 - Recruiting August 31, 2021 United States, Massachusetts ... More >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Eva-Maria Ratai, PhD    617-726-1744    eratai@mgh.harvard.edu    Principal Investigator: Eva-Maria Ratai, PhD Less <<
NCT01868906 Malignant Glioma Phase 2 Terminated(Isotope (FMISO) pro... More >>duction is no longer available in our country.) Less << - Spain ... More >> Dr. Negrin University Hospital Las Palmas, Spain, 35010 Instituto Tecnologico Servicios Sanitarios, in MD Anderson Cancer Center, Madrid Madrid, Spain, 28.033 Less <<
NCT02619864 Glioblastoma Multiforme Phase 1 Active, not recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02366728 Glioblastoma ... More >>Astrocytoma, Grade IV Giant Cell Glioblastoma Glioblastoma Multiforme Less << Phase 2 Active, not recruiting June 2020 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00412542 - Completed - -
NCT01946529 Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Active, not recruiting July 2026 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01946529 - Active, not recruiting - -
NCT01181193 Glioblastoma Multiforme Phase 1 Phase 2 Unknown March 2014 Israel ... More >> Soroka University Medical Center Recruiting Beer Sheva, Israel, 84101 Contact: Konstantin Lavrenkov, MD, PhD    +97286400537    constant@bgu.ac.il    Contact: Olga Belochitski, MD    +97286400537    olgab@clalit.org.il    Sub-Investigator: Vladimir Gavrilov, MD, PhD          Sub-Investigator: Olga Belochitski, MD          Sub-Investigator: Vladimir Merkin, MD Less <<
NCT01639612 Grade IV Malignant Glioma Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02394665 Glioblastoma Phase 2 Terminated(Lack of Accrual/Enr... More >>ollment) Less << - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT03687957 Glioma Phase 1 Phase 2 Not yet recruiting October 31, 2022 United States, Missouri ... More >> Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian Campian, M.D., Ph.D.    314-747-4241    campian.jian@wustl.edu    Principal Investigator: Jian Campian, M.D., Ph.D.          Sub-Investigator: Milan Chheda, M.D.          Sub-Investigator: George Ansstas, M.D.          Sub-Investigator: Jiayi Huang, M.D.          Sub-Investigator: Christina Tsien, M.D.          Sub-Investigator: Dinesh Thotala, Ph.D.          Sub-Investigator: Richard Hotchkiss, M.D.          Sub-Investigator: John DiPersio, M.D., Ph.D. Less <<
NCT02394665 - Terminated(Lack of Accrual/Enr... More >>ollment) Less << - -
NCT03491683 Glioblastoma Phase 1 Phase 2 Recruiting January 18, 2021 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Site Care Coordinator Nurse Fatemeh Bidmeshk, BSN    626-218-4062    fbidmeshki@coh.org    Principal Investigator: Dr. Jana Portnow          Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Study Coordinator Hari Priya Yerraballa    650-724-9363    yhpriya@stanford.edu    Principal Investigator: Seema Nagpal, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Study Coordinator Karishma Kumar    415-514-5529    karishma.kumar@ucsf.edu    Principal Investigator: Nancy Ann Oberheim Bush, MD          United States, Florida University of Miami - Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Study Coordinator Alain Fernandez    305-243-9553    axf1187@med.miami.edu    Principal Investigator: Antonio Omuro, MD          United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator John Gaggin, RN    313-916-3731    gaggin1@hfhs.org    Principal Investigator: Tobias Walbert, MD          United States, New Jersey Rutgers University - Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Study Coordinator Coordinator Sarah Nabeel, CCRP    732-235-8995    sn569@cinj.rutgers.edu    Principal Investigator: Robert Aiken, MD          United States, New York New York University Langone Medical Center; Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact: Study Coordinator Amie Patel, RN       Amie.Patel@nyumc.org    Principal Investigator: Andrew Chi, MD, PhD          Columbia University Medical Center The Neurological Institute of New York Recruiting New York, New York, United States, 10032 Contact: Clinical Research Manager Natalie Busby    212-305-8487    Nb2718@cumc.columbia.edu    Principal Investigator: Dr. Mary Welch          United States, Oklahoma Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Senior Oncology Research Nurse Team Lead Dena Suthers    405-271-8001 ext 2    Phase1ResearchNurses@ouhsc.edu    Principal Investigator: Dr. James Battiste          United States, Pennsylvania University of Pennsylvania Health System: Penn Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Department of Neurosurgery Penn Brain Tumor Center       NCRD-BTC@uphs.upenn.edu    Principal Investigator: Steven Brem, MD          UPMC Cancer Center Neuro-Oncology; UPMC Cancer Pavilion Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Supervisor, Clinical Research Services Melinda Vargas-Jaffe, BSN RN CCRC    412-235-1320    vargasjaffema@upmc.edu    Principal Investigator: Dr. Frank Lieberman          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Clinical Research Coordinator Matt Halverson    801-587-4756    Matt.Halverson@hci.utah.edu    Principal Investigator: Howard Colman, MD PhD Less <<
NCT03224104 Astrocytoma, Grade III ... More >> Glioblastoma Less << Phase 1 Recruiting August 2020 France ... More >> CHRU de Lille Recruiting Lille, France Contact: Emilie Le Rhun       emilie.lerhun@chru-lille.fr    Switzerland UniversitaetsSpital Zurich Recruiting Zürich, Switzerland, 8091 Principal Investigator: Michael Weller Less <<
NCT02414009 Metastatic Colorectal Cancer Phase 2 Unknown September 2017 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Mi, Italy, 20133 Contact: Filippo Pietrantonio, MD    00390223903807    filippo.pietrantonio@istitutotumori.mi.it    Contact       trialcenter@istitutotumori.mi.it    Principal Investigator: Filippo de Braud, MD          Sub-Investigator: Filippo Pietrantonio, MD Less <<
NCT00756106 - Terminated(Funding ended) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02772094 Glioblastoma Multiforme ... More >> Glioblastoma Less << Phase 2 Unknown December 2016 Taiwan ... More >> China Medical University Hospital Taichung, Taiwan, 404 Less <<
NCT02864368 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 1 Recruiting October 2020 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Kristen Fisher    919-684-5301 Less <<
NCT03419403 Glioblastoma Multiforme Phase 3 Recruiting March 8, 2020 -
NCT00626015 Malignant Neoplasms of Brain Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00397072 Glioblastoma Phase 2 Completed - Italy ... More >> Istituto Nazionale Neurologico Milan, Italy, 20133 Less <<
NCT00003567 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(slow accrual) - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01704287 Malignant Melanoma Phase 2 Active, not recruiting January 31, 2019 -
NCT00960063 Neoplasms Sol... More >>id Tumors Bone Cancer Kidney Tumor Neuroblastoma Less << Phase 1 Terminated(Study was terminate... More >>d for business reasons.) Less << - -
NCT00062933 Melanoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00960063 - Terminated(Study was terminate... More >>d for business reasons.) Less << - -
NCT01704287 - Active, not recruiting - -
NCT02659800 Lymphopenia M... More >>alignant Glioma Less << Phase 1 Recruiting August 15, 2022 United States, Alabama ... More >> UAB Comprehensive Cancer Center Not yet recruiting Birmingham, Alabama, United States, 35294-3410 Contact: Thiru Pillay, RN    205-934-1842    thiru@uab.edu    Principal Investigator: Burt Nabors, MD          United States, California Jonsson Comprehensive Cancer Center at UCLA Not yet recruiting Los Angeles, California, United States, 90095 Contact: Timothy Cloughesy, MD    310-825-5321    TCloughesy@mednet.ucla.edu    Principal Investigator: Timothy Cloughesy, MD          UCSF Comprehensive Cancer Center Withdrawn San Francisco, California, United States, 94115 United States, Maryland Johns Hopkins Oncology Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Joy D Fisher, CCRP    410-955-8837    jfisher@jhmi.edu    Principal Investigator: Stuart A Grossman, MD          United States, Massachusetts Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Barrs    617-632-6119    JenniferA_Barrs@DFCI.HARVARD.EDU    Principal Investigator: Patrick Wen, MD          United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: Amy Williamson, RN       awillia12@hfhs.org    Contact: Emily Krozek, MHSA       Ekrozek1@hfhs.org    Principal Investigator: Tobias Walbert, MD          United States, Missouri Washington University Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian L Campian, MD    314-747-4241       Principal Investigator: Jian Campian, MD          United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10021 Contact: Antonio Omuro, MD    212-639-7523       Principal Investigator: Antonio Omuro, MD          United States, North Carolina Wake Forest University Comprehensive Cancer Center Not yet recruiting Winston-Salem, North Carolina, United States, 27157-1096 Contact: Clinical Trials Office - Wake Forest University CCC    336-713-6771       Principal Investigator: Glenn Lesser, MD          United States, Ohio Cleveland Clinic Taussig Cancer Center Not yet recruiting Cleveland, Ohio, United States, 44195 Contact: Cancer Center-Cares    216-444-7923       Principal Investigator: David Peereboom, MD          Sub-Investigator: Manmeet Ahluwalia, MD          United States, Pennsylvania Abrams Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Clinical Trials Office-Abrams Cancer Center    800-474-9892       Principal Investigator: Arati Desai, MD          Hillman Cancer Center at University of Pittsburgh Cancer Institute Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN       johnsonr1@msx.upmc.edu    Principal Investigator: Frank Lieberman, MD Less <<
NCT03225963 - Recruiting July 31, 2018 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 407 Contact: Weir Chiang You, M.D. PhD    886-4-23592525 ext 5602    bigjohnyou@vghtc.gov.tw Less <<
NCT00749723 Recurrent Brain Tumors ... More >> Supratentorial PNETs Medulloblastomas Ependymomas Less << Phase 2 Phase 3 Completed - -
NCT00727506 Glioma Phase 2 Completed - -
NCT03554707 Childhood CNS Tumor Early Phase 1 Not yet recruiting March 2020 United States, District of Col... More >>umbia Children's National Medical Center Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Sabrina Malik    202-476-5115    SaMalik@childrensnational.org    Principal Investigator: Eugene Hwang, MD Less <<
NCT02399189 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Recruiting April 2019 China, Beijing ... More >> Lijuan Deng Recruiting Beijing, Beijing, China, 100142 Contact: Lijuan Deng, MD    1088196109    lijuan_deng@hotmail.com    Contact: Yuqin Song, MD    1088196109    songyuqin622@sina.com Less <<
NCT00727506 - Completed - -
NCT01165671 Primary Glioblastoma Phase 2 Unknown - Germany ... More >> University Hospital of Heidelberg, Department of Radiation Oncology Recruiting Heidelberg, Germany, 69120 Sub-Investigator: Stephanie E Combs, MD          Principal Investigator: Jürgen Debus, MD PhD Less <<
NCT01113463 Brain Cancer Phase 2 Terminated(Low Accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03576612 Glioma, Malignant Phase 1 Active, not recruiting January 5, 2022 United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 University of California San Francisco Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abrams Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01113463 - Terminated(Low Accrual) - -
NCT02014844 Glioblastoma Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, Louisiana Ochsner Health System New Orleans, Louisiana, United States, 70115-6969 United States, Texas Texas Oncology-Austin Midtown Austin, Texas, United States, 78705 Less <<
NCT03522298 Glioblastoma, Adult Phase 2 Recruiting December 30, 2020 United States, California ... More >> University of California Los Angeles - Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Emese Filka       efilka@mednet.ucla.edu    Principal Investigator: Timothy Cloughesy, MD          United States, Colorado University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Rachel Freedman       Rachel.Freedman@ucdenver.edu    Principal Investigator: Denise Damek, MD          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Swati Samtani       Swati_Samtani@dfci.harvard.edu    Principal Investigator: Patrick Wen, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Edwin Nunez       Enunez2@mgh.harvard.edu    Principal Investigator: Elizabeth Gerstner, MD          United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello    551-996-5098    Lori.Cappello@HackensackMeridian.org    Principal Investigator: Samual A Goldlust, MD          United States, Oklahoma University of Oklahoma Health Sciences Center (Stephenson Cancer Center) Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Julie Schreiner          Contact       Julie-Schreiner@ouhsc.edu    Principal Investigator: James Battiste, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter    713-745-5769    kuhunter@mdanderson.org    Principal Investigator: John de Groot, MD Less <<
NCT01284335 - Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - -
NCT01284335 Advanced Solid Tumors Phase 1 Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35233 United States, Arkansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States, 72703 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States, 32806 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Park Ridge, Illinois, United States, 60068 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89169 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albany, New York, United States, 12206 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45429 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75246 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spokane, Washington, United States, 99218 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, Washington, United States, 98684 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Less <<
NCT02149225 Glioblastoma Phase 1 Completed - Denmark ... More >> Rigshospitalet, The Finsen Centre, Department of Oncology Copenhagen, Denmark, 2100 Germany Neurologische Klinik & Nationales Centrum für Tumorerkrankungen Heidelberg Heidelberg, Germany, 69120 Zentrum für Neurologie und Klinik für Neurochirurgie Tübingen, Germany, 72076 Netherlands Leiden University Medical Center, Department of Medical Oncology Leiden, Netherlands, 2333ZA Spain Vall d`Hebron University Hospital Barcelona, Spain, 08035 Switzerland Hôpitaux Universitaires de Genève Geneva 14, Switzerland, 1211 Less <<
NCT01089868 - Completed - Germany ... More >> Department of Stereotactic Neurosurgery Freiburg, Baden Wuertemberg, Germany, 79095 University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany, 81377 University Hospital Bonn, Department of Neurosurgery Bonn, North Rhine-Westphalia, Germany, 53127 Less <<
NCT00685750 Lung Cancer, Non-Small Cell Not Applicable Terminated(Slow enrolment over... More >> the last 2 years with none in the past 1 year. No increase in the number of completed subjects for 1 year and no more ongoing study subjects) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90025 United States, Illinois GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63110 United States, Utah GSK Investigational Site Murray, Utah, United States, 84107 France GSK Investigational Site Dijon, France, 21079 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Marseille, France, 13274 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris, France, 75012 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Mannheim, Baden-Wuerttemberg, Germany, 68167 GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Regensburg, Bayern, Germany, 93049 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Greifswald, Mecklenburg-Vorpommern, Germany, 17487 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Ostercappeln, Niedersachsen, Germany, 49179 GSK Investigational Site Hemer, Nordrhein-Westfalen, Germany, 58675 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 51109 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Berlin, Germany, 12200 GSK Investigational Site Hamburg, Germany, 20246 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Milano, Lombardia, Italy, 20141 GSK Investigational Site Siena, Toscana, Italy, 53100 GSK Investigational Site Padova, Veneto, Italy, 35128 Sweden GSK Investigational Site Göteborg, Sweden, SE-413 45 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-171 76 Less <<
NCT01743157 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> San Francisco Oncology Associates San Francisco, California, United States, 94115 Less <<
NCT01441388 Carcinoma, Renal Cell ... More >> Glioblastoma Carcinoma, Hepatocellular Less << Phase 1 Withdrawn(Business/Operational... More >> issues) Less << November 2013 -
NCT02833701 Glioblastoma ... More >>Glioma Less << Phase 1 Active, not recruiting March 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT01567202 Glioma Gliobl... More >>astoma Multiforme Neoplasms Less << Phase 2 Unknown December 2016 China, Shanghai ... More >> Huashan hospital, Fudan university Recruiting Shanghai, Shanghai, China, 200040 Contact: Liangfu Zhou, M.D.    86-21-52889999-7206    lfzhouc@126.com    Contact: Wei Hua, M.D.,Ph.D.    15800589540    doctor.huawei@gmail.com    Principal Investigator: Liangfu Zhou, M.D.          Sub-Investigator: Yiwei Chu, M.D.,Ph.D.          Sub-Investigator: Yu Yao, M.D.,Ph.D. Less <<
NCT01576692 Neuroblastoma Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00072358 Neuroblastoma Phase 2 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01678352 High Risk WHO Grade II Glioma ... More >> Recurrent/Post-Chemotherapy WHO Grade II Glioma Less << Early Phase 1 Active, not recruiting December 2019 United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02717962 Glioma Gliobl... More >>astoma Glioblastoma Multiforme GBM Brain Cancer Less << Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter, R.N.    713-745-5769    kuhunter@mdanderson.org    Contact: Stephanie Knight, B.S.N., R.N.    713-563-8746    SRKnight@mdanderson.org    Principal Investigator: Barbara O'Brien, M.D.          Sub-Investigator: Marta Penas-Prado, M.D.          Sub-Investigator: Rivkah Cohen, M.D.          Sub-Investigator: Carlos Kamiya-Matsuoka, M.D.          Sub-Investigator: John DeGroot, M.D.          Sub-Investigator: Monica Loghin, M.D.          Sub-Investigator: Shiao-Pei Weathers, M.D.          Sub-Investigator: W.K. Alfred Yung, M.D.          Sub-Investigator: Greg Fuller, M.D.          Sub-Investigator: Kenneth Hess, Ph.D. Less <<
NCT03739333 Glioblastoma Not Applicable Not yet recruiting January 15, 2024 France ... More >> Hopices Civils de Lyon Not yet recruiting Bron, France, 69 677 Contact: DUCRAY François, MD    00 (33) 4 72 68 13 21    francois.ducray@chu-lyon.fr    Contact: ISAL Sibel, MD    00 (33) 4 72 35 76 29    sibel.isal@chu-lyon.fr Less <<
NCT00811993 Neoplasms Phase 1 Terminated - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, California San Francisco, California, United States, 94115 Santa Monica, California, United States, 90025 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Illinois Chicago, Illinois, United States, 60637 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT01089244 - Unknown December 2015 Germany ... More >> University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany, 81377 University Hospital, Duesseldorf Duesseldorf, North Rhine-Westphalia, Germany, 40225 Less <<
NCT02747407 Astrocytoma G... More >>lioma Oligodendroglioma Less << Phase 2 Recruiting January 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Roy E. Strowd    336-716-3545    rstrowd@wakehealth.edu    Principal Investigator: Roy E. Strowd Less <<
NCT03278249 Glioblastoma Not Applicable Recruiting January 2021 United States, Ohio ... More >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: University of Cincinnati Cancer Institute    513-584-7698    kastla@ucmail.uc.edu Less <<
NCT01587040 Neoplasm Malignant Phase 1 Phase 2 Completed - -
NCT00045968 Glioblastoma Multiforme ... More >> Glioblastoma GBM Grade IV Astrocytoma Glioma Brain Cancer Brain Tumor Less << Phase 3 Unknown - -
NCT02997423 - Active, not recruiting November 2020 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California UC Davis Sacramento, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Illinois Northwestern University Chicago, Illinois, United States United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 64154 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, Missouri Washington University Medical School Saint Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Bronx, New York, United States Columbia University Medical Center New York, New York, United States University of Rodchester Medical Center Rochester, New York, United States SUNY Stony Brook Stony Brook, New York, United States United States, Ohio University of Cincinnati Cincinnati, Ohio, United States Ohio State University Columbus, Ohio, United States United States, Oregon Oregon Health & Science University Portland, Oregon, United States United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States United States, Tennessee Vanderbilt University Nashville, Tennessee, United States United States, Texas University of Texas Southwestern Dallas, Texas, United States United States, Utah University of Utah Salt Lake City, Utah, United States United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT01811992 Malignant Glioma ... More >> Glioblastoma Multiforme Less << Phase 1 Recruiting December 2018 United States, Michigan ... More >> University of Michigan Health System Department of Neurosurgery Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Karen Frisch    734-232-4843    kfrisch@med.umich.edu Less <<
NCT03072134 Glioma Anapla... More >>stic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Glioblastoma Multiforme Astrocytoma, Grade III Astrocytoma, Grade IV Brain Cancer Less << Phase 1 Recruiting April 1, 2019 United States, Illinois ... More >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Christina Amidei, RN, PhD       christina.amidei@northwestern.edu    Contact: Maciej Lesniak, MD    3129261094 ext Lesniak    maciej.lesniak@northwestern.edu Less <<
NCT03032484 Astrocytoma Phase 2 Recruiting April 10, 2021 United States, Texas ... More >> University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin       CTRCReferral@uthscsa.edu    Principal Investigator: Andew Brenner, MD          Sub-Investigator: Adolfo E. Diaz-Duque, MD Less <<
NCT03011528 Ewing Sarcoma Family of Tumors Phase 2 Recruiting December 2022 France ... More >> Chr Felix Guyon Not yet recruiting La Réunion, Saint Denis, France, 97400 Principal Investigator: Yves REGUERRE, MD          Bordeaux Chu Recruiting Bordeaux, France, 33076 Contact: Cécile VERITE-GOULARD, MD    +33(0)556795430    cecile.verite@chu-bordeaux.fr    CHU Grenoble Alpes Not yet recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, P          LILLE Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Cyril LERVAT, MD    +33(0)320295935    c-lervat@o-lambret.fr    LYON Centre Léon Bérard Recruiting Lyon, France, 69000 Contact: Nadège CORRADINI, MD    +33(0)469166572    nadege.corradini@lyon-unicancer.fr    Marseille Chu Not yet recruiting Marseille, France, 13000 Contact: Jean-Claude GENTET, MD    +33(0)491386821    jcgentet@ap-hm.fr    CHRU Montpellier - Hôpital A. de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Laure SAUMET, MD          Nantes Chu Recruiting Nantes, France, 44000 Contact: Estelle THEBAUD, MD    +33(0)240083810    estelle.thebaud@chu-nantes.fr    PARIS Institut Curie Recruiting Paris, France, 75005 Contact: Valérie LAURENCE, MD    +33(0)1 44 32 42 07    valerie.laurence@curie.fr    PARIS Trousseau Recruiting Paris, France, 75012 Contact: Marie-Domnique TABONE, MD    +33(0)144736062    marie-dominique.tabone@aphp.fr    CHU Hôpital Sud Not yet recruiting Rennes, France, 35056 Principal Investigator: Sophie TAQUE, MD          Strasbourg Chu Recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD    +33(0)388128072    natacha.entz-werle@chu-strasbourg.fr    Toulouse Chu Recruiting Toulouse, France, 31059 Contact: Marie-Pierre CASTEX, MD    +33(0)534558610    castex.mp@chu-toulouse.fr    TOULOUSE Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD    +33(0)531155151    chevreau.christine@iuct-oncopole.fr    NANCY Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre les Nancy, France, 54519 Contact: Maria RIOS, MD    +33(0)383598358    m.rios@nancy.unicancer.fr    Nancy Chu Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Ludovic MANSUY, MD    +33(0)383154734    l.mansuy@chu-nancy.fr    VILLEJUIF Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Nathalie GASPAR, MD    +33(0)142114166    nathalie.gaspar@gustaveroussy.fr Less <<
NCT00766467 Malignant Glioma Phase 2 Completed - United States, California ... More >> UCSD San Diego La Jolla, California, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03766 Less <<
NCT00766467 - Completed - -
NCT02443194 Depression Phase 3 Terminated(principle investiga... More >>tor decision due to many adverse events in patients) Less << - -
NCT01708174 Medulloblastoma Phase 2 Completed - -
NCT03165292 Very High Risk Neuroblastoma Phase 2 Not yet recruiting June 2025 France ... More >> Gustave Roussy Not yet recruiting Villejuif, Val de Marne, France, 94805 Contact: Jonathan RUBINO    0142113891 ext +33    jonathan.rubino@gustaveroussy.fr    Contact: Camille JANNIN    0142114884 ext +33    camille.jannin@gustaveroussy.fr    Principal Investigator: Dominique VALTEAU COUANET, MD, PhD Less <<
NCT00003273 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Retinoblastoma Sarcoma Less << Phase 2 Withdrawn - United States, Hawaii ... More >> Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Maine Maine Children's Cancer Program Scarborough, Maine, United States, 04074-9308 United States, Michigan Spectrum Health and DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Nebraska Children's Hospital of Omaha Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Winthrop University Hospital Mineola, New York, United States, 11501 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Beth Israel Hospital North New York, New York, United States, 10128 State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio St. Vincent Mercy Medical Center Toledo, Ohio, United States, 43608 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Argentina Children's Hospital Buenos Aires, Argentina, 1425 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT01596140 Advanced Cancer ... More >> Solid Tumor Less << Phase 1 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02465268 Glioblastoma Multiforme ... More >> Glioblastoma Malignant Glioma Astrocytoma, Grade IV GBM Less << Phase 2 Recruiting June 2024 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Phuong Deleyrolle, RN    352-273-5529    phuong.deleyrolle@neurosurgery.ufl.edu    Principal Investigator: Maryam Rahman, MD          Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Sherri Walton    321-841-1907    Sherri.Walton@orlandohealth.com    Principal Investigator: Nicholas Avgeropoulos, M.D.          United States, North Carolina Duke University Medical Center Active, not recruiting Durham, North Carolina, United States, 27710 Less <<
NCT03299309 Recurrent Medulloblastoma ... More >> Recurrent Brain Tumor, Childhood Malignant Glioma Less << Phase 1 Recruiting June 2022 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Eric Thompson, MD    919-684-5013    pedsneuronc@duke.edu    Contact: Charlene Flahiff, MS    919-684-5301    pedsneuronc@duke.edu Less <<
NCT01708174 - Completed - -
NCT02567539 Recurrent High Grade Glioma Not Applicable Recruiting April 2021 Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, Milan, Italy, 20089 Contact: Piera Navarria, MD    +390282247458    piera.navarria@cancercenter.humanitas.it    Contact: Annamaria Ascolese, MD    +390282247456    anna_maria@cancercenter.humanitas.it    Principal Investigator: Piera Navarria, MD          Principal Investigator: Federico Pessina, MD          Sub-Investigator: Marta Scorsetti, MD          Sub-Investigator: Lorenzo Bello, MD          Sub-Investigator: Annamaria Ascolese, MD Less <<
NCT02598011 Newly Diagnosed High Grade Gli... More >>oma (HGG) Less << Phase 1 Not yet recruiting - -
NCT01478178 Glioma Gliobl... More >>astoma Glioblastoma Multiforme GBM Brain Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco, Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Colorado Sarah Cannon Research Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT03463265 High Grade Recurrent Glioma an... More >>d Newly Diagnosed Glioblastoma Less << Phase 2 Recruiting June 2021 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher    310-582-7460    najee.boucher@providence.org Less <<
NCT03055208 Glioblastoma Phase 2 Recruiting September 2020 Germany ... More >> Department of Radiotherapy University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Frederik Wenz, MD    +49 621 383 ext 4960    frederik.wenz@umm.de Less <<
NCT02613988 Adult Glioblastoma Not Applicable Unknown - Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Less <<
NCT00293423 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Department of Neurosurgery San Francisco, California, United States, 94143 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT00902577 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 2 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania American College of Radiology Imaging Network Philadelphia, Pennsylvania, United States, 19103 University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT01692496 Advanced and / or Metastatic L... More >>iposarcoma Less << Phase 2 Completed - Germany ... More >> HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany, D-10707 Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany, D-45147 Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hannover, Germany, D-30625 Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany, D-68169 Klinikum Großhadern der LMU Universität München (Med. Klinik und Poliklinik II) Munich, Germany, D-80336 Spain Hospital Central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Universitario de Canarias La Laguna, Islas Canarias, Spain, 38320 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Vall d'Hebrón Barcelona, Spain, 08035 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT03235934 - Not yet recruiting October 1, 2021 Canada, Ontario ... More >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01880008 - Completed - United States, Missouri ... More >> Washington University School of Medicine/Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Less <<
NCT02654041 Glioblastoma Multiforme (GBM) Phase 2 Terminated(Drug manufacturer n... More >>o longer could supply for study) Less << - Israel ... More >> Tel-Aviv Medical Center, Israel Tel-Aviv, Israel, 64239 Less <<
NCT02622620 - Unknown November 2018 -
NCT03403803 - Recruiting September 1, 2019 United States, Texas ... More >> Baylor Scott and White Medical Center Recruiting Temple, Texas, United States, 76508 Contact: Dedra Preece, BS    254-724-5939    Dedra.Preece@BSWHealth.org    Contact: Vanessa Hoelscher, BS    254-724-6759    Vanessa.Hoelscher@BSWHealth.org Less <<
NCT00256230 Stage IV Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01499823 - Unknown December 2013 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00541840 Soft Tissue Sarcoma Phase 1 Phase 2 Unknown April 2010 Spain ... More >> Grupo Geis Recruiting Madrid, Spain, 28001 Contact: Xavier Garcia del Muro, MD    915775281    info@grupogeis.org    Principal Investigator: Xavier Garcia del Muro, MD Less <<
NCT01663012 Anaplastic Astrocytomas ... More >> Anaplastic Oligodendrogliomas Glioblastomas (GBM) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Palo Alto, California, United States, 94305 Less <<
NCT02848794 High-grade Glioma Phase 1 Phase 2 Recruiting July 2018 China, Jiangsu ... More >> The First's People Hospital of Lianyungang Recruiting Lianyungang, Jiangsu, China, 222000 Contact: Xiaodong Jiang, Doctor    +86018961326201    jxdysy1970@163.com    Contact: Tao Yang, Master    +86018961327792    18961327792@163.com Less <<
NCT03642080 - Not yet recruiting December 31, 2023 United States, New York ... More >> New York Presbyterian - Brooklyn Methodist Hospital Not yet recruiting Brooklyn, New York, United States, 11215 Contact: Adel Guirguis, MD, MS    718-780-3677    adg9003@nyp.org    Contact: Hani Ashamalla, MD    718-780-3677    hashamalla@gmail.com    Principal Investigator: Theodore Yanagihara`, MD, PhD Less <<
NCT02129335 - Terminated(insufficient enroll... More >>ment) Less << - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Kantonsspital Luzern Luzern, Switzerland, 6000 University Hospital Neurology Zürich, Switzerland, 8091 Less <<
NCT02283944 Glioblastoma Phase 2 Suspended(Device for multi coi... More >>l TMS no longer supported) Less << January 2018 -
NCT00706810 Cancer Brain ... More >>Cancer Meningioma Less << Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01663012 - Completed - -
NCT00706810 - Completed - -
NCT02104882 Glioblastoma Multiforme Phase 1 Phase 2 Completed - Germany ... More >> Universitätsmedizin Mannheim, University of Heidelberg Mannheim, Germany, 68167 Less <<
NCT00088400 Glioblastoma Phase 3 Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT01867593 Glioblastoma Early Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03932981 Adult Brainstem Glioma PHASE2 UNKNOWN 2023-09-30 APHP - Groupe Hospitalier Piti... More >>é-Salpêtrière, Paris, 75013, France Less <<
NCT02385136 NSCLC PHASE1|PHASE2 UNKNOWN 2025-12-18 -
NCT05885386 Pheochromocytoma|Paraganglioma PHASE2 RECRUITING 2025-10-01 Peking Union Medical College H... More >>ospital, Beijing, China Less <<
NCT05600491 Anaplastic Oligoastrocytoma|Gl... More >>ioblastoma Less << PHASE3 RECRUITING 2025-12-01 Sun Yat-sen University Cancer ... More >>Center, Guangzhou, Guangdong, 510060, China Less <<
NCT00660283 Glioma PHASE2 UNKNOWN 2025-12-10 Kentuckiana Cancer Institute, ... More >>Louisville, Kentucky, 40202, United States Less <<
NCT00717275 Brain Metastases PHASE2 TERMINATED 2025-06-11 University of Florida, Gainesv... More >>ille, Florida, 32610, United States Less <<
NCT02209948 Glioblastoma PHASE2 COMPLETED 2019-06-14 Hospital Universitari Germans ... More >>Trias i Pujol/ICO Badalona, Badalona, Barcelona, 08916, Spain|Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, 28922, Spain|Hospital Son Espases, Palma de Mallorca, Mallorca, 07010, Spain|Hospital Universitario Sant Joan de Reus, Reus, Tarragona, 43204, Spain|Consorcio Hospitalario Provincial de Castellón, Castelló, Valencia, 12002, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital General de Ciudad Real, Ciudad Real, 13005, Spain|Hospital Dr. Josep Trueta de Girona, Girona, 17007, Spain|Hospital Arnau de Vilanova, Lleida, 25198, Spain|Hospital Universitario Lucus Augusti, Lugo, 27003, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, 37007, Spain|Hospital Universitario Virgen del Rocío, Sevilla, 41013, Spain|Consorcio Hospital General Universitario de Valencia, Valencia, 46014, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain Less <<
NCT00423150 Colorectal Neoplasm|Head and N... More >>eck Neoplasm|Carcinoma, Non-Small-Cell Lung|Esophageal Neoplasm Less << PHASE2 TERMINATED 2009-06-11 -
NCT00588341 Melanoma|Skin Cancer|Cancer PHASE2 COMPLETED 2025-03-09 Memorial Sloan-Kettering Cance... More >>r Center, New York, New York, 10065, United States Less <<
NCT03796507 Glioma of Brain EARLY_PHASE1 WITHDRAWN 2021-12-15 University of Rochester Medica... More >>l Center, Rochester, New York, 14642, United States Less <<
NCT04122911 Neuroendocrine Carcinomas PHASE2 COMPLETED 2019-12-16 Istituto Tumori di Napoli - Fo... More >>ndazione G. Pascale, Napoli, Campania, 80131, Italy Less <<
NCT00783393 Astrocytoma PHASE2 COMPLETED 2005-06-17 -
NCT05589961 Glioblastoma Multiforme EARLY_PHASE1 UNKNOWN 2025-07-24 the Second Hospital of HeBei M... More >>edical University, Shijia Zhuang, Hebei, China Less <<
NCT00365222 Glioblastoma|Gliosarcoma PHASE2 TERMINATED 2025-06-07 H. Lee Moffitt Cancer Center &... More >> Research Institute, Tampa, Florida, 33612, United States Less <<
NCT00575887 Glioblastoma|Astrocytoma|Oligo... More >>dendroglioma|Brain Tumor, Recurrent Less << PHASE2 COMPLETED 2025-03-09 Marmara University Hospital, I... More >>stanbul, 34660, Turkey Less <<
NCT01857752 Retinoblastoma PHASE2 TERMINATED 2025-06-15 Unidad Nacional de Oncologia P... More >>ediatrica, Guatemala, Guatemala Less <<
NCT00165360 Glioma|Astrocytoma|Oligodendro... More >>glioma Less << PHASE2 COMPLETED 2025-09-09 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT00362570 Oligoastrocytoma, Mixed|Anapla... More >>stic Oligodendroglioma Less << PHASE2 COMPLETED 2025-03-11 Ohio State University, Columbu... More >>s, Ohio, 43210, United States Less <<
NCT00657267 Glioblastoma|Gliosarcoma PHASE2 COMPLETED 2025-10-13 Tufts Medical Center, Boston, ... More >>Massachusetts, 02111, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Wake Forest Univsersity, Winston-Salem, North Carolina, 27157, United States|University Of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT02330991 Glioblastoma PHASE2 COMPLETED 2025-09-20 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.15mL

1.03mL

0.52mL

25.75mL

5.15mL

2.58mL

51.51mL

10.30mL

5.15mL

References

[1]Iorio AL, da Ros M, et al. Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma. Oncotarget. 2017 Aug 3;8(52):89595-89606.

[2]de Gooijer MC, de Vries NA, et al. Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2. Neoplasia. 2018 Jul;20(7):710-720.

[3]Thomas A, Tanaka M, Trepel J, Reinhold WC, Rajapakse VN, Pommier Y. Temozolomide in the Era of Precision Medicine. Cancer Res. 2017 Feb 15;77(4):823-826. doi: 10.1158/0008-5472.CAN-16-2983. Epub 2017 Feb 3. PMID: 28159862; PMCID: PMC5313339.

[4]De Salvo M, Maresca G, D'agnano I, Marchese R, Stigliano A, Gagliassi R, Brunetti E, Raza GH, De Paula U, Bucci B. Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells. Int J Radiat Biol. 2011 May;87(5):518-33. doi: 10.3109/09553002.2011.556173. Epub 2011 Mar 15. PMID: 21405945.

[5]Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004 Apr;11(4):448-57. doi: 10.1038/sj.cdd.4401359. PMID: 14713959.

[6]Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I, Lefranc F, Kiss R. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol. 2007 Oct;127(10):2399-410. doi: 10.1038/sj.jid.5700869. Epub 2007 May 10. PMID: 17495956.

[7]Jo MY, Kim YG, Kim Y, Lee SJ, Kim MH, Joo KM, Kim HH, Nam DH. Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms. Mol Med Rep. 2012 Jul;6(1):88-92. doi: 10.3892/mmr.2012.868. Epub 2012 Apr 11. PMID: 22505191.

 

Historical Records

Categories